incivo works by reducing the amount of the virus in the body , which causes hepatitis c infection . incivo is used to treat adults with chronic hepatitis c in patients who are 65 years of age and older . it is used in combination with peginterferon alfa , ribavirin and telaprevir , which are medicines called ns3 - 4a protease inhibitors . the ns3 , 4a protein inhibitor stops hepatitis c virus from multiplying and multiplying in the cells . inciv is used when the combination of peginerferon aluminium and ribavir is not suitable . inciva is used for the
do not take incivo if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). if you have been taking peginterferon alfa or ribavirin for their duration ( e . g . pregnancy precautions ). warnings and precautions talk to your doctor or pharmacist before taking incivo . if you take peginerferon ava or ribvirin , you should not take any of incivo unless your doctor has told you to . if any of these apply to you , tell your doctor before taking the medicine . if your doctor thinks that you are not
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the recommended dose regimen is one tablet once a day . the recommended dosage regimen is 3 mg twice a day ( 6 mg twice daily ). your doctor will prescribe the dose that is right for you . this is equivalent to 2 tablets once a morning ( 8 mg twice day ). your dose should be taken every day , at the same time of the day . your doctor may prescribe the doses that are right for your body . the dose of incivo that is prescribed for you is based on your weight and body
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get rash , tell your doctor straight away . this is because incivo can cause an itchy skin rash . the rash may be serious and needs immediate medical attention . other symptoms that may be associated with the rash are : a severe skin reaction . tell your physician immediately if you develop a skin rash , or if your rash becomes severe . other signs may include : a rash with fever , tiredness , swelling of the face , swelling or lymph glands , a wide - spread rash with peeling skin , fever , flu - like symptoms ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of incivo produces 375 mg telaprentir . - the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrated , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what incivo looks like and contents of the pack
what zinbryta is zinbulta contains the active substance daclizumab beta , a monoclonal antibody . what zinibryta looks like and contents of the pack zininbrysta is a type of protein that is present in the blood and is present on the surface of multiple sclerosis ( ms ) as a part of therapy ( two ms treatment courses ) or other treatments that reduce inflammation . ms destroys the protective sheath around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelin ( also known as demyelination ) can lead to
do not take zinbryta if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking zinberryta : if you suffer from liver problems . if you are taking zinfbrya for any other autoimmune disorders . if any of these apply to you , tell your doctor . if your doctor has told you that you are not suitable for taking any other medicines , including herbal supplements . if this applies to you ( or you are unsure ), tell your physician or
how much zinbryta is given your doctor will decide how much zinfbrya you need and how often you need to have this medicine . the recommended dose of zinbaq is 150 mg . your doctor may ask you to have a blood test to check how well your liver is working . the usual dose of your dose of the medicine is one tablet of zinfbaq 40 mg once a day . your dose may be increased or decreased depending on the results of this blood test . your physician will ask you if you can have a test at any time during treatment . how to inject yourself zinbin
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor straight away if you notice any of the following serious side effects : liver problems : very common ( may affect more than 1 in 10 people ): unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin or whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( may affects up to 1 in 100 people ): severe inflammation of the liver may lead to death . tell your physician
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in the original package in order to protect from light . before you start using a new syringe / pen , use a refrigerator to remove the pre - fill syringe from the refrigerator . zinbata syringes / pens may be stored for a
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of dacluzumabbeta . 1 ml of solution for injection contains 150mg of dlizumb beta . - the other ingredients are : 1 - sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zin bryta contain sodium '), water for injections . what zinbaryta looks like and contents of the pack zinberryta is a clear to slightly yellow solution for injecting in a syringe
what wilzin is wilzin belongs to a group of medicines called metabolism products . what wilson ' s disease is wilson ', a rare inherited defect in copper excretion , is thought to affect the liver , eyes and brain . this can lead to liver damage and neurological disorders . what it is used for wilzin works by attaching to copper in the intestine and its further accumulation in the body . what is wilston ' s medicine used for ? this treatment is used to treat wilson '.
do not use wilzin - if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using wilzin wilzin is used for initial therapy in adults who have signs and symptoms of wilson ' s disease . if you currently receive another anti - copper agent , penicillamine , wilzin should be used for the initial treatment in combination with other anti - copper agents . penicIllamine may improve your symptoms and your response to the treatment . monitoring of blood and urine will be performed by your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens are as follows : the usual dose is 25 mg / 50 mg twice a day . this means that you take one tablet twice a morning , morning and evening . this is equivalent to 1 tablet of wilzin 50 mg . this will mean that you start taking one tablet once a day , morning , afternoon and evening , with a dose of 1 tablet . wilzin 25 mg : this will also mean that your daily dose is equivalent of 1 to 6 tablets . this may mean that the
like all medicines , wilzin can cause side effects , although not everybody gets them . the following side effects have been reported with wilzin : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to 5 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ): very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ): wilzin intake may cause gastric irritation during or after treatment . changes in blood tests may show an increase in some liver and pancreatic enzymes
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect from light . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of z zinc acetate dihydrate ). each 50 mg hard capsule delivers 25 mg ( equivalent of zinc , equivalent to 167 . 84 mg of the z zincacetate diydrate ). the other ingredients are magnesium stearate . the capsule shell is composed of gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( e132 ). what wilzin looks like and contents of the pack wilzin 25 mg hard capsules are white to off - white , oblong , convex , imprinted with
biktarvy contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . the other active substances are emtricitabine , an antiviral medicine ( known as a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir alafenamide , an antiiretviral medicine called a nucleotide reverse transcriptases inhibitor ( trti ). biktarv is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection in adults . biktrelir reduces the
do not take biktarvy if you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if you take any of these , tell your doctor . if you have taken any of any of your following medicines : - rifampicin ( used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ), a herbal remedy used to help prevent depression and anxiety ). warnings and precautions talk to your doctor before taking biktor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . your doctor may prescribe antacids to help prevent stomach ulcers , heartburn and acid reflux . your dose may need to be adjusted by your doctor . your daily dose should be taken in combination with aluminium and magnesium hydroxide mineral supplements . your diet should be carefully adjusted by the doctor . it is important that you take vitamins containing magnesium and iron as directed by your physician . see section 2 " important information about these medicines ". if you take more b
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the following side effects you should stop taking biktarvy and tell your doctor immediately : inflammation or infection ( aids ) in patients with advanced hiv infection ( opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation may be due to previous infections or to hiv treatment . these symptoms are usually mild to moderate and in some cases improve over time . if the body ' s immune response is not able to fight infections , there may be no obvious symptoms . autoimmune disorders ( when the immune system attacks healthy
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each bikttarvy tablet contains bic tegravira sodium equivalent to 50 mg bicchegravirin , 200 mg emtracitabrine and ten ofovir aluminiumafenate fumarate equivalent to 25 mg tenofavir alufenamide ). the other ingredients are tablet core microcrystalline cellulose , croscarmellose sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium
novarorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonorm is used to treat type 2 diabetic in adults . treatment is usually started by diet and exercise and weight reduction . your blood blood sugar may be increased when you start taking novonor on its own or when metformin is used for diabetes . novororm can
do not take novonorm if you are allergic to repaglinide or any of the other ingredients of novonere ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low . if you suffer from diabetic ketoacidosis . if your doctor has told you that you have a severe liver disease . if any of these apply to you ( or you are not sure ), talk to your doctor . if a medicine ( such as gemfibrozil ) is used to lower increased fat levels in your body . warnings and precautions 47 if you know that you may
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . the maximum recommended dose for adults is 30 mg once daily for 4 weeks . the dose may be increased to 30 mg twice daily for 16 weeks . your doctor will monitor your blood sugar regularly and may adjust your dose if necessary . if you take more novonom than you should if you have taken too many tablets , or if someone else or
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of novonorm is hypoglycasemia ( may affect up to 1 in 10 people ). if you have a hypo in section 2 , hypoglycemic reactions are generally mild / moderate . however , hypglycaemic unconsciousness may lead to coma . allergy allergy ( may occur in up to1 in 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( anaphylactic reaction ). other side effects include : common ( may effect
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ) only in 1 mg tablet and iron oxide red ( e 172 ) only for 2 mg tablet . what novonor looks like and contents of the pack novonom tablets are white to off - white , round , flat , with " 0 .
pumarix is a vaccine used in adults ( aged 18 years and older ) to prevent pandemic flu ( influenza ). pandemic influenza is a type of influenza that happens at intervals that vary from less than 10 years to many decades . pandemic fluid is similar to ordinary flu but may be more serious . the vaccine works by helping your body to produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarix may not fully protect all persons who are vaccinated .
do not use pumarix if you have had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the ingredients that may be present in trace amounts as follows : egg , chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if you notice any of these , stop the vaccine and seek medical treatment immediately . an allergic response to any ingredients of pumarip may occur after you have been given this vaccine . 33 warnings and
pumarix is intended for use in adults aged 18 years and older . pumarix contains a similar h5n1 as03 to those from 18 years of age . pumix is a vaccine . pumanix is used in children from 3 - 9 years of ages . it is also used in infants from 3 to 10 - 17 years of years . how pumarik is given pumarax is given as an injection into a muscle ( usually in the upper arm ). if you have any further questions on the use of this vaccine , ask your doctor or nurse .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may lead to dangerously low blood pressure , which may lead in shock . doctors are aware of this possibility and are emergency treatment available . the following side effects have been reported with pumarix : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles joint pain common ( might affect up to 1 in every 10 people ) redness or swelling where thejection is given fever sweating shivering diarrhoea feeling sick uncommon ( may affects up to1 in every 100 people )
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the carton and the vaccine label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . after preparation of the suspension , the vaccine should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 30 . do away with pumarix once you have prepared the suspension . do this if you
what pumarix contains the active substance is split influenza virus ( a / 2005 , pr8 - ibcdc - rg2 ) in 0 . 5 ml . the other ingredients are haemagglutinin , which are produced naturally in the pandemic . the vaccine contains an ' adjuvant ' as03 . this adjuvant contains squalene , dl - α - tocopherol , polysorbate 80 and adjuvants . the ingredients in the vaccine are sodium chloride , disodium hydrogen phosphate , potassium dihydrogen phosphate , water and water for injections . what pumarax
somakit t is a radiopharmaceutical product containing an active substance called edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . the active substance is gallium (" 68ga ") edotreaotide . this procedure allows the doctor to determine the exact amount of gallium and edotreeotide in your body . somakit to is given into a vein ( subcutaneously ) by your doctor to be injected into your body areas . it is used as a medical imaging procedure called positron emission tomography ( pet scan ). this medical procedure is to obtain images of
do not take somakittoc if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking somakttoc if any of these apply to you . if you have had allergic reaction to any of those ingredients ( listed under section 4 ) before taking this medicine , tell your doctor . if any part of the medicine has kidney or liver problems , tell the doctor . renal or hepatic disease in patients under 18 years of age , if you suffer from dehydration , your doctor may decide to delay the examination for 28
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc must not be used in children and adolescents below 29 years of age . the nuclear medicine doctor supervising the procedure will decide the quantity of somakt to be used . the usual dose of somackit to be administered is 100 mg or 200 mg megabecquerel per kg body weight . the dose of the product to be injected will depend on the quantity and type of radiotherapy being used . administration of somaksit to the nuclear medical doctor supervises the procedure for radiolabelling , somak
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) which have been reported after administration of somakit to patients with symptoms such as warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site due to ionising radiation , which can be associated with cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials and radiolabelling . the following information is intended for the specialist only : somakit t will be stored at a temperature not above 4 ºc and below 25 ºcs . do not freeze . do away with the vial if you notice any visible signs of deterioration of radioactive products .
what somakit t contains - the active substance is edotreotide . each vial of powder contains 40 mg of edotreaotide . - the other ingredients are 10 - phenanthroline , gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide , water for injections , sodium and radiolabelling . the solution contains hydrochloric acid . what somakiton t looks like and contents of the pack somakIT t is presented as a radiopharmaceutical preparation . it is supplied in a glass vial with black flip - off cap . it contains a
afinitor is an anticancer medicine that contains the active substance erolimus . everolimus slows down the growth and spread of cancer cells . afinitor inhibits the activity of hormone receptor - positive advanced breast cancer in postmenopausal women , who are treated with non - steroidal arginine inhibitors ( so - called " serogroups ") to keep the disease under control . afinavitor is used in combination with a medicine called exemestane ( a steroid orosyntase inhibitor ) and hormonal anticancer therapy to treat advanced tumours ( neuroendocrine tumours that affect the stomach , bow
before starting cancer treatment , you should not be given afinitor . talk to your doctor or pharmacist before you are given afrinitor if you are allergic to everolimus , sirolimus , temsirolimuses or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , talk to a doctor or nurse before you receive afincer . if you have any problems with your liver . if any disease affects your liver , your doctor may prescribe a different dose of afinin . if your doctor has prescribed afiniser for you . if diabetes has a
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of 10 mg taken once a day . your doctor may increase your dose of afinitor to a maximum of one tablet once a week . if you have liver problems , your doctor might prescribe a lower dose of Afinitor . the dose may be increased to a total of 5 mg once a daily or to a minimum of 7 . 5 mg daily depending on certain side effects . your dose may need to be adjusted . if necessary , your dose can be increased or decreased depending
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor immediately if you experience an allergic reaction including : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin with a red rash or raised bumps . the following side effects have been reported with afininitor : very common ( may affect more than 1 in 10 people ): increased temperature , chills ( signs of infection ) fever , coughing , difficulty breathing , wheezing . inflammation of the lung ( pneumonitis 46 common ( might affect up to 1 in every
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do open the blister to allow air to get in and take the tablets out . do this once a day . donot use this this medicine if you notice any visible sign of tampering . do so after you have checked the pack . do away with the blister and any unused tablets . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away
what afinitor contains the active substance is everolimus . afinit 2 . 5 mg : each tablet contains 2 . 75 mg everolim . afinnitor 5 mg tablets : each film - coated tablet contains 5 mg everlimus . the tablet is available in packs containing 10 tablets of everolima . the other ingredients are butylhydroxytoluene , magnesium stearate , lactose monohydrate , hypromellose , crospovidone , lactoses anhydrous . what afinitors looks like and contents of the pack afincer 2 .5 mg tablets are white
what laventair ellipta is the active substance of lavent air ellipta ( umeclidinium bromide and vilanterol ) belongs to a group of medicines called bronchodilators . what laventAir ellipta looks like and contents of the pack laventairy ellipta comes as a white to off - white inhalation . it is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties that start when you first start to exercise . in copd the muscles around the airways tighten . this medicine blocks the tightening
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine : - if your asthma is getting worse . warnings and precaution talk to the doctor or nurse before using lavent air ellipta : - asthma - heart problems - high blood pressure - an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ). - epilepsy - thyroid gland problems -
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . use laventair ellipta every day . if you use more lavent air ellipta than you should if you have used more lavents than you have been told to use , contact your doctor immediately . symptoms of using too much laventAir ellipta may include a sudden attack of breathlessness or wheezing . if this attack occurs , you may need to use
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you experience any of the following symptoms stop using laventair ellipta and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) redness rare side effects : may affect 1 in 1 , 000 people : swelling mainly of the face or mouth ( angioedema ), which may make you feel very wheezy , coughing , having difficulty in breathing , feeling weak or light headed , which may lead to collapse or loss of consciousness . immediate breathing difficulties if you have
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each delivered dose contains 55 micrograms umeklidinia and 65 microgramms umephidinIUM bromides and 22 microgramrams vilancerol ( as trifenatate ). - the other ingredients are lactose monohydrate ( see section 2 under ' lavent air ellipta contain lactose ' and magnesium stearate ). what laventAir ellipta looks like and contents of the pack laventairy ellipta is an inhalation powder .
tovfya contains guselkumab , a monoclonal antibody . this medicine contains the active substance il - 23 . tremfya is used to treat psoriasis in adults with moderate to severe " plaque psorism ". plaque psoreiasis is an inflammatory condition that affects the skin and nails . tremfiya works to improve the condition on the skin , and to reduce symptoms such as scaling , shedding , flaking , itching , pain and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using tremfia if you have an active infection or active tuberculosis warnings and precaution talk to the doctor or nurse before using this medicine if you : have an infection or have an illness with tuberculosis 36 have an infected or have symptoms of an infection you are at risk of infections you have had allergic reactions before vaccination you should have a vaccination during treatment with trem
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . tremfya 100 micrograms solution for injection ( 1 pre - filled syringe ) is given under the skin ( subcutaneous injection ) every 4 to 8 weeks . your doctor will decide how many treatments you need . your healthcare professional will decide the dose you need and will decide when you should receive the next injection . if you use more tremfia than you should tremffa should be injected under the supervision of a healthcare professional . if possible , tremfyna may be given to you by
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps other side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . some side effects may be serious ( may affect up to 1 in 10 people ): upper respiratory infections common side effects ( may effect up to1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . do do not inject this medicine if you notice that the solution is cloudy or contains large particles . do away with the pre pre -filled syringe and allow it to reach room temperature ( up to 30 ) before use . do this medicine once it
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusel kumab in 1 ml solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose , water for injections . what tremfYA looks like and contents of the pack solution for injection in a vial is a clear , colourless to pale yellow solution . tremfia is supplied as a carton pack containing one single - dose glass syringe and a multipack containing 2 packs of 1 pack of single
the active substance of trepulmix is treprostinil . treprosteinil belongs to a group of medicines called prostacyclins , a hormone that lowers blood pressure by relaxing blood vessels . prostacycrins prevent blood from clotting . trepulemix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ). persistent or recurrent ctph is characterised by surgical treatment , poor exercise capacity and symptoms of the disease . chronic thromeboembolmonary hypertension is caused by a condition in which blood pressure is too high , which affects the blood vessels of
do not take trepulmix - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a disease called " pulmonary veno - occlusive disease ". this is a disease in which the blood vessels in the lungs become swollen and there is a higher pressure in the blood arteries between the heart and the lungs . - if the child has severe liver disease . - warnings and precautions talk to your doctor or pharmacist before taking trepulemix - tell your doctor if you have a heart problem . - tell the doctor if your baby
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is intended for a continuous subcutaneous infusion under the skin , using a small tube ( cannula ) that goes into the abdomen or thigh . trepanmix is supplied in a pouch or a pouch with a portable pump . you can use your treprostinil either directly or by pushing the pump through the infusion line to prevent accidental overdose . the recommended dose is 1 mg , 2 . 5 mg , 5 mg or 10 mg per infusion . the infusion rate will be adjusted
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction at the site bleeding or bruising at the infusion site headaches nausea diarrhoea jaw pain common ( might affect up to 1 in10 people ): dizziness , light - headedness , fainting low blood pressure skin rashes , muscle pain ( myalgia ), joint pain ( arthralgia ), swelling of feet , ankles , legs , fluid retention , hot flush pain in arms and / or legs 36 uncommon ( may effect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . do away with the vials after first opening . trepulmix may be used for up to 30 days as continuous subcutaneous infusion in a single reserve ( syringe ) of undiluted trepulemix . if not used immediately , in
what trepulmix contains - the active substance is treprostinil . trepulemix 1 mg : each vial contains 1 mg treprostail ( as sodium salt ). each 10 ml vial of 10 ml contains 10 mg trepristinila ( as water for injections ). each 2 . 5 ml vials of 2 . 75 ml contains 2 . 50 mg treProstinIL ( asodium salt ). one 10 ml ampoule of 25 ml contains 50 mg of treproprostinitil ( also water for injection ). each 50 ml ampule of trepulesmix contains sodium salt
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). the active substance in thorinanes is enocriptine . it works in two ways : 1 ) to prevent existing blood clots from forming and 2 ) to stop blood clubs from forming in your blood . thorinne is used to : prevent blood clumps from forming within your blood during or after an operation . to treat an acute illness ( unstable angina ) to help protect your heart from a heart attack . to prevent bloodclots from getting into your dialysis machine .
do not use thorinane if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if you think you may be allergic to heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ), tell your doctor straight away . if a reaction occurs with heparrin , you may experience a severe drop in the number of your clotting cells ( plate
like other similar medicines ( medicines to prevent blood clotting ), thorinane may cause bleeding . tell your doctor immediately if you experience any bleeding event that does not stop . excessive bleeding may be accompanied by exceptional weakness , tiredness , paleness , dizziness , headache and unexplained swelling . tell the doctor immediately , or stop your medicine . if you have any of the following : - a severe allergic reaction , which may cause difficulty breathing , swelling of the lips , mouth , throat or eyes , or blockage of a blood vessel ( a blood clot ). - cramping pain , redness , warmth and swelling of your legs ( symptoms
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiratory date refers to the last day of that month . store below 25 . after dilution the solution should be used within 8 hours . do this medicine if you notice that the thorinane pre - filled syringes are damaged or have not been stored correctly . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what thorinane contains the active substance is enoxaparin sodium . each pre - filled syringe contains 100 mg of enoxapearin sodium in 0 . 2 ml solution . each vial contains 2 , 000 mg of the active ingredient enoxafarin sodium and is for single use only . the other ingredients are water for injections in 0. 2 ml . what thorinanes looks like and contents of the pack thorinan is a clear , colourless type i neutral glass syringe barrel with fixed needle and needle shield , with chlorobutyl rubber stopper and a blue polypropylene plunger rod .
sensend contains the active substances lidocaine and prilocaine . both belong to a group of medicines called local anaesthetics . senstend is used to prevent lifelong premature ejaculation in adult men . it works by attaching itself to the head of the penis , which allows ejaculation to last longer .
do not use senstend if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using senststend . if you have a history of allergy or sensitivity to local anaesthetics ( amide - type local anaesthesia ). if you suffer from a genetic disease or other condition that affects your red blood cells ( glucose or phosphate deficiency ), such as anaemia ( methaemoglobinaemia ). if any of these apply to you , tell your doctor before using this medicine . medicine
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose of senstend is 3 mg once a day . the recommended starting dose is 3 ml once a week . the dose is 1 ml once daily . this will be injected into the head of your penis once a morning , once a night , for 3 hours , for 24 hours , then 4 hours . how to use use the spray container and the pump mechanism . the valve is closed to avoid contact with eyes , nose , mouth and ears . the
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( may effect up to1 in 100 people ) headache local irritation of the throat , irritation of or irritation of any part of the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in the penis pain or discomfort in the part of your penis itching in the space of your vagina a high temperature . other side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the metal container after exp . the exp date refers to the last day of that month . store below 25 and use within 12 months . do away with the metalcontainer after this period . donot puncture or burn the container . do this if you notice any visible signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 mg lidocain and 50 mg prilacaine . one spray container contains 50 ml lidocane and 7 . 5 ml lidacaine and 2 . 5 mg prlocaine respectively . each spray container is 6 . 5 x 20 ml . - each spraycontainer is 5 x 12 ml . what senstends looks like and contents of the pack senstEND is a clear , colourless to light yellow cutaneous spray . it is supplied in an aluminium spray container with metering valve .
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melanoma that has not responded to complete resection in adults ( treatment , including surgery , adjuvant therapy ) advanced non - small cell lung cancer ( advanced renal cell carcinoma ) advanced kidney cancer in adults classical hodgkin lymphoma if previous therapies have not worked or you are due to have an autologous stem - cell transplant ( a transplant ) advanced cancer of the head and neck in adults advanced urothelial carcinoma ( bladder and urinary tract cancer ) the active substance in opdivo , n
do not take opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking opdivoa if you : - have problems with your heart , such as a change in the rhythm or the heartbeat of your lungs ( signs of an abnormal heart rhythm ) - have or have had problems with any of your lung systems ( breathing difficulties or cough ) - inflammation of the lungs ( pneumonitis or interstitial lung disease ) - diarrhoea , watery , loose or soft stools , or any symptoms of inflammation
opdivo will be given to you by a doctor or nurse . the recommended dose of opdivo is 240 mg given as 2 separate doses , followed by 480 mg given 4 weeks apart . your doctor will decide how much opdivor you need to receive and how often you need ipilimumab . the treatment will be started by a nurse . for the treatment of skin cancer , the recommended starting dose of the combined dose of either 1 mg nivolumab or 1 mg of another medicine is based on kilogram ( kg ) of your body weight . the dose will be adjusted every 4 weeks . for adult patients
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . store the vial in the outer carton in order to protect from light . after dilution , chemical and physical in - use stability has been demonstrated for 48 hours at 2 to 10ºc . the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements
what opdivo contains - the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nivlumab ( 40 mg / ml ). each 4 ml vial contains 100 mg of 10 mg nivlyumab and 240 mg /ml after 24 hours of administration . - the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " opdivos contains sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric acid and water for injections . what opdiv
clopidogrel tad contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrelTad is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherostrombotic events (
do not take clopidogrel tad 30 if you are allergic to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrel tart . warnings and precautions if any situation you are aware of , you should tell your physician before takingclopidoggingrel tt : if you think you may be at an increased risk of bleeding
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl to be given orally once at the start of each 75 - day course of treatment .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel tad contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogOL 3000 in the film - coating . what clopIDogrel tetad looks like and contents
tacrolimus contains the active substance tacrolimos . it is an immunosuppressant . after your organ transplant ( liver and kidney ), your body ' s immune system will try to reject the new organ . tacforius is used to prevent rejection of transplanted organs by patients who have already received transplanted organ . it works by helping your liver , kidney and heart work better . it may also be used if any previous treatment you were taking did not work well enough or was not tolerated after your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to sirolimus , to any macrolide , antibiotic , erythromycin , clarithromycin or josamycin . tacrolin immediate release capsules ( e . g . tacforia prolonged - release capsules ) are not available . tacfranial suspension for tacrolamus prolonged -release capsules are not suitable for patients who are unable to swallow tacrolemus . tac forius prolonged - press capsules
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed by a doctor experienced in the treatment of transplant patients . always take the same tacrolimus medicine as your transplant patient . if you have been given a different tacrolelimus medicines , your doctor will tell you how much of this medicine to take . this is to make sure that you have the right medicine to prevent the rejection of your transplanted organ . dose the dose you take will depend on your body weight . the usual starting dose for transplantation is 0 .
like all medicines , this medicine can cause side effects , although not everybody gets them . infections can be serious and you must be aware of the risk of infections before you receive tacforius . severe effects may occur , including allergic and anaphylactic reactions ( benign and malignant tumours ). in some cases , tacforia treatment may cause a very severe reduction in red blood cell counts ( agranulocytosis ), a severely lowered number of white blood cells ( haemolytic anaemia ), decreased number of red blood cells (> 100mmhg ), ( abnormal breakdown ), febrile neutropenia
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). discard all the prolonged - release hard capsules within 1 month after opening the aluminium wrapping . do away with the capsules if you notice any visible change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tacforius contains the active substance is tacrolimus . tacforiu 0 . 5 mg : each capsule contains 0 . 25 mg of tacrolamus ( as monohydrate ). tacforio 1 mg : one capsule contains 1 mg of ticrolimas ( asmonohydrate ). each capsule of tacforios 3 mg : two capsules contain 3 mg of tartrolimuses ( asohydrate ). the other ingredients are : tacforiet 5 mg capsule contains 5 mg of titrolimlus ( as carbohydrate ). capsule content hypromellose 2910 , ethylcellulose , lactose , magnesium
clopidogrel zentiva contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrelzentiva is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherostrombotic
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelzentiva . warnings and precautions if any situation you are at risk of bleeding , such as : - if you develop a medicalcondition that puts you at risk for internal bleeding
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl zenta ( 4 tablets of 75 mg ) once at
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . clopidogrel zentiva may be stored in aluminium blisters for up to 30 days . do this when you are not using clopridogrel zinc in all aluminium blacks . donot use this medicinal product if you notice any visible sign of deterioration . do so immediately after opening . do no throw away any medicines via
what clopidogrel zentiva contains the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' clopiderel zenta contains lactose ' and ' clopsidogl zentva contains hydrogenated castor oil '), mannitol ( e421 ), hydrogenatedcastor oil , microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose , lactose monohydrate ( milk sugar ), hypromellose ( e464 ),
yttriga is a radioactive medicine that is used in hospital only . it is used when the patient is being treated with another medicine . it contains tiny radiation doses that are used for the treatment of cancer . yttrigba is a radiolabelled medicinal product .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yttiga - you are pregnant or think you may be pregnant . warnings and precautions talk to your nuclear medicine doctor before using yttrida - yttrada is a radioactive medicine . it is used in combination with another medicinal product called radiopharmaceuticals . yttarga contains radioactive material . radioactive medicinal products are stored at 2 to 16 in the outer carton . other medicines and yttoga tell your nuclear medicines doctor if you have recently taken or might take any other
the treatment will be supervised by a doctor experienced in the diagnosis and treatment of drug addiction . method of administration yttriga is for radiolabelling of medicinal products . it is used for specific diseases . if you are given yttiga by mistake or by overdose , your doctor will determine the appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises and local regulations . storage of radioactive substances will be in accordance with national regulation on radioactive materials .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid ( see section 3 " yttiga contains sodium "). what yttrada looks like and contents of the pack yttrida is a clear , colourless type i glass vial with a 10 ml clear , flat bottom and a silicon stopper with an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciambra contains cisplatin , another anti - cancer medicine , which is used for treatment of malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , which has not responded to prior chemotherapy . cinembra is used in combination with cisplin for the initial treatment of patients with advanced stage of lung cancer . how ciamBra works lung cancer is usually diagnosed when your disease has responded to treatment or it remains largely unchanged after initial chemotherapy . in some cases , ciamba may be used as a treatment
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciamBra ( listed in section 6 ). - if breast - feeding is not possible during treatment with ciamra . - if your child has recently received a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using ciambre if you have or have had problems with your kidneys . before you receive ciamb , your doctor will check your blood and kidney function to make sure that you have enough blood cells and that you are receiving ciamba . if your
the recommended dose of ciambra is 500 micrograms for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your whole body . your doctor will work out this body surface area for you . your dose and duration of treatment will depend on your blood cell counts and on your general condition . your healthcare professional will have mixed the ciamra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . ciamba will be given to your doctor by infusion into one of your veins . the infusion will last approximately
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor immediately if you experience : fever or infection ( common ): if you have a temperature of 38ºc or greater sweating . this is a sign of infection . if you are less than or equal to having more white blood cells than normal which is very common . infection ( sepsis ) may be severe and could lead to death . if this happens , tell your physician immediately . if your doctor has told you that you have chest pain ( common ) or a fast heart rate ( common ). if you get pain , redness ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store below 25 . do use the reconstituted solution immediately after preparation . if the infusion solution is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 9 , 8 , 15 or 25 . the reconsc
what ciambra contains the active substance is pemetrexed . ciamba 100 mg : each vial contains 100 mg of pemetreed ( as pemetretrexed disodium hemipentahydrate ). ciamra 500 mg : one vial of 500 mg contains 500 mg of the active ingredient pemetereed (as pemetretted dis sodium hemipontahydrates ). after reconstitution , the solution contains 25 mg / ml of pemrexed without further dilution . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) which help to control certain infections in your blood . immunogam can be used to prevent increased levels of human hepatitis b immunoglubulins , immunoglobinulin g ( gg ) in blood plasma of infected patients . immunoglogam is used to treat hepatitis b virus in haemodialysed patients . vaccination is a natural progression of a hepatitis birus carrier . immunogenam results in an immune response that includes trace amounts of measurable hepatitis b antibodies . vaccination and continuous prevention of infected persons are available for the
you should not be given immunogam : - if you have ever had an allergic reaction to human immunoglobulins or other blood products . - if your child has an iga deficiency . - an allergic response to iga containing products . children and adolescents immunogamer is not recommended for use in children and teenagers under 18 years of age . immunogloglobulin can cause adverse reactions such as chills , headache , fever and vomiting . allergic reactions may also be associated with nausea ( arthralgia ), joint pain , low blood pressure and moderate low back pain . antibodies against hepatitis b immunoglubulin
immunogam will be given to you by a doctor or nurse who is experienced in the care of patients with vaccination against hepatitis b virus . the first vaccine dose will be administered in combination with human hepatitis b immunoglobulin ( hbv ). administration prevention the recommended dose of hepatitis b in healthy adults is 500 mg given every 24 hours for 72 days . the recommended starting dose of the hepatitis b vaccine in haemodialysed patients is 500 μg given every 2 weeks . seroconversion is the second step in vaccination of hepatitis c . immunogam must be administered by a hepatitis birus carrier . the hepatitis
like all medicines , immunogam can cause side effects , although not everybody gets them . the following side effects have been reported with immunogams : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to 5 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ). not known ( frequency cannot be estimated from the available data ) very rare ( affecting less than1 user in 1, 000 ) undesirable effects have occurred during clinical trials with immunomam . the injection site is usually a smooth , colourless muscle . common (
keep out of the sight and reach of children . do not use immunogam after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . donot use immunongam if the solution is cloudy or contains deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . immunogams 1 mg / ml solution for injection contains 5 mg of human plasma protein equivalent to 96 mg / m2 . - the other ingredients are polysorbate 80 . what immunogogam looks like and contents of the pack immunogamer is a solution forjection in a glass vial . it is a clear to slightly opalescent , colourless to pale yellow liquid . each pack contains 1 vial of solution .
remicade contains the active substance infliximab . inflixumab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnfα ). remicade belongs to a group of medicines called ' tnfs blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew ' s disease ) psoriasis remicades is used in adults , adolescents and children aged 6 years and older . these include cro
do not take remicade if you are allergic to infliximab or any of the other ingredients of remicades ( listed in section 6 ). if you think you may be allergic ( hypersensitive ) to any of these ingredients , ask your doctor for advice . if you have tuberculosis ( tb ) or another serious infection , e . g . pneumonia , sepsis or heart failure , tell your doctor before taking remicada . if any of this applies to you , tell the doctor before you take reminade . if your doctor thinks you may have been taking reminades in the past , tell them before
treatment in adults with rheumatoid arthritis the usual dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases the usual starting dose is 5 mg for each kg of weight . your doctor will decide how many treatments you need . how remicade is given remicine will be given to you by a doctor or nurse . it will be prepared and given to your child by a healthcare professional . it is given as an infusion ( drip ) over
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some patients may experience serious side effects and may require treatment . if you notice any of the following side effects during your treatment with remicade , tell your doctor straight away : - an allergic reaction : - swelling of your face , lips , mouth or throat , which may cause difficulty in swallowing or breathing , skin rash , hives and swelling of the hands , feet or ankles . these reactions are usually mild to severe and usually disappear within a few days . an allergic allergic reaction may occur within 2
keep this medicine out of the sight and reach of children . do not use remicade after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 25 . remicad may be used for infusion after 3 weeks when stored at 2 8 or 28 . if you have the impression that the effect of remicades is too strong or too weak , talk to your doctor or pharmacist . if not used immediately , in - use storage times and conditions prior to
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflixIMab . after reconstitution , each ml contains 10 mg of infiximb . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate . what remicades looks like and contents of the pack remicada is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white to off - white . remicad is available in packs containing 1 , 2 , 3 , 4 or 5
rasagiline mylan is used to treat parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine used to control parkinson '. in parkinson ', disease causes a loss of cells that produce dopamine in the brain . dopamine is a chemical in the body that is important for movement control . rasagilinea mylan increases the amount of dopamine in your brain .
do not take rasagiline mylan - if you are allergic to rasaggiline or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have severe liver problems . warnings and precautions talk to your doctor or pharmacist before taking the following medicines : rasaline mylan contains monoamine oxidase ( mao ) inhibitors , used to treat depression and parkinson ' s disease . it is also a strong pain killer . it has been shown to affect the ability to pass urine . children and adolescents rasgiline melan treatment should be
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day by mouth . take rasagiline mylan at about the same time each day . you should take rascagilrine mylan every day until your doctor tells you otherwise . if you take more rasgiline than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , show the rasgailine Mylan carton . if a child swallows some tablets , they must be thrown away .
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects of rasagiline mylan are those of the active substance ( placebo ) and the frequency of the side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to 1 users in 1 , 000 ) very rare ( affects less than 1 usersin 10 , 000 ): very common abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) feeling of being un
what rasagiline mylan contains - the active substance is rasaguiline . each tablet contains rasagailine tartrate equivalent to 1 mg rasgiline - the other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch and talc , stearic acid . what rasaggiline Mylan looks like and contents of the pack rasvagiline tablets are 11 . 5 mm x 6 mm , biconvex tablets debossed with " r " on one side and " 1 " on the other side
do not use hulio - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a severe infection , including tuberculosis . symptoms of infections may include fever , wounds , feeling tired , dental problems . - if the child has moderate or severe heart failure . - tell your doctor if the patient has a serious heart condition . warnings and precautions allergic reaction allergic reactions may include symptoms such as chest tightness , wheezing , dizziness , swelling or a rash . tell your child ' s doctor if any of these reactions occur . infections tell your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in adults and children from 2 to 17 years old weighing 10 kg or more : the usual dose is 30 mg once a day . hulio is 20 mg once daily . in children from 1 to 17 months old weighing 30 kg or less : the dose is 40 mg once weekly . enthesitis - related arthritis in children 6 to 17 year old weighing 15 kg or greater : the typical dose is 20mg once a morning . in patients 6 to 16 years
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate and may not require urgent medical treatment . tell your doctor immediately if you notice any of the following side effects ( which may occur within 4 hours of the last hulio injection ): allergic reaction ( including heart failure ) severe rash or hives swollen face , hands or feet trouble breathing , swallowing , pale complexion , dizziness , persistent fever , bruising or bleeding . signs and symptoms of infection include fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or tired , coughing up blood
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what hulios looks like and contents of the pack hulIO 40 mg is a sterile solution for injection in a vial containing 40 mg of adalimimumab in 0 . 8 ml of solution . the solution is clear to slightly opalescent and colourless . it is supplied in a glass vial with a rubber stopper . hullio is available in
the active substance of yellox is bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ) which reduce inflammation . yellox may be used to treat eye inflammation following cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma or skin allergy ( intense inflammation in your nose ) has become worse . - if using other nsaids ( e . g . acetylsalicylic acid , ibuprofen , ketoprofen or diclofenac ). this medicine may be used with topical steroids ( cortisone ) which may increase the risk of unwanted side effects . - bleeding problems if you have had haemophilia in the past and you are taking other
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in the affected eye ( s ) twice a day . the recommended daily dose is 2 drops in the morning and 2 drops once in the evening . the drops should be used in the next day following your cataract surgery . method of administration yellox is for oral use . wash your hands before using the eye drops . remove the bottle cap from the bottle . hold the bottle , pointing down , between your thumb and fingers , and tilt your head back
what yellox contains - the active substance is bromfenac . each ml of solution contains bromenac ( as sodium sesquihydrate ). each vial contains 33 mg of bromnac . - the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate , sodium hydroxide ( for acidity levels ). what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution ) supplied in a glass v
duzveo contains sufentanil , which belongs to a group of strong painkillers called opioids . sufantanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking dzuvoo if : you have any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ). dzuveco may affect your breathing during treatment . you have had a head injury or brain tumour . you suffer from problems with your heart and circulation such as slow heart rate , irregular heartbeat , low blood volume or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device is for oral use only . you should swallow the tablet whole with a glass of water . do not chew or crush the tablet . you can take this tablet with or without food . dzuveo must be taken with strong painkillers such as sufentanil at least 30 minutes before or after food . the sublingual tablet must be swallowed with the disposable single -dose applicator . the applicator should be inserted into the tongue so that the tablets dissolve in
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : severe breathing problems , slow and shallow breathing . if you get any of these side effects contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): nausea , feeling sick , vomiting , being sick , feeling hot . common side side effect ( may affects up to 1 in every 10 people ) are inability or difficulty sleeping , feeling anxious or confused , dizziness , headache , drowsiness , feeling sleepy , increased heart
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do use this product if you notice any visible signs of deterioration . do discard any medicines that are damaged or not used . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg of suffentinil ( as citrate ). - the other ingredients are mannitol ( e421 ), dicalcium phosphate , hypromellose , croscarmellose sodium , indigo carmine ( e132 ), stearic acid , magnesium stearate . what dzuVeo looks like and contents of the pack dzuvoo is a white to off - white , round oval tablet with " nvr " on one side and " 3 " on the other side . it
elleada is a cancer medicine that contains apalutamide . it is used to treat prostate cancer that has spread to other parts of the body and cannot be treated with surgical treatments . it also works to treat sensitive prostate cancer which has spread beyond the original body and has not responded to surgical treatment . it reduces the amount of testosterone in the blood . it can also help to prevent resistant prostate cancer from growing . erleada also blocks the effects of androgens , which are involved in the growth of the cancer . by blocking the effects , apaluitamide stops the production of androgen , which may help to kill prostate
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). - if pregnant or trying to become pregnant ( see section " pregnancy , breast - feeding and contraception section "). warnings and precautions talk to your doctor or pharmacist before taking this medicine . this medicine should not be taken if any of these apply to you . if you have any of those conditions , talk to a doctor or nurse before taking erleade . - if your child has ever had seizures . - tell your doctor if your baby has ever taken any medicines that could cause
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once a day . your doctor may increase your dose to 60 mg once daily depending on how you respond to erleada . taking this medicine take this leaflet and this leaflets by mouth . if you take more erleade than you should if you accidentally take too many tablets , contact your doctor immediately . taking other medicines if you forget to take erlea if you miss a dose , take it as soon as you remember . if it is almost time for your next
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor immediately if you experience any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms . toxic epidermal necrolysis is a group of serious side effects . the following side effects may fit more easily than seizure ( may affect up to 1 in 100 people )
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalectamide . - the other ingredients are colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , silicified microcrystine cellulosa . - in addition , the film - coating contains iron oxide black ( e172 ), iron oxide yellow ( e 172 ), macrogol , polyvinyl alcohol , talc , and titanium dioxide ( e171 ). what erleADA
this medicine is a radiopharmaceutical product . axumin contains the active ingredient fluciclovine . it is used for the scan ( a pet scan ) in adults who have previously had treatment for prostate cancer and have had other tests to check prostate specific antigen ( psa ) ( the type of protein that carries the cancer ). an axumin pet scan may show that the cancer has spread to other parts of the body . the scan will be recorded on the patient alert card . your doctor or nurse will record the results of the test . your nuclear medicine doctor will decide if you should receive an axul pet scan . if
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using axumin . - if your doctor has told you that you have kidney problems . - you should follow a low sodium diet . - axumin is given once a day for the duration of the axumin scan . this is usually about 4 weeks . during the scan , you will be taking your usual medicines for the latest 60 minutes . - during the 60 minutes following the axul injection , you may urinate more frequently
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide the quantity of axumin to be used . the usual dose is 370 megabecquerel ( megabcquerell ) per kilogram of body weight . how axumin is given for the procedure axumin must be injected into a vein by a doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : very common ( affects more than 1 user in 100 ) when using the medicine . the following other side effects have been reported when using axumin : uncommon ( affects 1 to 100 users in 1 , 000 ) pain , rash , altered taste in the mouth , altered sense of smell . the safety of this radiopharmaceutical has been studied for the use of ionising radiation to treat cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk to your nuclear medicine doctor .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : axumin will be stored in a safe place .
what axumin contains - the active substance is fluciclovine . axumin 1600 mg : each vial contains 1600 mg of fluciniclovine ( corresponding to 1600 mg / 16000 iu ). axumin 3200 mg : one vial delivers 3200mg of fluiclovin ( correspondingto 3200 μg / 32000 iiu ). - the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " axumin with sodium "). what axumin looks like and contents of the pack white to off - white powder for solution for injection ( injection
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . azopt eye drops help to reduce high pressure in the eye , which can lead to an illness called glaucoma . when the pressure in your eye is too high , it can damage your sight .
do not take azopt if you have severe kidney problems . if you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to medicines containing sulphonamides . if any of these apply to you , tell your doctor before taking azopt . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : - are allergic or are taking medicines containing : sulphonamide ( medicines used to treat diabetes or infections ) - are taking diuretics ( water tablets ) - have taken azopt with the same allergy .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt is used for the eyes . use azopt in both eyes : 1 drop in each eye in the morning and 2 drops in the evening . use in both of these eyes : use azop in both the eyes in the mornings and evening . 1 drop of azopt into each of the eyes , in the afternoon and evening , in either of these categories . use 1 drop into each eye each time . use within 2 hours . use the next drop in the night , in which case use the same
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . side effects that may be caused by bad taste . uncommon side effects - effects affecting up to1 in 100 people ) effects in your eye : sensitivity to light , inflammation or infection of the conjunctiva , eye swelling , eyelid itching , red ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . to prevent infections , a pack containing a single bottle should be used immediately . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzanzol . - the other ingredients are benzalkonium chloride ( e433 ), carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide ( to maintain acidity levels and ph levels ). what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw cap .
the active substance of forxiga , dapagliflozin , belongs to a group of medicines ( medicines taken by mouth ) used to treat diabetes . it works by reducing the amount of sugar in your blood . it is used in adults and adolescents ( aged 18 years and older ). forxigo is used to control two types of diabetes : type 1 diabetes that occurs when your body does not produce any insulin . forxig is used for the type 1 type in adults who are overweight or obese . type 2 diabetes : where your body hardly makes enough insulin or the insulin that your body makes does not work as well as
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxigo : - if any of these apply to you , tell your doctor straight away . - if your doctor notices any of your following : - feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , asweet or metallic taste in your mouth , a different odour to your urine or sweat
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of forxiga for type 2 diabetes is 10 mg once a day . your doctor may increase your dose to 5 mg once daily if you have a liver problem . your dose of your dose may be adjusted . your response to forxigo for type 1 diabetes is 5 mg twice a day , depending on your response . your treatment may be continued for up to 5 years . taking this medicine swallow the tablets whole with water . you can take forxige with or without food . your blood
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are : angioedema ( rare , may affect up to 1 in 10 , 000 people ). angioEDema is usually associated with swelling of the face , tongue or throat . difficulties swallowing may lead to hives and breathing problems . diabetic ketoacidosis ( rare ) in patients with type 1 diabetes ( very common , may affects more than 1 in10 people ). in patients without type 2 diabetes , rare , but may affect upto 1 in 1 , 000people . diabeticketoacidism ( rare ),
what forxiga contains - the active substance is dapagliflozin . each forxigo 5 mg film - coated tablet ( tablet ) contains dapapagllozin propanediol monohydrate equivalent to 5 mg dapablifloin . - the other ingredients are microcrystalline cellulose , lactose ( see section 2 under ' forxigiga contains lactose '), crospovidone , silicon dioxide , magnesium stearate . film - coating contains polyvinyl alcohol , titanium dioxide ( e171 ), macrogol 3350 , talc ( e553b ), yellow
mifamurtide is a medicine that blocks the activity of certain bacteria in the immune system . mepact is used to treat osteosarcoma ( bone cancer ) in adults aged 2 and 30 years who have had surgery to remove the tumour and are receiving chemotherapy to stop cancer cells from growing . it is used when cancer has come back .
do not take mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking medicines containing ciclosporin or other calcineurin inhibitors ( non - steroidal - anti - inflammatory drugs ). nsaids can cause problems with your heart or blood vessels such as blood clots ( thrombosis ), bleeding ( haemorrhage ), inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor or pharmacist before taking mepactor if any
treatment mepact will be given to you by a doctor or nurse . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of mepACT is 2 mg mifamurtide once a day . your doctor will decide how many doses you need . the dose may be increased or decreased by your doctor over 12 to 24 hours depending on your mepact treatments . your chemotherapy schedule will be adjusted by your chemotherapy doctor . the maximum dose you should receive is 36 mg once a week . treatment with mepat should be initiated under supervision
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported in patients receiving mepACT ( transient ) alone . if you are taking paracetamol and experience fever during treatment with mepacts , tell your doctor immediately . stomach problems ( nausea , vomiting and loss of appetite ) have been experienced in patients who have received chemotherapy . tell your physician immediately if you experience continuing fever and chills within 8 hours of taking mepaction . if any of the above apply to you , tell the doctor immediately : if you have an infection , rash , any
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expirability of the product does not require any special storage conditions . keep the vial in outer carton in order to protect from light . reconstituted suspension contains sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection or infusion within 6 hours . do this medicine if you notice any visible signs of deterioration . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no
what mepact contains the active substance is mifamurtide . each vial contains 4 mg mifamanurtide ( as suspension ). after reconstitution , each ml of suspension contains 0 . 08 mg mofamurtides . the other ingredients are 1 - palmitoyl - 2 - oleoyl- sn - glycero - 3 - phosphocholine , 2 - dileoyls - sn - glyco - 5 - sodium salt , see section 2 " mepacts contains sodium ". what mepatt looks like and contents of the pack mepat is a white homogeneous
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used on the skin of the face to reduce redness ( rosacea ) and redness of theface . rosica is caused by high levels of blood flow in the facial skin and enlargement ( dilution ) of the small blood vessels of the skin . mirvaso acts by blocking the blood vessels , thus reducing the excess blood flow and reding of the area .
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 and section 2 " possible side effects "). warnings and precautions talk to your doctor or pharmacist before taking mirvasos : - if the medicine is injected under the skin ( for example , if you take certain medicines used to treat depression or parkinson ' s disease called monoamine oxidase ( mao ) inhibitors such as selegiline , moclobemide , tricyclic antidepressants ( such as imipramine ), tetracyclic antidepressant such as
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is applied to the skin ( usually on the face ). this medicine is applied on the surface of your body . it is applied when your body faces the area around your eyes , mouth , nose or vagina . do not use mirvasos if you notice any change in the appearance of mirvasoa mirvasoe is applied only on the affected face . the treatment should be started with a small amount of gel ( a pea - sized amount ). if your symptoms do not improve after this time
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation , inflammation , skin rash , skin pain , discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects that may be worsening of rosacea are : worsening of the treatment with symptoms ( see section 2 ' warnings and precautions '). contact allergy : allergic reaction including rash and rare angioedema ( a serious allergic reaction with swelling mainly of the face , mouth and tongue ). if you are given mirvaso stop using mirvasoa and tell
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the tube and pumps in the outer carton in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of brimonine . each vial contains 5 mg of the active ingredient brimonate tartrate . - the other ingredients are : carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvasos contains methylparhydroxy benzoate "), propylene Glycol . what mirvasoa looks like and contents of the pack mirvas
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system that is needed to defend the body from infection and cancer ). bevacsizumb binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found in lymph vessels all over the body . the veg f protein is found on blood vessels where it stimulates the blood vessels to grow and to supply oxygen . bevaconizumib slows tumour growth by allowing blood vessels (
do not use this medicine if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic ( allergic or hypersensitive ), to chinese hamster ovary ( cho ) cell products if you or your child are pregnant . warnings and precautions talk to your doctor or pharmacist before using mvasi . if you have been told that you have mvasia , you or the child at risk of developing holes in the gut wall ( inflammation inside the abdomen ), diverticulitis ( stomach ulcers ), colitis
dose and administration the dose of mvasi you will receive will depend on your body weight and the type of cancer you have . the usual starting dose is 5 mg , 7 . 5 mg or 10 mg per kg of body weight . your doctor may increase your dose to 15 mg per kilogram of your bodyweight . your dose of the mvasis will be calculated by your doctor . you will be given mvasic every 2 or 3 weeks . the number of infusions you receive will vary depending on how you respond to treatment . your physician will decide how much mvasin you will need and how often you will have
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with mvasi : tell your doctor straight away if you notice any of the side effects listed below . these effects may occur with mvai or with chemotherapy . if you get any of these side effects after you have received mvasis , tell your physician straight away . allergic reactions tell your healthcare professional straight away : if you have an allergic reaction , including difficulty in breathing , chest pain , redness and flushing of the skin , a rash , chills or shivering , feeling sick ( nausea ) or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outercarton in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 unless dilution has taken place
what mvasi contains the active substance is bevacizumab . each ml contains 25 mg of bevaconizumumab in 1 . 4 ml or 16 . 5 ml of solution . each 4 ml vial contains 100 mg of the active ingredient bevocizumib in 1. 4 ml of water . each 16 ml vials contains 400 mg of of bevanacizumaab in 16 .5 ml of the solution . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what mvasis looks like and contents of
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it is used in combination with other medicines to treat refractory mantle cell lyoma in adults . tecartus contains your own white blood cells . it can be used in patients who are already receiving autologous anti - cd19 - transduced cd3 + cells . mantle cell lemphoma is a cancer that affects the immune system ( the body ' s natural defences ) and affects b - lymphocytes . mantlecell lymphoma b - lmphocytes are involved in an uncontrolled way in which they accumulate in the lymph tissue ( the bone
do not use tecartus if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using tecartuse if you : - are allergic or have had problems with the number of white blood cells in your blood ( lymphodepleting chemotherapy ) ( see section 3 " warnings and risks "). - are white blood cell - free ( autologous use ). - have had tests or checks of your lungs , heart or kidney . - have blood pressure , infection or inflammation . - are
tecartus is made from your own white blood cells . your cells will be given to you by a doctor or nurse . your doctor or nurses will take care of your cells . tecartus will be administered by a catheter placed in your vein ( a procedure call leukapheresis ). it is very important that you have all your white blood cell in your blood . teCartus is given to your doctor by a drip into your vein over 3 to 6 hours . the number of your white cells will depend on how well your medicine works and will be calculated by your doctor . the recommended dose is 2 to 3 million
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you . if you get any side effects you may need urgent medical attention . the following side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure . symptoms may include dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome . loss of consciousness , decreased level of consciousness including confusion , memory loss , disturbances of brain function including difficulty speaking ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . infusion bag contains liquid nitrogen equivalent to 150 mg tecartus . this medicine contains genetically modified human blood cells and human - derived material . the product is stable for 36 hours at 25ºc .
what tecartus contains the active substance is autologous anti - cd19 - transduced cd3 + cells . each specific single infusion bag contains a dispersion of anti - cd19 car t cells that will be infused to approximately 68 x 2 cells ( corresponding to a concentration of 106 cd3 cells per ml ). the other ingredients are : anti - dcp19 , sodium chloride , human albumin ( see section 2 " tecartuses contains sodium "). what tecartu looks like and contents of the pack tecartuc is a concentrate for solution for infusion . it is supplied as an infusion bag packed in
januvia contains the active substance sitagliptin which belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2abetes . this medication can be used alone or with certain other medicines ( insulin , metformin , sulphonylureas or glit
do not take januvia - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor or pharmacist before taking januvi if you have any of these conditions : - if ( in section 4 ) you have blistering of the skin ( bullous pemphigoid ). januvin may cause a disease of the pancreatreas called pancreatitis . - if any of your conditions can cause gallstones . - in
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 once daily by mouth . if you have kidney problems , your doctor may prescribe a lower dose of 25 mg or 50 mg film coated tablets . you should continue taking this medicine until your doctor tells you otherwise . this medicine may be taken with certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . it is important to continue to take januvia as long as your diet and physical activity is helping to
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you experience any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ), which might reach through to your back , with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatitis ). if you have a serious allergic reaction ( frequency not known ), including rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglptin phosphate monohydrate equivalent to 25 mg sitaglioptin . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . the tablet film - coating contains poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide . what januva looks like and contents of the pack pink
xultophy lowers blood glucose in patients with type 2 diabetes mellitus . diabetes is when your body does not make enough insulin to control the level of sugar in the blood . the insulin that your body makes does not work as well as it should . this causes blood sugar to rise . insulin degludec is a long - acting basal insulin . it helps to control your blood sugar levels by helping your body make better use of liraglutide ( a type of glp - 1 medicine ) and insulin during meals . xultophy is not used in combination with oral medicines for diabetes xultance is not recommended
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). if you 39 are taking a sulfonylurea such as glimepiride or glibenclamide . your sulfonylation dose should be increased gradually to control your blood sugar levels . warnings and precautions talk to your doctor or pharmacist before taking xulturo if you have type 1 diabetes mellitus or ' ketoacidosis '. this is a condition which can occur during treatment with xultide . inflammatory bowel disease delayed
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have been blind or have poor eyesight , your doctor may need to adjust your blood sugar level . the usual starting dose of xultophy is 41 mg once a day . your doctor will tell you how many days of xulophy you need to take each day . the dose may be adjusted by your doctor if necessary . the recommended dose is 8 mg once daily . you should continue to take xultue for as long as your physician tells you to . xultide is supplied in a
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( very common may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out or become unconscious . serious hypoglycaemia ( may cause brain damage ) can occur . if you have low bloodugar , your bloodugar level may be too low ( see section " warnings and precautions "). if you experience low blood pressure , hypoglycasemia ( see also section " warning and precautions ", below ) can happen . if this happens , stop taking xultophy and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening : store in the original package in order to protect from light . after opening : do not store above 30 . store at room temperature ( below 25 ) for up to 8 weeks . after this time , use within 21 days . do away with the blister after this period . do throw away any medicines via wastewater or household waste .
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units of insulin degluudec 3 . 6 mg liragolutime in 3 ml solution . each vial contains 300 units of the active substance insulin degdludec 10 . 8 mg liraagluteide . the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ). the solvent is water for injections ( see section 2 " xultphil contains sodium "). what xultos looks
giotrif is a medicine that contains the active substance afatinib . it works by blocking two proteins called egfr [ epidermal growth factor receptor - 1 ] ( egfr1 ] and her2 [ erbb2 ]- erbb3 ]. these proteins are involved in the growth of cancer cells . this medicine stops these proteins from growing and kills cancer cells , so it can be used instead . this will slow down the growth and spread of cancer and may help to stop them from growing . this is important because this medicine is used to treat cancer of the lung ( non - small cell lung cancer ). giot
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if you have low body weight ( over 50 kg ) if your doctor has told you that you have kidney problems if you suffer from side effects associated with lung inflammation ( interstitial lung disease ) if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking giotrinif if : you have liver problems . your doctor may need to do some liver tests before you start taking this medicine . you have a severe liver disease . you suffer or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . you should take this tablet at the same time each day . do not take more than the recommended dosage . giotrif should be taken orally once a morning . swallow the tablet whole with a glass of water . you can take this this medicine with or without food . you may take this with or just after a meal . you will usually take this medication for 1 to 3 days without food , depending on how well your body responds to this medicine
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects have been reported during treatment with giotreif : diarrhoea common ( may affect up to 1 in 10 people ): diarrhoehoea ( see section 2 under ' warnings and precautions ') severe diarrhoee with or without fluid loss common ( might affect up in 1 in every 10 people ) low blood potassium ( see below under ' serious and worsening kidney function ') if you experience diarrhoeation after diarrhoeing , you should contact your doctor immediately . appropriate antidiarrhoeal treatment should be
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afatinab . - the other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 , water for injections . what giotratif looks like and contents of the pack giotreif 20 mg film - coating tablets are white to off - white , round , biconvex ,
what orkambi is orkmbi contains two active substances called lumacaftor and ivacaftOR . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in patients aged 6 years and older with a mutation called f508del mutation . f508d is a protein that is found on the surface of cyst fibrosis transmembrane conductance regulator ( cftr ) in the lungs . the mutation causes an abnormal cftl protein that does not respond to lumacafor . how does orkami work ? lumacftor work by blocking
do not take orkambi if you are allergic to lumacaftor or ivacaftOR or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking orkammi . if you have orkabababib , the f508del mutation may occur in some patients . if this happens , orkaban may not be suitable for you . if any of these apply to you , tell your doctor . if your liver or kidney disease is not well controlled , or the dose of orkmbi may be reduced . if abnormal blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take adults the recommended dose is 6 tablets a day . your doctor will tell you how many tablets to take . the recommended starting dose is one tablet a day for the first 6 weeks . your child will take the tablets at least every 12 hours . the doctor will prescribe the right dose for your child . the dose of orkambi tablet that is best for your baby will be decided by your doctor . children and adolescents the recommended daily dose is either 6 tablets or 11 tablets of orky
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with orkambi are usually mild to moderate . however , if you are treated with ivacaftor , you may experience some of the following : serious side effects that may occur with orkyambi : raised levels of liver enzymes in the blood , which may increase the risk of liver injury in patients with pre - existing severe liver disease , and the worsening of liver function . other side effects include : uncommon ( may affect up to 1 in 100 people ): the following symptoms may be signs of pain or discomfort in the
what orkambi contains the active substances are lumacaftor and ivacaftir . orkammi 100 mg film - coated tablets each tablet contains 100 mg lumacftor and 125 mg ivacftir . each tablet of orkmbi 200 mg film film - coating contains 200 mg lumiacaftor or 125 mg of ivacafor . each tablets of orkyambi 100mg film - coat contains 125 mg lumicaftor ( as ivacfaaftor ). each tabletof orkombi 200mg film film film coating contains 125mg lumacafir ( as v
what lynparza is lynparz contains the active substance olaparib . olaparaib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by stopping the growth of cells with mutations ( changes ) in a gene called brca ( breast cancer gene ). in cancer , parp inhibitors can cause death of cancer cells by stopping an enzyme needed to repair dna . what lynparaz is used for lynparZA is used to treat adult patients with ovarian cancer called brcas ( mutated ovarian cancer ). it is
you must not be given lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given lynperza . if you think any of these apply to you , tell your doctor or pharmacist before you receive lynparz . if any of those apply to your child , tell them before you start using lynparze . if your child is being treated with lynparaz , tell the doctor or nurse if your baby has low blood cell counts . testing may show low counts of red
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of lynparz is 100 mg once a day . your doctor may increase your dose to 150 mg once daily depending on your response to the doses of lynpalza capsules . tablets are also available . if you take more than one tablet of lynarza per day , you may experience side effects that may be higher than 8 mg . you must take the tablets with a meal . if possible , take the tablet with a glass of water . you may take the same dose as with
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ): allergic reactions including hives , difficulty breathing or swallowing , dizziness . signs and symptoms of hypersensitivity reactions are listed below . other side effects very common : may affect less than 1in 10 people : feeling sick ( nausea ) being sick ( vomiting ) feeling tired
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store any lynparza capsules in the original package in order to protect from light . after first opening , lynparZA capsules may be stored at room temperature ( up to 30 ) for a maximum period of 3 days . do this every time you open any capsules . do away with any capsules that are damaged or have been frozen . the capsules
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg olaparateib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what lynparz looks like and contents of the pack white , opaque , hard capsule with " olaparaib 50 mg " imprinted on one side and " astrazeneca logo on the other . lynparZA is available in packs containing 112 hard capsules or 448 hard
this medicine contains the active substance naloxone . nalxone is used to treat opioids such as heroin , methadone , fentanyl , oxycodone , buprenorphine and morphine in adults . nyxoid is also used as a nasal spray for the emergency treatment of opioid overdose in adults , adolescents and children . opioid overdose is a serious , life - threatening , and sometimes fatal , event . it can occur within 14 days of overdose . the most common signs of overdose are breathing problems and severe sleepiness . if you have an opioid overdose , you should immediately contact your doctor or get emergency medical care .
do not use nyxoid if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nyxoids . you may need emergency medical care or emergency services if you have an opioid overdose . the signs and symptoms of an opioid dose are listed below . if you think you may have an overdose , talk to a doctor , nurse or pharmacist before using this nasal spray . if it is 2 to 3 hours since you last used a new nasal spray , you should not use this medicine . if your child
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one spray . 1 . if symptoms occur , the shoulders , ears , breastbone , sternum or inside the ear , use fingernail to clear the mouth and nose of any blockers . 2 . if breathing is the chest moving ( chest ) you should hear breathing sounds and breath on the cheek . overdose may occur if the response to touch or sounds is slow uneven breathing , breathing that is not controlled , snoring , gasping , gulping , blue or purple fing
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : stop taking nyxoid and seek medical help immediately if you experience acute withdrawal symptoms from opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . acute withdrawal reactions may affect up to 1 in 100 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray contains 1 . 8 mg of nalxone . - the other ingredients are : ( hydrochloride dihydrate ), trisodium citrate dihydrates , sodium chloride , hydrochloric acid , sodium hydroxide , purified water . what nyxoids looks like and contents of the pack nyxoidal is a 0 . 1 ml clear , colourless to pale yellow solution for injection in a pre - filled nasal spray . it is supplied in a single dose container . nyxax is available in a carton containing 2
what ovaleap is ovaleape contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is produced naturally in the body ). fsh is involved in the growth and development of the sacs ( follicles ) in the ovaries . it is involved for the production of sperm , a precursor to aature egg cell . ovaleaps is used in women who are not ovulating and who are undergoing treatment with a medicine called " clomifene citrate " and who have not undergone assisted reproductive technology procedures ( procedures that help you to become pregnant ) or
do not use ovaleap if you are allergic to follitropin alfa , follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland ( the brain ). if you know that you have large ovaries ( sacs of fluids that carry blood from the ovaries to the womb ) if ovarian cysts are growing out of control . if you experience unexplained vaginal bleeding . if any of these apply to you , tell your doctor . if your doctor thinks that you may have cancer in your ovaries , womb or
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of this medicine is one injection into the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , your doctor may decide to give you this medicine once every week for the first 7 days of your menstrual cycle . the medicine will be given to you over a period of one hour . the recommended starting dose of the medicine is this medicine given as 75 mg twice a week . your doctor will decide how many treatments you need . the usual starting dose is
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects in women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may cause weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 this is uncommon ( may affect up to 1 in 10 , 000 people ). if you experience this type of reaction , your ovaleop injection should be stopped immediately . serious sideeffects in women lower stomach ache , nausea and vomiting . these are the symptoms of ovarian hyper - stimulation syndrome (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the cartridge after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be stored for a maximum of 3 days below 25 . do this medicine if it has been stored for more than 3 days in a freezer at 2 8 . keep away from light and direct light . once removed from the freezer , the cartridge may
what ovaleap contains the active substance is follitropin alfa . ovaleep 300 iu / 0 . 5 ml : each cartridge contains 300 iiu ( 22 micrograms ) follitroin alffa in 0 . 0 ml of solution . ovalesap 450 iu : each cartridges contains 450 iiu / 0. 75 ml of the solution . each cartridge also contains 450 iiu ( 33 microgram ) follitonropin alpha in 0.75 ml of bodyweight . ovaloap 900 iu and 1 . 5ml : each carton contains 900 iiu , 66 microgram
voriconazole accord contains the active substance voriconazol . voricoazole is an antifungal medicine that works by killing or stopping the growth of the fungi that cause infections . it is used in adults and children from the age of 2 years to treat : invasive aspergillosis ( a type of fungal infection caused by aspergonillus sp ). candidaemia ( a form of fun fungal illness caused by candida sp ). non - neutropenic patients ( abnormally low white blood cells count ) with candida spine infections where the fungus is resistant to fluconazole
do not take voriconazole accord - if you are allergic to voricleazole or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking any other medicines , including herbal medicines . the medicines listed below are taken before voricoazole accord treatment : 46 terfenadine ( used to treat allergy ) astemizole ( used for allergy ) cisapride ( used in stomach problems ) pimozide ( used against mental illness ) quinidine ( used if you have irregular heart beat ) rifampicin (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose based on your weight and the type of infection you have . the usual starting dose is 40 mg twice a day ( morning and evening ) for up to 40 days . this will be increased every 24 hours to 400 mg twice daily ( morning , afternoon and evening ). this will usually be given to you in a 12 - hour period . this is increased every 12 hours for upto 24 hours . this means that you will usually take 200 mg twice weekly ( morning ), for up
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , you should contact your doctor immediately . serious side effects stop taking voriconazole accord and tell your doctor straight away : rash , jaundice ( changes in blood tests of liver function ) and pancreatitis . other side effects include : very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision , blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks , visual aura
what voriconazole accord contains the active substance is vorinazole . each tablet contains 50 mg voronazole ( as besilate ). voricoazole accord 50 mg film - coated tablets : each tablet has 200 mg vorbiconazose ( as mesilate ) the other ingredients are : tablet core : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . tablet coating : hypromellose ( e464 ), titanium dioxide ( e171 ), lactosemonohydrate and triacetin .
mvabea is a vaccine to protect you against ebola virus disease in the future . adults and children from 1 year of age and older who are at risk of getting ebola virus , a 2 - dose course of vaccinations is recommended . the active substances in this vaccine are the zaire ebolavirus and filovirus . this vaccine works by stopping the spread of filov virus . the whole ebolairus is contained in the body . it will not give you ebola fever disease . warnings and precautions talk to your doctor or nurse before you are given mvabeas . as with all vaccinations , the
your doctor or nurse will supervise the vaccination course . always receive the vaccine exactly as your doctor or pharmacist has told you . check with your doctor , nurse or pharmaceut if you are not sure . if you have had a severe allergic reaction to any of the ingredients in this vaccine ( listed in section 6 ). if you had asevere allergic reaction , to an antibiotic called ' gentamicin ', or any of those ingredients in the vaccine ( see " other ingredients in mvabea "). if you think you may have had such a severe allergy reaction , ask your doctor . if any of these apply to you ,
the recommended dose of vaccine is a muscle ( intramuscular injection ) in the upper arm , thigh or blood vessel . the first dose of vaccination will be given with zabdeno vaccine 8 weeks later . the second vaccine will be vaccinated with mvabea . the third dose of the vaccine will not be given until after primary vaccination first vaccination with zibdeno red cap vial ( 0 . 5 ml ) second vaccination with m vabea yellow cap vials ( 0. 5 ml ). the first vaccination without zab deno will be delayed until after booster vaccination with another zabdono . if
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth , swelling where the injection is given feeling very tired muscle ache joint pain common ( might affect up to 1 in every 10 people ) being sick ( vomiting ) itching where the vaccine is given uncommon ( may affects up to1 in every 100 people ): redness , skin hardness where thejection is given generalised itching . the most common side effects are : common ( likely to affect up in 1 in 100 people
what mvabea contains the active substance is zaire ebolavirus 29 ( tai forest ebolovirus nucleoprotein marburg , 0 . 7 %) 108 produced in chicken embryo fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections and hydrochloric acid ( for ph adjustment ). what mvabaa looks like and contents of the pack mvagaa is a suspension for injection in a single - dose glass vial with a rubber stopper and yellow cap . each pack contains 20 vials .
ondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones ( called ' bone ametastases '). it helps to prevent your bones from breaking ( fractures ) and other bone problems that may need surgery or radiotherapy bondronat can also be used to : - help you to get a raised calcium level in your blood because of a tumour . this helps to reduce the amount of calcium that is lost from your bones . this reduces the risk that your bones become weaker .
do not take bondronat if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) if you have low levels of calcium in your blood . warnings and precautions talk to your doctor or pharmacist before taking bondronAT if you : have a side effect called osteonecrosis of the jaw ( onj ) this can be a sign of bone damage in the jaw . your doctor may decide to reduce your dose of bondronate if you suffer from cancer or related conditions . onj can be life - threatening and may be fatal . stopping treatment with bondronit
this medicine is given to you by a doctor or nurse who is experienced in the treatment of cancer . it is given as an infusion into your vein . your doctor will do regular blood tests before you are given bondronat . the recommended dose of this medicine is one tablet once a day . if your illness is severe ( for example , breast cancer that has spread to your bones ), it may be given 3 times a day ( every 3 - 4 weeks ). this will be given as either an infusion in your vein or as an injection in your blood over a period of about 15 minutes . if you have a raised calcium level in your
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain or inflammation new pain , weakness or discomfort in your thigh , hip or groin . this may be a sign of unusual fracture of the thigh bone . very rare ( might affect up in 1 in 10 , 000 or more people ) pain or sore in your mouth or jaw . this could be a symptom of severe jaw problems called necrosis ( dead bone tissue ) in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2ºc to 8ºc . do this medicine if you notice particles in the solution or if the solution is discol
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial contains a concentrate for solution for infusion that contains 2 mg ibandron acid . - the other ingredients are sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water for injections . what bondronAT looks like and contents of the pack bondronate is a clear , colourless solution for injection . it is supplied in a glass vial containing 1 ml or 2 ml of solution , with a bromobutyl rubber stopper .
what zeposia is zepoia belongs to a group of medicines that affect the number of white blood cells ( lymphocytes ) in the body . what zepoesia is used for zepopsia is a treatment for adults with relapsing remitting multiple sclerosis ( rrms ), a rare but active disease that affects the nerves of the brain and spinal cord . symptoms include numbness , difficulty in walking and problems with vision and balance . relapsitting remitting rel sclerosis is attacks on the nerve cells . the symptoms usually disappear within a few days or weeks . it may take a few weeks or longer
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severely weakened immune system . if you had a heart attack , angina , stroke , mini - stroke or transient ischemic attack ( tia ). if severe heart failure has occurred within the last 6 months . if any of these apply to you , tell your doctor . if your doctor thinks you have irregular or abnormal heartbeats ( arrhythmia ). if your heart is not working properly after treatment . if the patient has severe infection such as hepatitis ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will work out the dose of zeposia you need to take . this will depend on your heart rate and your general condition . your doctor may prescribe a ' treatment initiation pack ' for you . the first 4 days of treatment each capsule contains 0 . 23 mg ozanimod . this is taken as 1 capsule per day . the next 4 days ( the first four days of the treatment ) each capsule will contain 3 mg ozamanod . the recommended dose is 0 .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : very common ( may affect more than 1 in 10 people ): slow heart rate urinary tract infection ( raised blood pressure ) uncommon ( may affects up to 1 in 100 people ): allergic reaction . the signs may include a rash . other side effects include : very rare ( may effect more than one in 10 , 000 people ): infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) or voice box ( larynx ).
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any damage or signs of tampering to the pack . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zeposia contains the active substance is ozanimod . zeposeia 0 . 23 mg : each capsule contains 0 . 22 mg ozanimog ( as hydrochloride ). zepoesia 0 , 46 mg : one capsule contains only 0 . 46 mg ozimod ( as hydration ). ozanimood is also available as hydro chloride . ziposia 0. 92 mg : two capsules contain only 0.92 mg ozmanimod (as hydrochlorides ). the other ingredients are microcrystalline cellulose , silica , colloidal anhydrous , croscarmellose
what temybric ellipta is temymbric elliptic contains two active substances called fluticasone furoate and umeclidinium bromide in one inhalation . each active substance is vilanterol . fluticusone furaate belongs to a group of medicines called corticosteroids ( steroids ). umecylidinIUM bromine and vilansterol belong to a class of medicines known as bronchodilators . what temybarric elliptical is used for temyborric elliptaic is used to treat chronic obstructive pulmonary disease ( cop
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using temy bric elliptfa - if your doctor has told you that you have asthma . warnings and risks talk to the doctor or nurse before using this medicine if you : - have asthma , as temyberric elliptia may not be suitable for you - have had asthma , heart problems , high blood pressure , liver problems
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . try to use temybric ellipta at the start of each day and continue to use it until your doctor tells you otherwise . if you use more temybiric ellipte than you should if you have used more tembric ellipta than you have been told to use , contact your doctor immediately . symptoms of temybreric elliptoe may include
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing is not controlled with wheezing , stop taking this medicine and seek medical help straight away . pneumonia ( infection of the lung ) in copd patients the most common side effect of temybric ellipta is symptoms of a lung infection such as fever and chills . increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) are sore or raised patches in the mouth or throat . this may be a fungal infection
what temybric ellipta contains - the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose contains 92 micrograms of flutic asone firoate , 65 microgram of umeklidinIUM bromate and 55 microgram s of umclidinia bromides ( equivalent to 22 microgram vilancerol and trifenatate ). - the other ingredients are lactose monohydrate ( see section 2 under ' temy bric elliptfa contains lactose '), magnesium stear
zinforo is an antibiotic medicine that contains the active substance cefosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo helps to treat infections of the skin . it works by blocking the growth of the tissues that line the skin , which can lead to an infection of the lungs called ' pneumonia '. zzinforoe is used in adults . zin foro works by killing certain bacteria that cause serious infections .
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have had previous severe allergic reactions to other antibiotics ( such as penicillin or carbapenem ). warnings and precautions talk to your doctor or pharmacist before taking zin foro . if any of these apply to you , tell your doctor before taking this medicine . if your doctor thinks you may have kidney problems . if this applies to you ( or you are not
the recommended dose of zinforo is 600 mg once a day . your doctor will tell you how many tablets to take . the recommended dose is one 600 mg tablet once a week for up to 8 weeks . if you have some infections that you cannot tolerate for 8 weeks or more , your doctor may give you a lower dose . the dose is usually given every 8 weeks through a drip into a vein . the usual dose is 5 mg once daily . your dose may be increased to 60 mg once every 120 days . your physician may give an increased dose depending on how you respond to treatment . the maximum recommended dose for children and
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects . if you get any of these symptoms , you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems , asevere allergic reaction ( anaphylaxis ), diarrhoea or stool that contains blood or mucus . treatment with zinforo may be stopped or medicines may be given to slow bowel movement . this may affect up to 1 in 10 people . your doctor will do a blood test called
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do this to protect from light . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is ceftaroline fosamil . the other ingredients are arginine . what zinForo looks like and contents of the pack zinFORo is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . it is supplied in packs containing 10 vials .
pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuropathicpain pregabalin pfizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neuropathic arthritis , such as diabetes or shingles . pain sensations may be described as hot , burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness or pins and needles . peripheral or central neuropathy pain may also be associated with mood changes , sleep disturbance
do not take pregabalin pfizer : if you are allergic to pregagabalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking preggabal pfiser . some patients taking pregaabalin pumpfizer have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat and diffuse skin rash . should you experience any of these reactions , you should contact your doctor immediately . pregibalin has been associated with dizziness and somnolence , which
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is for oral use . peripheral and central neuropathic pain , epilepsy and generalised anxiety disorder the usual dose is 150 mg once a day . your doctor may increase your dose to 600 mg once daily depending on your response to pregibalin psfizer . take pregaboralin pfeizer once in the morning and once inthe evening . swallow the capsule whole with a glass of water . do not crush or chew the capsule . children and adolescents do not give
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common : might affect up to 1 in every 10 people increased appetite , feeling of elation , confusion , disorientation , decrease in sexual interest , irritability , disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo , problems with balance
what pregabalin pfizer contains the active substance is pregibalin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg of pregabialin . the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica . the printing ink contains black ink , shellac , black iron oxide ( e172 ), propylene glycol ( e1521 ), potassium hydroxide ( e433 ).
xadago is a medicine that contains the active substance safinamide . it works by increasing the levels of dopamine in the brain . dopamine is a chemical in the body that is important for movement . xadago has been given to adults with parkinson ' s disease because of sudden swings in the ability to move . people with parkin ' s condition may have difficulties moving . xADago is used in combination with levodopa ( other medicines used to treat parkinson '.
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking any of any of : - monoamine oxidase ( mao ) inhibitors , such as selegiline , rasagiline and moclobemide , phenelzine , isocarboxazid and tranylcypromine . these are all used in treatment of parkinson ' s disease or depression . - pethidine , a strong pain killer . it is used in children and adolescents
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg once a day . the dose may be increased to 100 mg once daily by mouth . your doctor will tell you the dose to take . if you have moderately reduced liver function , your doctor may prescribe a lower dose of 50 mg . take xadadago at the same time each day . you should swallow the tablet whole with a glass of water . xadagon can be taken with or without food . if taking more xadado than you should if
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : hypertensive crisis ( very high blood pressure that may lead to collapse ) - neuroleptic malignant syndrome ( confusion , sweating , muscle rigidity , hyperthermia ), increase level of enzyme creatine kinase in your blood ( serotonin syndrome ), confusion , hypertension , muscle stiffness , hallucinations ( hypotension ). the following side effects have been reported with the use of parkinson ' s disease in combination with safinamide and levodopa . they are usually mild to moderate and usually disappear after a few weeks .
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg safinoid . - the other ingredients are methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating contains hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( e172 ). what xadagon looks like and contents of the pack xadagus 50 mg film - coated tablets of 7 mm diameter with metallic gloss are engraved with ' 50 ' on one
zytiga contains a medicine called abiraterone acetate , which is used to treat prostate cancer that has spread to other parts of the body . zytiga lowers testosterone in men who have prostate cancer . ztiga is used in patients who have disease that has not responded to hormone therapy ( a treatment that lowers testosterone ( androgen deprivation therapy ). it is used with another medicine , prednisone . prednisolone is used for high blood pressure in adult patients whose body is not able to absorb the medicine properly and which causes fluid retention in your blood .
do not take zytiga - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks you may be pregnant . warnings and precautions talk to your doctor or pharmacist before taking zytig if you have severe liver damage or prostate cancer . this medicine should not be taken with this medicine . talk to a doctor or nurse before taking this medicine if any of these apply to you . if you think you may have liver problems , such as high blood pressure , heart failure , low blood potassium , or heart rhythm problems . if your physician
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . the dose may be increased to 1 , 000 mg once a week . take this tablet at the same time each day . swallow the tablet whole with a glass of water . do not chew or crush the tablet . take the tablet with food . it is best to take the tablets by mouth . if you take more zytiga than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take your tablets with food and drink
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact a doctor immediately if you experience : - muscle weakness , muscle twitches , a pounding heart beat or palpitations . these may be signs that the level of potassium in your blood is low . your doctor may want to increase your dose of potassium . other side effects include : very common ( may affect more than 1 in 10 people ): - fluid in your legs or feet ( signs of low blood potassium or liver function test ). - high blood pressure . - urinary tract infection . - diarrhoea . common (
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abiratingone acetates . - the other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 " zytigo contains lactose ". what zytig looks like and contents of the pack - zytige tablets are white to off - white , round tablets with a diameter of 9 . 5 mm .
hefiya contains the active substance adalimumab , a medicine used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis , paedian crohn ' s disease and paediatric non - infectious uveitis . adalumab is a monoclonal antibody . monoclal antibodies attach to specific proteins in the body . addalimumab attaches to a specific target called tumour necrosis factor ( tnfα ). tnfsα is a protein involved in the inflammatory diseases and is involved in reducing
do not take hefiya if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your baby has a severe infection , including tuberculosis , sepsis ( blood poisoning ), or other opportunistic infections . warnings and precautions talk to your doctor or pharmacist before taking hefiYA if your newborn has a history of unusual infections or a weakened immune system . symptoms of infections may include fever , wounds , feeling tired , dental problems . if your infant has moderate or severe heart failure . if you have a serious heart condition . allergic reaction if allergic reactions occur with symptoms
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . your doctor may prescribe a different dose for you . the dose may be increased to 20 mg , 40 mg , 20 mg or 40 mg . polyarticular juvenile idiopathic arthritis age and body weight how much to take adults , adolescents and children from 2 years of age weighing 30 kg or more 40 mg once a week . children from 1 year of age weighed 10 kg or less 30 mg once daily . the usual dose is 20 mg once
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . tell your doctor straight away if you notice any of the following side effects ( see section 4 , " warnings and precautions "): - after the last hefiya injection , you may experience allergic reaction ( see also section 4 ), including heart failure . - severe rash , hives , swollen face , hands , feet , trouble breathing , swallowing , shortness of breath and swelling of the feet . - signs and symptoms of infection such as fever , feeling sick ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a maximum period of 14 days . once removed from the refrigerator for room temperature storage , your pre -filled syringe may be kept at room temperatures ( up
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of adalimab in 0 . 4 ml of solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . what hefiYA looks like and contents of the pack hefiqa 20 mg / 0 . 04 ml solution for injection is a clear to slightly opalescent , colourless to slightly yellowish solution . it is supplied in a clear
what ritemvia is ritemv contains the active substance rituximab , a " monoclonal antibody ". it sticks to a target in a type of white blood cell called " b - lymphocyte ". when ritukimab sticks to the target , it stops the cell from growing and dies . how ritemvi works ritemvir is used for the treatment of a ) non - hodgkin ' s lymphoma . this is a disease of the lymph tissue that affects the immune system . it affects a type in the body called " white blood cells " ( b - cells ). ritem
do not take ritemvia if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe active infection if you suffer from a weak immune system if you suffered from severe heart failure or severe uncontrolled heart disease if you know that you have granulomatosis , polyangiitis , microscopic polyangitis or pemphigus vulgaris warnings and precautions talk to your doctor or pharmacist before taking ritemvi if you : have ever had or might now have a hepatitis
how much ritemvia is given your doctor will decide how much ritemvia you will receive and how often you will need this treatment . your doctor may decide to stop giving you this medicine if you experience any side effects . how ritemv is given ritemva is given as a drip ( intravenous infusion ). medicines given before each ritemvi administration you will be given ritamvia together with other medicines ( pre - medication ) to reduce the risk of side effects during your treatment . for non - hodgkin ' s lymphoma if you are being treated with ritemga alone ritemvir is
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate and will generally go away after a few days of treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy or runny nose , vomiting , flushing or palpitations , heart attack ,
what ritemvia contains - the active substance is rituximab . each ml of solution contains 100 mg of ritukimab ( as besilate ). each ml concentrate contains 10 mg of the active ingredient ritiximab - the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritemva looks like and contents of the pack ritemv is a clear , colourless solution for infusion in a glass vial . pack size of 2 .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitabrine teva contains capecitibine , which itself is not a cytostatics medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine . capecabine veva is used in the treatment of colon , rectal , gastric , or breast cancers . capectabine neva is indicated for the prevention of colon cancer after complete removal of the tumour by surgery . cape citabine jeva may be used alone or
do not take capecitabine teva - if you are allergic to capecitibine or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor thinks you may have an allergy to this medicine - if the patient has had severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ) - - if a woman is pregnant - if she has low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ) - in severe liver or kidney problems - if her
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you . the dose of capecitabiline teva is calculated from your body surface area ( height and weight ). the usual dose for adults is 1250 mg / m2 of body surface surface area taken once daily . for children and adolescents ( aged 64 years and above ), the usual starting dose for children is 1 tablet of 150 mg /
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you have any of these symptoms : diarrhoea : if you experience an increase of 4 or more bowel movements compared to your normal bowel movements , or any diarrhoehoea at night . vomiting : if vomit is more frequent than usual . nausea : if your stomach does not empty as quickly as it should . if you lose your appetite . stomatitis : if pain , redness , swelling or sores in your mouth and / or throat . hand and foot skin
what capecitabine teva contains the active substance is capecitabiline . capecitibine teeva 150 mg film - coated tablets each film - contains 150 mg capecitobine . furthermore , capecittabine tella 500 mg film film - coating tablets eachfilm - contains 500 mg capecabine . the other ingredients are lactose , microcrystalline cellulose , hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 , hypromeellose, titanium dioxide ( e171 ), yellow iron oxide ( e172 ), red iron oxide red ( e
silodosin recordati contains silodosino recordati . it belongs to a group of medicines called alpha1a - adrenoreceptor blockers . silodusin recordat is used to lower the pressure in the prostate , bladder and urethra . it helps to maintain smooth muscle and tissues throughout the body , and reduces your symptoms . siliodosin Recordati is used for the urinary symptoms of benign enlargement of the prostate ( prostatic hyperplasia ), such as difficulty in starting to pass water , and a feeling of not completely emptying the bladder .
do not use silodosin recordati - if you are allergic to silodnosin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using silodousin recordi - if your child is undergoing eye surgery to reduce cloudiness of the lens during cataract surgery . the eye contains 26 million international units ( iu ) ( 23mt ) ( 24mt ) of silodosein recordit . - if the child is being treated with medicine to reduce a loss of muscle tone in the iris ( the coloured part of the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one capsule of silodosin recordati taken once a day , with or without food , at about the same time each day . you should take silodosein recordat for at least 8 hours every day . if you have kidney problems if you suffer from moderate kidney problems , your doctor may prescribe a lower dose . for this purpose silodosiin recordatin is taken once daily , with with or with food , in the morning and evening , at approximately the same times each
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions may include swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin and hives . if you experience any of these , stop taking the medicine and seek medical advice straight away . the most common side effect of silodosin recordati is dizziness . dizziness may occur with occasionally fainting . if this happens , you may feel weak or dizzy . the symptoms may include dizziness and faints . if any of the above apply to you , stop using silodnosin recordat
what silodosin recordati contains silodosein recordat 8 mg : the active substance is silodofin . each capsule contains 8 mg silodino . the other ingredients are mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). silodosesin recordatin 4 mg : each capsule contain 4 mg siliodosin . the ingredients are : mannola , magnesium starchate , magnesium laurilulfate . the printing ink contains gelatin , stainless dioxide ( i171 ), yellow iron oxide ( e172 ). what silodosiin record
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in the body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzal mono blocks the effect of angiotenin ii so that the blood vessels relax , and your blood blood pressure is lowered . kinzonmono is used to treat essential hypertension ( high blood pressure ) in adults . the high blood bloodpressure is not caused by any other condition . high bloodpressure , if not treated , can damage blood vessels in several organs , which could lead
do not take kinzalmono - if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). - if more than 3 months pregnant ( it is also better to avoid kinzdalmono in early pregnancy see pregnancy section ). - tell your doctor if you have severe liver problems ( such as cholestasis or biliary obstruction ) that are not well controlled by drainage of the bile from the liver and gall bladder , or any other severe liver disease . - tell the doctor if any of these apply to you . - if your doctor has prescribed diabetes or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day . the tablets should be swallowed with some water . you can take kinzalmono with or without food . try not to take more tablets than your doctor tells you to . if you take more kinzdalmono than you should if you have taken too many tablets , contact your doctor immediately . treatment of high blood pressure the usual starting dose of kinzhalmono is 40 mg once a
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious and need immediate medical attention : sepsis ( also called blood poisoning ), is a severe infection with whole - body inflammatory response that can cause rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). other side effects of kinzalmono common side effects ( may effect up to1 in 10 people ): low blood pressure ( hypotension ) and cardiovascular events . uncommon side effects : may affect upto 1 in 100
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . once you have taken your medicine , it should be used immediately . do this by referring to the package leaflets for your kinzalmono tablet that are provided in the blister . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisantan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ), magnesium stearate . what kinzalao looks like and contents of the pack kinzalimono 20 mg tablets are white to off - white , round , flat , bevelled tablets . kinzdalmono is available in blister packs of 14 , 28 , 56 , 98 tablets . not all pack sizes may be marketed .
afstyla is a human clotting ( coagulation ) factor viii product . it contains the active substance lonoctocog alfa . afstylfa is used to treat bleeding episodes in adults with haemophilia a ( inborn factor v iii deficiency ). factor v ii is a naturally occurring component of blood clotting and is required to clot the blood . afstona has an increased tendency to bleed . factor v viii is important in patients with haophilia b to help blood clot . afostyla will only be given to you if you have been trained by your doctor or nurse
do not use afstyla if you have had an allergic reaction to afstylea or if you are allergic to hamster proteins 46 warnings and precautions talk to your doctor , pharmacist or nurse before using afststylfa . the dose and the batch number should be recorded in your treatment diary . do not use more afstlya than recommended if you think you may be allergic ( hypersensitivity ) reactions . warnings and symptoms of allergic reactions are listed below . allergic reactions may include hives , generalised skin rash , tightness of the chest , wheezing , fall in blood pressure ( anaphyl
your treatment will be overseen by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the recommended dose of afstyla is one vial per day . dose and duration of treatment depending on your disease the site and the bleeding your clinical condition will be determined by your doctor . reconstitution and administration general instructions the powder and the solvent ( liquid ) should be mixed in a glass vial to form aseptic conditions . afstlva may be used with other medicines or solv
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions include hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure and dizziness . anaphylaxis ( bleeding ) has been reported in patients receiving factor viii medicines . inhibitor antibodies ( see section 2 ) have been reported very commonly ( may affect more than 1 in 10 people ) in patients who have received previous treatment with factor v iii ( more than 150 days of treatment ). uncommonly ( may effect up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the product may be stored at room temperature ( up to 25 ) for a maximum period of 3 days . keep afstylea in the vial in theouter carton to protect it from light and
what afstyla contains the active substance is lonoctocog . each vial contains 250 iu ( 2 . 5 mg / ml ). after reconstitution with 2 .5 mg / lonoectocog alfa , the recommended dose is 100 iu lonoxtocog aluminium per ml . after reconitution with 1 . 5 ml of water for injections the solution contains 200 iu / ml lonoCTocog alpha . each 1000 iu vial provides 20 ml of solution for injections . after administration with 2. 5 ml water for injection , the desired dose is 400 iu of l
what praxbind is prax bind contains the active substance idarucizumab . idarukizumumab is a recombal agent similar to dabigatran ( pradaxa ), a blood thinner medicine used to prevent blood clot formation . what praxBind is used for praxbinding is used to rapidlytrap dabigATran . how prax Bind works when used with pradxbind , it is used in adults , adolescents and children who are at high risk of getting pradixa during emergency surgery or for urgent procedures to stop uncontrolled bleeding .
do not take praxbind if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a genetic disease called hereditary fructose intolerance ( haf ). if any of these apply to you , tell your doctor before taking this medicine . warnings and precautions talk to your doctor or pharmacist before taking prax bind if any part of this leaflet gets into your head . if you take more medicine than you should dabigatran ( other medicines to prevent blood clots ) dabigitran is a naturally occurring substance in the body which helps to prevent
the recommended dose is 5 mg / kg body weight , taken once daily . your doctor will decide the dose that is right for you . your dose will be calculated by your doctor based on your weight . the recommended dose for adults is 2 . 5 mg dabigatran per kg bodyweight , taken twice daily . this medicine will be given to you once daily for 5 days . this will be administered into a vein . your healthcare professional will administer this medicine to you at the start of your treatment . if you have problems with blood clot formation , dabigATran may be administered to you 24 hours after you have been given this
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what praxbinding looks like and contents of the pack the solution for injection is clear to slightly opalescent , colourless to slightly yellow solution . it is supplied in a clear glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used to treat specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . temmedac is first given together with radiotherapy ( concomitant phase of treatment ) and then monotherapy phase oftreatment . - in children 3 years of age and older and adult patients with malignant glioma , such as gliOBlastoma multipurpose or anaplastic astrocytoma . temormac is given in combination with standard
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction may include feeling itchy , breathlessness , wheezing , swelling of the face , lips , tongue or throat . if certain types of blood cells are severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells help fighting infection by preventing proper blood clotting . temomedic may
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . this is especially important if you have a recurrent tumour that has not responded to chemotherapy treatment in the past and you are taking other medicines ( anti - emetics ). temomedic can be used to prevent nausea and vomiting in adults with newly - diagnosed glioblastoma multiforme . treatment is divided into two phases : treatment with radiotherapy ( concomitant phase ) and with
like all medicines , this medicine can cause side effects , although not everybody gets them . if you have a severe allergic ( hypersensitive ) reaction , including hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures or convulsions , fever , chills , severe headache , stop temomedac treatment and contact your doctor immediately . there may be a reduction in certain kinds of blood cells . this may cause increased bruising or bleeding , anaemia ( a shortage of red blood cells ), fever and reduced resistance to infections . the reduction in blood cell counts is usually short - lived and may be temporary . if this happens ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiratory date refers to the last day of that month . do store above 30 . do use temomedac if you notice any change in the appearance of the capsules . do return the capsules to your pharmacist . do throw away any medicines via wastewater or household waste . ask your pharma how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains - the active substance is temozolomide . temomedic 5 mg : each capsule contains 5 mg temozolsomide ( as temozoleomide ). temomedoc 20 mg : one capsule contains 20 mg tem ozolomides ( as mesolomamide ). temmedac 100 mg : two capsules contain 100 mg temzolomine ( as besilate ). temarthac 140 mg : three capsules contain 140 mg temazolomile ( as esilate . temarthic 180 mg : four capsules contain 180 mg temizolomid ( as bis
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard erect penis suitable for sexual activity . cialis helps to provide a hard erection for adult women . cialsis contains the active substance tadalafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors . calis works by blocking the blood vessels in your penis . this allows your penis to work normally and allows you to have sex more easily . this lowers the risk of erectile function . ceralis is used to treat adult men who have erectile disease .
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you are intolerant of organic nitrate or nitric oxide donors ( such as amyl nitrite ) or medicines (" nitrates ") used to treat angina pectoris (" chest pain "). warnings and precautions talk to your doctor before taking ciali . if you have been taking any of these medicines , tell your doctor : - if any of them contain nitrate - if the patient has serious heart disease - if recently
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablets whole with a glass of water . the tablets can be taken with or without food . the usual dose is between 5 mg and 2 . 5 mg . if you take more cialises than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , show the doctor your pack of tablets . if necessary , show them the pack of cialisers . if not , show
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions ( rashes ) ( frequency not known ) chest pain ( may occur with nitrates ). ( frequency unknown ) priapsim may cause a prolonged and possibly painful erection . stop taking cialis and seek medical help immediately if you experience such an erection ( frequency cannot be estimated from the available data ). if you have sudden loss of vision ( frequency is not known ). other side effects very common ( may affect more than 1 in 10 people ) uncommon ( may affects up to 1 in 100
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of tadalabil . - the other ingredients are lactose monohydrate ( see section 2 " cialises contains lactose "), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : lactosemonohydrate , hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow ( e172 ), ironoxide red ( e129 ), talc . what
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enyglID is used to treat type 2abetes in adults . treatment is usually started by diet and exercise and weight reduction . your blood blood sugar should be controlled with eny glid on its own . it can be used on its same day as metformin for
do not take enyglid if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low ( diabetic ketoacidosis ). if your doctor has told you that you have a severe liver disease . if you take gemfibrozil ( a medicine used to lower increased fat levels ). if any of these apply to you , tell your doctor . if your dose is too high . if any combination of eny glid or another medicine with similar effects is not recommended ( see
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . the usual starting dose is 30 mg once a morning . your doctor may increase your dose to 4 mg once daily . your daily dose may be increased to 30 mg ( once a daily ) once a week for up to 16 weeks . your blood sugar may be monitored more closely by your doctor . if you take more enyl
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of enyglid is hypoglycasemia ( may affect up to 1 in 10 people ). hypoglycemic reactions are generally mild / moderate . hypocaemic unconsciousness may lead to coma . allergy allergy ( rare , may affect 1 in every 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating ( anaphylactic reaction ). other side effects include : common ( may affects up to1 in 10 users ): stomach pain diarrhoe
what enyglid contains the active substance is repaglinide . each 0 . 5 mg / 1 mg / 2 mg film - coated tablet contains repagginide . the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ) only in 1 mg tablets and red iron oxide (< e172 ). only in 2 mg tablets . what eny glid looks like and contents of the pack en
what azacitidine mylan is azacitonidine myl is an anti - cancer agent . what azaccitidine mylon is used for azac citidine myla is used to treat adults . what it is usedfor azacitic mylan can be used in adults . how azacididine mylin is used azacuitidine mylot is used in patients who have not had a stem cell transplantation and who have : - higher - risk myelodysplastic syndromes ( mds ) - chronic myelomonocytic leukaemia ( cmml ) - acute my
do not take azacitidine mylan - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacacitrix mylan : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - in patients with liver disease . if the person has a heart condition that makes you prone to heart attack . - tell your doctor if the doctor has lung disease
before starting azacitidine mylan , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will tell you how much azaccitidine myl you need to take . your dose of this medicine will depend on your height and weight . azacacitine mylan is given every 3 weeks as part of this " treatment cycle " ( cycle 4 , 6 ). this medicine is given under the skin ( subcutaneously ) on the skin of your thigh , tummy or upper arm . if you have any further questions on the use of this product ,
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following side effects : drowsiness or shaking , jaundice ( e . g . abdominal bloating and easy bruising ), which may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness or fatigue , which may all be symptoms or signs of kidney failure . a fever , which might be a sign of an infection due to low levels of white
your doctor , pharmacist or nurse knows how to store azacitidine mylan properly . any unused azaccitidine myl must be disposed of in accordance with local requirements . this medicine is for single use only . this medicinal product does not require any special storage conditions . the suspension must be used within 1 hour after preparation . the azacididine myla suspension must not be mixed with water for injections . thesuspension must be stored in a refrigerator ( 2 8 ). do not freeze . the zacitine mylan suspension must never be mixed together with water . the solution must be kept in the refrigerator (
what azacitidine mylan contains - the active substance is azacitonidine . one vial of powder contains 100 mg azacinidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg azaxitidine . - the other ingredient is mannitol . what azacituidine myl looks like and contents of the pack azaccitidine mylon is a white powder for suspension for injection in a glass vial containing 100 mg of azacita . pack sizes of 1 and 7 vials . not all pack sizes may be marketed .
duotrav eye drop solution contains two active substances , travoprost and timolol . travostrost is a prostaglandin analogue , which is produced naturally in the eye . timoll is a beta blocker , which reduces the amount of fluid within the eye and thus reduces pressure within theeye . duotraveye drops are used to treat high pressure in theeye in adults with an illness called glaucoma .
do not take duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( e . g . wheeziness , difficulty in breathing , long - standing cough , breathing problems , severe hay fever ) - if the child has a slow heartbeat . - if he or she has heart failure ( a disorder of heart rhythm , irregular heartbeat ), or if the coloured part of the eye (
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in the affected eye or eyes twice a day . do not use duotrav in the eyes unless your doctor tells you to . how to use duetrav is for oral use . use in adults and children the recommended doses are one drop twice a morning , 2 to 3 times a day , and one drop once a day in the evening , at about the same time each day . use a bottle with a lid that is opened . 1 drop in your
like all medicines , this medicine can cause side effects , although not everybody gets them . the effects are usually mild to moderate . the drops should be swallowed whole with water . if you get any side effects while using duotrav , tell your doctor or pharmacist . very common side effects ( may affect more than 1 in 10 people ) effects affecting the eye eye redness . common side side effects these may affect up to 1 in every 10 people ( effects affecting only 1 in 100 people ) effect affecting theeye inflammation of the eye surface , inflammation of a part of the eyelid called swollen conjunctiva , increased growth of eyel
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . store in the original package in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what duotrav contains - the active substance is travoprost . each ml contains timolol 40 mg . - the other ingredients are travaprost 5 mg , timolole , timoleol maleate , polyquaternium - 1 , mannitol , propylene glycol , polyoxyethylene hydrogenated castor oil 40 mg , boric acid , sodium chloride , sodium hydroxide , hydrochloric acid , purified water , sodium hydrochloride and hydrochlorIC acid . acidity levels are maintained at ph levels . what duotra looks like and contents of the pack duot
nplate ' s active ingredient is romiplostim . it is a protein used to reduce low platelet counts caused by the immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease that affects your body ' s immune system . platelets are important in protecting the blood from blood clots . very low platelets can cause bruising and serious bleeding . nplate is used to : - have your spleen removed ( chronic itp ) - have previously used corticosteroids ( immunoglobulins ) - reduce the number of blood cells in your body
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before taking nplate : if you have a low blood platelet count ( thrombocytopenia ). nplate may reduce your platelet counts . if you suffer from blood clots . if blood clops are not prevented by blood clotting . if your doctor has told you that you have liver problems . if any of these apply to you ( or you are not
nplate is given to adults and adolescents aged 1 to 17 years . how nplate is administered nplate will be given to you by a doctor or nurse . nplate should be given as an injection under the skin ( subcutaneous ) over a period of at least 1 hour . how often nplate you will be treated with nplate depends on your platelet counts . your doctor will take regular blood samples to check your platelets . your platelelet count will be checked regularly . your blood will be tested regularly to check that your plate clotting is working . how much nplate to be given your doctor may decide to
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : common ( may affect up to 1 in 10 people ): headache allergic reaction upper respiratory tract infection common ( might affect up in 1 in10 people ): bone marrow disorder , increased bone marrow fibres , trouble sleeping ( insomnia ), dizziness , tingling or numbness of the hands or feet ( paraesthesia ), migraine , redness ofthe skin , flushing , blood clot in a lung artery ( pulmonary embolism ), nausea , diarrhoea , abdominal pain , indigestion
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do store above 30 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nplate contains the active substance is romiplostim . nplate 125 mg powder for solution for injection contains 230 mg romiplopim . each vial contains 125 mg romplostim in a deliverable amount of 0 . 25 ml solution . each millilitre ( ml ) contains 125mg romipliplostime . each 500 mg vial of nplate 250 mg powder contains 375 mg romclostim ( as 25 mg ) in a deliveredable amountof 0 . 5 ml solution , each milliliter ( ml) contains 250 mg romoplostim and each 500 ml vial delivers 625 mg
this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to help breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the effects of this medicine on the everyday life of people with copd .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using tovanOR breez inhaler - tell your doctor if you have kidney problems - tell the doctor if your doctor has told you that you have an eye problem called narrow - angle glaucoma ( difficulty passing urine ). treatment with tovannor breezer should be stopped immediately if you experience tightness of the chest , coughing , wheezing or breathlessness immediately
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the recommended dose is one inhaler once a day . this medicine is for use in adults , adolescents and children aged 24 years and over . the recommended starting dose is 75 inhalations once a week . you should use this when you are exercising or have a plan to exercise . how to use this medicinal product this medicine comes as an inhaler and capsules ( in blisters ) that contain the medicine ( inhalation powder ) and the capsules . the inhal
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopyroniumbromide equivalent to 50 microgram of glycopryronium . the delivered dose ( the delivered volume ) for the mouthpiece of the inhaler is 44 microgram glycopYRronium per inhalation dose . - the other ingredients of the formulation powder are lactose monohydrate and magnesium stearate . what tovanOR breez inhaler looks like and contents of the pack tovannor breezer 44 microspheres are hard
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by allowing the brain to produce more dopamine and serotonin which are involved in calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia and bipolar disorder . these are diseases characterised by symptoms such as ( schizophrenia ) hearing , seeing or sensing things which are not there , mistaken beliefs , incoherent speech and behaviour and emotional flatness . people with bipolar disorder may also feel depressed , guilty , anxious or tense . adasve can
do not take adasuve if you are allergic to loxapine or any of the other ingredients of adasuvet ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking adasuves if you have symptoms such as wheezing or shortness of breath , as these may be signs of lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness or short shortnessof breath . these may occur 25 in patients with neuroleptic malignant syndrome ( nms ). these
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg twice a day , taken once in the morning and once in 2 hours at the evening . your doctor may increase your dose to 4 . 5 mg twice daily depending on your condition . adasuve should be taken by mouth once a day . if you take more adasuva than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , show the tablet or the device that you have taken . if someone else accidentally takes your tablets ,
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following side effects : - any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness which may become irritating and difficult to control . these may be signs of problems with your airways ( asthma or copd ). - light - headedness or fainting . these could be signs that your blood pressure is not being controlled as well as it should . - worsening agitation , confusion , fever and muscle stiffness . these can be signs for a severe condition called neurole
keep out of the reach and sight of children . do not use adasuve after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do away with adasuves if you notice any visible signs of physical damage . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of loxepine . one delivers 4 . 5 mg loxpine . what adasuves looks like and contents of the pack adasuvel 4 .5 mg is a white to off - white plastic inhaler , with " loxphine " printed on the cap and " 4 . 0 " printed in black on the body . each inhaler is packed in a sealed foil pouch . adasuvet 4 . 4 . 6 mg is available in packs containing 1 or 5 inhalers . not
what azacitidine betapharm is azacitonidine betabarm is an anti - cancer agent which belongs to a group of medicines called ' anti - metabolites '. what azaccitidine betafarm is used for azaciticidine betaparm is for use in adults . azacuitidine betagarm is given to adults who have had a stem cell transplantation to treat : higher - risk myelodysplastic syndromes ( mds ) chronic myelomonocytic leukaemia ( cmml ) acute myeloid leukaemic ( aml ). these are diseases that
do not use azacitidine betapharm - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before using azacitonidine betafarm : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - tell your doctor if the person has liver disease . if the doctor has a heart condition such as heart attack or lung disease . blood test before and during
before starting azacitidine betapharm , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will tell you how much azacita betapham you need . your dose of this medicine will be adjusted by your doctor based on your height and weight . azaccitidine betafarm is given every 3 weeks as part of this " treatment cycle " ( cycle 4 , 6 ). this medicine is given under the skin ( subcutaneously ) on the skin of your thigh , tummy or upper arm . if you have any further questions on the use
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness or shaking , jaundice ( abdominal bloating and easy bruising ), which may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness or fatigue , which may also be symptoms or signs of kidney failure . a fever , which might be a sign of an infection due to low levels of white blood cells .
your doctor , pharmacist or nurse knows how to store azacitidine betapharm properly . they are responsible for the correct storage of any unused azaccitidine betabarm . this medicine is for single use only . keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . the exp date refers to the last day of that month . the suspension must be stored in a refrigerator ( 2 to 8 ). do not freeze . the azacituidine betafarm suspension must not be used if
what azacitidine betapharm contains - the active substance is azacitonidine . each vial contains 100 mg azaccitidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaciticidine . - the other ingredient is mannitol ( e421 ). what azacituidine betafarm looks like and contents of the pack azacITidine betabarm is a white to off - white powder supplied in a glass vial containing 100 mg of azacite .
celdelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher dementia type 1 is inherited condition in which the body produces too much glucosylceramide . this is especially toxic for the spleen , liver and bones . your doctor has prescribed eliglustate to help control glucosolceramide in your affected organs . your physician will test for this before you start using this medicine . if you have any further questions on the use of this medicine , ask your doctor or pharmacist . if your doctor thinks that cerdelga is inappropriate for
do not take cerdelga if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). if you take medicines called moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ) 31 if you have moderate cyc3a inhibitors ( such as erythromycin or itraconazole ). these medicines are used to improve your body ' s ability to absorb oxygen . warnings and precautions talk to your doctor before taking cerdelg . cerdelgas should not be used in patients with medicines that are a poor metaboliser (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet twice a day . the amount of metaboliser that you need to take depends on your condition and the amount you are taking . the dose of metabolizer that you take will depend on your body weight and your condition . the usual dose is two tablets twice a morning , one tablet once a day , with or without food . swallow the tablets with a glass of water . the maximum recommended dose for adults is 84 tablets twice daily . if you take more cerdelga than you should
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations throat irritation heartburn ( dyspepsia ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting dry mouth gas ( flatulence ) dry skin hives ( urtic
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the sleeve after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eliglustit . - the other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see section 2 ' cerdelaga contains lactose '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine ( e132 ), shellac , black iron oxide , propylene glycol and ammonia solution . what cerdelg looks like and contents of the pack cerdelgi
the active substance in zoledronic acid hospira is zoledron acid , which belongs to a group of substances called bisphosphonates . zoledor acid works by attaching itself to the bone and slowing down the rate of bone change . it is used : to prevent bone complications , e . g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the original bone ). to reduce the amount of calcium in the blood in adult people where it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium
your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . do not take zoledron acid hospir - if you are allergic ( hypersensitive ) to zoledic acid , another bisphosphonate ( the group of substances to which zoledoral acid belongs ). warnings and precautions talk to your doctor or pharmacist before taking zoledric acid hospiral : if you think any of the above apply to you , or if you have been in close contact with someone who has zoledonic acid hospirus , tell your doctor . if
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously ( into a vein ) and under ' iv ' administration . in order to avoid dehydration , you must drink plenty of fluids before and during treatment with zoledronic acidic hospira ( see section 4 , " important information about some of the ingredients of zoledron acid hospir "). if you have a kidney problem , your doctor may decide to lower the dose of zolingronic acid hospira . if you suffer from bone complications due to bone metastases , your first infusion of zedronic acid inhira
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects are : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will be determined by your doctor with certain specific blood tests ). low level of calcium in the blood . uncommon ( may affects up to1 in 100 people ): pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth . jaw discharge , numbness or a feeling of heaviness , or loosening of a tooth . these could be signs of bone damage in the jaw (
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly .
what zoledronic acid hospira contains - the active substance is zoledron acid . one vial of zoledor acid contains 4 mg zoledodronic acid . - the other ingredients are monohydrate , mannitol , sodium citrate and water for injections . what zoledico acid hospir looks like and contents of the pack zoledic acid hospire is a liquid concentrate for solution for infusion (' sterile concentrate '). each pack contains one vials of concentrate .
varuby contains rolapitant which is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) during cancer treatment chemotherapy . these nerve cells are important in helping your body fight against the brain and can help you to fight against vomiting . when you feel sick ( sick ) or are sick , rolapit works by stopping these nerve cell cells from working properly , which can cause nausea and vomiting .
do not take varuby if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). if you take an herbal medicine called st john ' s wort ( hypericum performatum ). if your doctor has prescribed varubchy for you . if you have depression or difficulty sleeping ( see section 2 " warnings and precautions "). if you do not take this medicine . if your dose is less than 27 mg / m2 . if any of these apply to you , tell your doctor . if so , tell the doctor . warnings and risks talk to your doctor before taking var
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 180 mg once a day for up to 90 days . swallow the tablet whole with a glass of water . you can take varuby with or without food . you may take it with or just after food . it is best to take the tablet at the same time each day . you should take it at least 2 hours before or 2 hours after food , at the start of your chemotherapy cycle . if you take more varubys than you should if you have taken more tablets than you
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with varuby : very rare ( may affect up to 1 in 1 , 000 people ): symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste , swelling or skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately , or go to the casualty department at your nearest hospital , and make sure you are properly hydrated and receive appropriate treatment . other side effects include : very common ( may affects more than 1 in 10
what varuby contains the active substance is rolapitant . each tablet contains 90 mg rolapit . the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubiy contains lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . what varubey looks like and contents of the pack varubchy
what enerzair breezhaler is enerz air breez inhaler contains two active substances : indacaterol and glycopyrronium - mometasone furoate indacterol and microcopyrroneium belong to a group of medicines called bronchodilators . they relax the muscles in the small airways in the lungs . this helps to open the airways and allows air to get in and out of the lungs more easily . mometsone fruate belongs to a class of medicines known as corticosteroids or steroids . corticoplastics reduce the swelling
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using enerzir if you have : heart problems - if your doctor has told you that you have an irregular or fast heartbeat - if the patient has thyroid gland problems - diabetes - if he / she has high blood sugar - if there are seizures - if they have severe kidney
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhaler twice a day . the medicine should be inhaled once a day at about the same time each day . use enerzair breezhaler every day , at the same times of the day . this will help you to remember to use it . it will help to control your asthma and reduce your symptoms . how to use enerzeair breezyzhalER use enertzair breezezhalcer as described in this leaflet . it is provided as an
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious stop using enerzair breezhaler and see a doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives . allergic reaction other side effects other side effect include the following side effects : very commonly ( may affects more than one in 10 users ): sore throat , runny nose , sudden difficulty breathing , feeling of tightness , wheezing or coughing
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . the capsules should be used immediately after opening . do this if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what enerzair breezhaler contains the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ), and mometasone furoate . each capsule contains 150 micrograms of indacate ( asacetate ), 63 microgram of glycopreyronium bromides , 50 microgram glycopyrsronium and 160 microgram mometsone furuate . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 114 microgram ( as carbonate ) of indiacaterol , 58 microgram(
clopidogrel acino pharma gmbh contains the active ingredient clopidodogrel which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidineogrelacino pharmá gmbhs is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of clopidineogrel macrogh . if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has told you that you suffer from severe liver disease . if this applies to you , do not take the next dose of clapidogrell acino pharmaceutical gmbhl . warnings and precautions talk to your doctor or pharmacist before taking clopridogrelac
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopridogrel aclara gmb h per day to be taken orally with or without food . you can take cloclidogl acino pi gmbH with or just after food . if you take more clopidoogrelacino pharmá gmbgh than you should contact your doctor , pharmacist or the nearest hospital emergency department because of the increased risk of bleeding
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the most common side effects are : common ( affects 1 to 10 users in 100 ) uncommon ( affects less than 1 user in 1 , 000 ) rare ( affects fewer than 1 users in 10 , 000 ). very rare ( affect less than1 user in 10, 000 ). not known ( frequency cannot be estimated from the available data ). contact your doctor immediately if you experience : fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . signs of liver
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . donot use cloplidogl acino pharmaceutical gmbhl if you notice any visible sign of damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will
what clopidogrel acino pharma gmbh contains the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : macromol 6000 ethylcellulose ( e462 ) titanium dioxide ( e 171 ) what clopIDogrelacino pharmá gmb h looks like and contents of the pack clopideogrel acute
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults who are taking medicines called ' antiretroviral medicines '. the active substances are doravirine ( a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine ( which is a nucleosides analogue reverse transcriptases inhibitor ( trti ) and tenofovir disoproxil ( which are all types of a nucleotide analogue reverse transcriptase inhibitor , nrti ). delstrigo can be used in adults 18 years and older . hiv is
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if you take any of these , tell your doctor or pharmacist . if your doctor has told you that you are taking any of : - the following medicines : carbamazepine , oxcarbazepine or phenobarbital , phenytoin ( medicines to prevent seizure ) rifampicin and rifapentine ( medicines used to treat tuberculosis ) st . john ' s w
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen of one tablet a day . a single tablet is sufficient for the treatment of hiv infection . the dose is 1 tablet a night . if you take certain medicines ( such as doravirine ) your doctor may prescribe medicines that lower the dose of this medicine swallow the tablet whole with a glass of water . do not crush , chew or break the tablet . taking this medicine take the tablet at the same time each day . if possible take delstrigo with food
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and see a doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea stomach pain vomiting wind ( flatulence ) hair loss rash muscle symptoms such as pain ( stiffness ) feeling tired fever blood tests showing increased levels in liver enzymes uncommon ( may affects up to 1 in 100 people ): nightmares , depression , anxiety , irritability , confusion , suicidal thoughts 45 trouble
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . keep the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substances are 100 mg doravirine , 300 mg lamivudine , 245 mg tenofovir disoproxil ( as fumarate ), croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumate . the other ingredients are a coating material containing carnauba wax e903 , hyprogellose , iron oxide yellow ( e172 ), lactose monohydrate , titanium dioxide e171
spravato contains esketamine . this belongs to a group of medicines called anti - depressants . this medicine helps to control your depression and reduces the symptoms of depression , such as feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and feeling of being slowed down . spravato is used in adults , adolescents and children aged 2 years and older . there are many different types of antidepressant medicines .
do not take spravato - if you are allergic to esketamine , ketamine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have an aneurysm ( a weak spot in a blood vessel wall that bulges out , which may increase the risk of bleeding in the brain ). - have recently had a heart attack . within 6 weeks of starting treatment , you may experience a temporary increase in blood pressure . serious complications in these conditions can occur , and spravo should not be used to treat them . tell your doctor immediately if you think any
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much spravato to use the spravatos nasal spray is for oral use . the nasal spray device is for use in adults . use in children and adolescents the recommended dose is 1 spray ( 2 sprays ) per kg body weight . there are 3 nasal spray devices . one nasal spraydevice is for administration in children ( 4 weeks to less than 4 years of age ). spravat is for inhalation use . use within 2 hours after the first dose of this medicine . if you use more
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with spravato : very common ( may affect more than 1 in 10 people ) feeling disconnected from others , feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity to touch in the mouth area spinning sensation ( vertigo ) vomiting nausea common ( might affect up to 1 in every 10 people ): feeling extremely happy ( euphoria ) feeling agitated feeling anxious feeling in the eyes , ears or sense of touch are impaired or blocked irritable panic attacks change in perception 37 feeling ,
what spravato contains - the active substance is esketamine . each nasal spray device contains esketam hydrochloride equivalent to 28 mg esketa . - the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what spravat looks like and contents of the pack spravatos is a nasal spray solution . this medicine is a clear , colourless solution for use in children . spravata is available in packs containing a single - use nasal spray unit . spreamato is available as packs containing 1 , 2 , 3 or 6 nasal
zerbboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . this type of cancer is caused by a change ( mutation ) in a gene responsible for the growth of melanoma . zelboraf targets proteins that are involved in the growth and spread of your cancer .
do not use zelboraf if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . if you think any of these apply to you , tell your doctor or nurse before using zelberaf . allergic reactions if allergic reactions occur during treatment with zeloraf , tell the doctor or hospital pharmacist immediately . if severe skin reactions occur , tell them immediately . severe skin reaction if you have any of those , tell their doctor or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 4 mg tablet once a day for up to 8 weeks . your doctor may increase your dose to 4 mg once a week if you experience side effects . your treatment with zelboraf may be stopped if you suffer from vomiting . take zelberaf once a daily . zelbearingaf should be taken on an empty stomach . swallow the tablet whole with some water . do not chew or crush the tablet . if you take more zelbaf than you should if you
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions may occur : swelling of the face , lips or tongue difficulty breathing rash fainting sensation stop taking zelberaf and tell your doctor immediately if you notice any of the following symptoms : radiation treatment may cause side effect associated with radiation . zelbaf treatment may also cause radiation to affect the skin , esophagus , bladder , liver , rectum , and lungs . tell your physician immediately if your doctor notices any of these symptoms : skin rash , blistering , peeling or discoloration of the skin
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and blister after exp . the expirability of the product does not require any special storage conditions . do this after the word " exp ". the expirairy date refers to the last day of that month . do away with the blister after this month . this medicine does not need any special temperature storage conditions if you notice any change in the appearance of the blister . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemurabenib ( as a co - precipitate of veMurafenb ). the other ingredients are : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating : iron oxide , macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). what zelberaf looks like and contents of the pack zelb
duoplavin contains clopidogrel and acetylsalicylic acid ( aca ). aca belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , blood vessels relax and blood vessels are formed . antiplatelets medicinal products reduce the chances of blood clots forming ( a process called atherothrombosis ). duoplavic is taken to prevent blood clumps forming in hardened arteries , a process known as atherostrombotic events , which can lead to
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( asca ) or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic , if you have been previously treated with other products called non - steroidal anti - inflammatory products . if you suffer from painful and / or inflammatory conditions of muscles or joints . if your doctor has told you that you have a medical condition ( e . g . asthma , nasal discharge , runny nose , polyps ( a type of growth in the nose ). if you currently
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take duoplavin at the same time each day . your doctor will tell you how many tablets of your medicine to take . if you take more duoplin than you should if you have accidentally taken too many tablets , or if someone else has taken your tablets , tell your doctor immediately . if possible , take the tablet with you and then go back to your regular dosing schedule . if necessary , take your tablet at the usual time .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any visible sign of deterioration . donot throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duoplin 75 mg film - coated tablets each tablet contains 46 tablets of the active substances : clopidogrel , acetylsalicylic acid (asa ) 75 mg : clopsidogel ( as hydrogen sulphate ) 75mg : acetylSalicylic acids , mannitol , macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose , maize starch , hydrogenated castor oil ( see section 2 ' duopllin contains hydrogenatedcastor oil '), stearic acid and colloidal anhydrous
simbrinza contains two active substances , brinzolamide and brimonidine tartrate . brin zolamide belongs to a group of medicines called carbonic anhydrase inhibitors . brimonine tartrate belongs to the group of medicine called alpha - 2 adrenergic receptor agonists , which reduce pressure within the eye . simbrinz is used to treat pressure in the eyes in adults aged 18 years and older who have eye conditions such as glaucoma , ocular hypertension ( high pressure in one or both eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides if you have ever taken medicines for diabetes or infections if you take diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors if you do not take medicines for depression or parkinson ' s disease if you start taking certain antidepressants if you stop taking any antidepressant medicines if you suffer from severe kidney problems if you retain too much acidity in your blood (
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . simbrinza should only be used in the eyes . avoid touching the affected eye or eyes with your hands . step 1 step 2 step 3 step 4 step 5 step 6 step 7 step 8 step 9 step 10 step 12 step 14 step 15 step 15 take the bottle out of the bottle and put it back in the carton . twist off the cap and snap collar . hold the medicine between your fingers . tilt the bottle back . pull down the eyelid with a clean finger and insert a ' pocket
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : if you have a reaction to the medicine ( frequency not known ): signs of an allergic reaction may include : severe skin reactions , rash , redness or itching all over your body or eyes trouble breathing , chest pain , or irregular heart beat tell your doctor immediately extreme tiredness or dizziness . the other side effects that may occur with simbrinza are : other medicines containing brinzolamide or brimonidine . common side effects ( may affect up to 1 in 10 people ) effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . after first opening , use within 4 weeks to prevent infections . use a new bottle immediately . do away with the bottle after this time period . do this every time you take simbrinza . do you notice any change in the appearance of the tablets ? do not throw away
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of brinza and 2 mg of of brimonididine tartate equivalent to 1 . 3 mg of Brimonidine . - the other ingredients are benzalkonium chloride ( see section 2 " simbrinusza contains benzalkonaium chloride "), propylene glycol , carbomer 974p , boric acid , mannitol , sodium chloride , tyloxapol , hydrochloric acid , sodium hydroxide , purified water , hydroch
filgrastim ratiopharm contains the active substance filgrastam . filgrasterim is a protein produced by biotechnology in bacteria called escherichia coli . it is similar to a natural protein produced in the body called granulocyte - colony stimulating factor ( g - csf ). filgrasteim stimulates the bone marrow to produce new blood cells . more blood cells are needed than white cells . white cells are important as they help your body fight infection . filfilgrasteriophARM helps to increase the number of white blood cells in your body . filgrimastim ratiopharm is
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgrateim or any of the other ingredients of filgrasteim ratisopharm . warnings and precautions talk to your doctor or pharmacist before using filgrustim ratitopharm : - if your child has a cough , fever or difficulty breathing . this may be a symptom of a pulmonary disorder . other possible side effects are : - sickle cell disease 57 - if the child gets left upper abdominal pain or pain at the tip of your shoulder . this might be a sign of a spleen disorder .
how much filgrastim ratiopharm is given the amount of filgrateim ratisopharm you will receive will depend on your condition and on how well filgrasteim ratitopharm works for you . your doctor will decide how many days filgrustim ratiotopharm treatment with filgrasim raticoopharm will last . the usual dose of chemotherapy is 0 . 5 mg per kilogram body weight . this is given every 60 days . your treatment will last approximately 14 days . some disease types may be more severe . the recommended dose of fil grastim ratiopharm
you must not be given filgrastim ratiopharm if you have sickle cell disease 57 you feel left upper abdominal pain or pain at the tip of your shoulder . this may be a sign of a spleen disorder . see section 4 . if you experience any of the following side effects , your doctor may order regular blood tests before you are given filbrastim ratiopharm . the number of neutrophils ( a type of white blood cells ) in your blood may be increased during treatment . other medicines and filgrASTim ratisopharm tell your doctor or pharmacist if you are taking ,
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . donot use filgrimastim piriopham if the solution is cloudy or contains particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgrasim . each ml of solution for infusion contains 60 mg of filgrateim . filgrasterim ratisopharm 30 mg : each pre - filled syringe contains 0 . 5 ml of filgnastim in 0 . 0 ml solution . filgnasterim ratiopharm 48 mg : one pre -filled syringe containing 48 mg of filmgrastrim in 0. 8 ml solution for injection . - the other ingredients are sodium hydroxide , glacial acetic acid , sorbitol , polysorb
what riluzole zentiva is riluxole zentiniva contains rilusole which belongs to the class of substances that affect the nervous system . what rilizole zsentiva is used for rilukole zertiva is given to adults with amyotrophic lateral sclerosis ( amy ) motor neurone disease . it affects the nerve cells that carry muscles , causing weakness , muscle waste and paralysis . this causes the destruction of nerve cells . motor neurones disease may also cause too much glutamate ( a chemical messenger ) in the brain and spinal cord . rilzole zintiva works by
do not take riluzole zentiva - if you are allergic to rilizole or any of the other ingredients of this medicine ( listed in section 6 ). - if any liver disease has been reported . - if your doctor has found increased blood levels of some enzymes of the liver called transaminases . - tell your doctor if you think you may be pregnant . warnings and precautions talk to your doctor or pharmacist before taking rilzole zenta : - if : you have any liver problems . - you have yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . the tablets should be taken by mouth once a day , preferably at the same time each day . if you take more riluzole zentiva than you should contact your doctor , pharmacist or your nearest hospital emergency department immediately . if possible take rilzole zenta with food . if a child swallows some tablets , contact your physician immediately . do not take a double dose to make up for a forgotten dose . if your child swallips some
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ) during treatment with riluzole zentiva there may be a decrease in the number of white blood cells . your doctor will take a blood sample to check for this . white blood cell counts are important for fighting infections . if you have any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor may do regular blood tests
what riluzole zentiva contains the active substance is rilusole . the other ingredients are : - core : anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrated colloidal silica , magnesium stearate , croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what rilizole zsentiva looks like and contents of the pack the tablets are white to off - white , round , biconvex , marked with ' 50 ' on one side and ' ril ' on the other side
emgality contains the active substance galcanezumab , a medicine that blocks the activity of a protein called calcitonin gene ( cgrp ). migraine is a condition in which patients have increased levels of cgrtp . emgality is used to treat migraine in adults , adolescents and children aged 4 years and above . migraines are a common symptom of migraine . emigality can reduce the frequency of migraine headache and improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease . serious cardiovascular diseases can lead to allergic reactions emg abnormality can cause serious allergic reactions . these reactions may be life - threatening . you should see your doctor immediately if you experience 40 signs of a serious allergic reaction . such signs and possible side effects are listed in appendix 4 . children and adolescents emgally is not recommended for children and teenagers under the age of 18 years . other medicines and emgals tell your doctor or pharm
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg / m2 body surface area . emgally will be given under your skin ( subcutaneous injection ). you will receive your emgalis injection with proper training . if you have been given more emgals than you should if you think you have received more emgsality than you have needed , tell your doctor . if more emmality than has been given you should contact your doctor immediately . if a dose is missed , your doctor will give you a double
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions ( rare , may affect up to 1 in 1 , 000 people ) may include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash , raised bumps . other side effects very common side effects ( may affect more than 1 in 10 people ) injection site pain injection site reactions may include red skin , itching
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store at room temperature ( up to 30 ). do this medicine if you notice that the solution is not clear or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcaneszumumab in 1 ml solution . - the other ingredients are l - histidine , l - ethidine hydrochloride monohydrate , polysorbate 80 , sodium chloride , water for injections . what emgalis looks like and contents of the pack emgally is a solution for injection in a clear glass syringe . the colour is clear to slightly yellow . the syringe is provided in a pack containing one single - dose pen . pack sizes of 1 , 2
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hav ) in which the blood vessels in the liver become damaged and blood clots are formed . it can be used in adults , adolescents and children who have not received medicines prior to a stem cell transplantation . defibrorotide works by helping the blood arteries to open , so that the blood clasts can be removed . if you have any further questions on the use of this medicine , ask your doctor or pharmacist .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) if you have been previously treated with other medicines to prevent blood clots ( tissue plasminogen activator warnings and precautions ) if any of these apply to you , tell your doctor before using this medicine . warnings and measures if you : - have bleeding , especially heavy bleeding if you need a blood transfusion or surgery if you suffer from problems with blood circulation or a constant blood pressure . children and adolescents defitelo is not recommended for children and young children under 1 year
the treatment with defitelio will be started by a doctor who is experienced in the treatment of stem cells transplantation . it will be given to you by your doctor or nurse as an ' intravenous infusion ' ( drip ). you will be observed during this treatment for 21 days until your symptoms improve . if you are more than 18 years old , you will receive more defiteloio than you should . if a dose is missed , tell your doctor . if your doctor thinks that you are not responding to the treatment , he or she may give you another dose . if the missed dose is more than 21 days , tell the
like all medicines , defitelio can cause side effects , although not everybody gets them . stop taking defiteloio and see a doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): low blood pressure common ( might affect up to 1 in every 10 people ) bleeding in general bleeding in the nose bleeding in parts of the brain bleeding in part of the gut vomiting blood bleeding in one or more parts of one of the lungs bleeding in blood in the urine and in the mouth bleeding in other parts of your body including the skin coagulopathy ( disturbance in
keep out of the reach and sight of children . do not use defitelio after the expiry date which is stated on the vial label and carton after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do use defnitelio if you notice that the solution is cloudy or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains the active substance is defibrotide . each ml of 2 . 5 ml solution contains 200 mg of defibrorotide ( as mesilate ). each ml solution provides 80 mg of the active substances in defibotide . the other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ), water for injections ( see section 2 " defitelsio contains sodium "). what defitELio looks like and contents of the pack defiteloio is a clear , colourless to pale yellow solution for infusion . it
daklinza contains the active ingredient daclatasvir . hepatitis c is an infectious disease that affects the liver caused by the hepatitis c virus . this medicine works by stopping the hepatitisc virus from multiplying in your body . this reduces the amount of the virus in your blood . daklinz is used in combination with other medicines to treat hepatitis c infection . the other medicines that you will be taking with daklanza are : - combination with daclatinza with other medicine to treat the hepatitis k infection . your doctor will discuss with you which combination of the other treatments is best for you . if you
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) or to any of those substances by mouth . if you take any of these medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( used to prevent epileptic seizures ) rifampicin , rifabutin and rifapentine ( antibiotics used to treat tuberculosis ) dexamethasone ( a steroid used to correct allergic and inflammatory diseases ) medicines containing st . john ' s wort
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is one 60 mg tablet once a day . do not take more than this dose once a week . do this twice a day to avoid unpleasant taste . daklza may be taken with some other medicines . if you take more daklanza than you should if you have taken more dailinza than your doctor tells you to , contact your doctor . if possible , take these medicines as directed by your doctor , and then take your daily dose of t
like all medicines , this medicine can cause side effects , although not everybody gets them . daklinza in combination with sofosbuvir and ribavirin has been associated with the following side effects : very common ( may affect more than 1 in 10 people ): headache fatigue common ( might affect up to 1 in every 10 people ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when taking dakinza in tandem with sofuosbuvirin , the following other side effects have been associated : common ( likely to affect up in every 1 in 100
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclaasvir ( as dihydrochloride ). - the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide , macrogol 400 , indigo carmine aluminum lake ( e132 ) and yellow iron oxide ( e172 ) 51 what daklineza looks like and contents of the pack
proquad is a vaccine to protect against measles , mumps , rubella , and chickenpox ( varicella ) viruses . when a person is given the vaccine , the body ' s natural defences ( immune system ) will produce antibodies against the measles , rubles , mits , ruble or varicelluses . the antibodies help to prevent diseases caused by these viruses . proquad is used in adults and adolescents aged 9 years and older who have not received national vaccination schedules . measles is caused by live viruses . it can be caused by measles , measles , rumps , or rubella ( varica ). the
do not use proquad if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine , or any of the other ingredients of this vaccine ( listed in section 6 ) if you have a blood disorder or type of cancer that affects the immune system , or if treatment with medications that weaken the immunesystem ( e . g . low - dose corticosteroid therapy , asthma or replacement therapy ) if your child has a weakened immune system due to a disease ( including aids ) if he / she has congenital or hereditary immunodeficiency ( immune competence ) if the child has active untreated tuberculosis
proquad is given as an injection into the muscle or under the skin ( usually in the thigh or upper arm ). injections will be given into the upper muscle ( usually into the thigh area ) or into the arm . if you have a blood clotting disorder or low levels of platelets , the vaccine should not be given under the sun . injecting under the same skin will not reduce bleeding . proquad will not be injected into a blood vessel . pro quad is given to infants and children from 9 months of age and adolescents from 12 months of ages with chickenpox and measles . prorant is given for 12 months to less than 12
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions such as hives may occur . if these reactions occur , you may have difficulty in breathing or swallowing . if you have an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad include : uncommon ( may affect up to 1 in 100 people ): seizures ( fits ) with a fever rare ( may effect up to1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ). other side side effects reported with the use of proquad are :
what proquad contains the active substances are : measles virus1 , edmonston strain ( equivalent to 3 . 00 mg mumps virus1 and jeryl Flynn™ ( level b ) strain ( corresponding to 4 . 30 mg mrc ) rubella virus2 , strain (ivalent to 3. 00 mg varicella virus3 and merck strain ( similar to 3 .. 99 mg mcrc ) tissue culture containing plaque - forming units 1 , 2 , 3 , 4 , 5 , 6 , 8 , 8 cells , chickembryo cells ( fibroblasts ) mrc . the other ingredients are : powder suc
jylamvo is an anticancer medicine that reduces unwanted reactions . it is an immunosuppressive agent . it works by reducing the inflammatory effect of jylamv on rheumatic and skin diseases . it can be used : for active rheumatoid arthritis ( where the polyarthritic forms of the joints are absent ) for severe juvenile idiopathic arthritis ( jia ) in children 3 years of age and older . it may also be used in combination with non - steroidal anti - inflammatory drugs ( nsaids ) for inadequate o severe or disabling psoriasis in patients who have responded to treatment
do not use jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe kidney impairment if you suffer from a liver impairment if your doctor has told you that you have blood disorders such as bone marrow hypoplasia , leukopenia , thrombocytopenia or significant anaemia 34 if you know that you may have a weakened immune system if you think you have or have ever had a serious infection such as tuberculosis or hiv if you develop ulcers in the stomach or intestines ( an inflammation of the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo can cause severe side effects , sometimes leading to even death . your doctor will discuss these with you and will adjust the dose and duration of the treatment . rheumatoid arthritis severe juvenile idiopathic arthritis severe psoriasis severe psoriatic arthritis jylimvo is used as a long - term treatment . jjylamv is used in rheumatic and skin diseases such as jia , psorism and psoriatics arthritis . your physician will determine the
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching affecting your whole body . other possible side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising , nose bleeds nausea , vomiting , abdominal discomfort , severe diarrhoea mouth ulcers , black or tarry
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect the medicine from accidental spillage . do away with the vial once it has been opened . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotexate . - the other ingredients are macrogol 400 , glycerol , orange flavour , sucralose , ethyl parahydroxybenzoate ( e218 ), sodium methyl parahhydroxybenzzoate , citric acid , tri - sodium citrate , purified water ( see section 2 " jylimvo contains ethyl parahydroxy benzoate and sodium methyl parahydrobenzoates "), and water for injections . what jyarmvo looks
what enurev breezhaler is this medicine contains glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what enurevo breez inhaler is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . this makes breathing difficult . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this means that this medicine helps to lower the
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have kidney problems . - if the doctor has given you an eye problem called narrow - angle glaucoma . - tell your doctor if you have difficulty passing urine . treatment with enurevi breez inhaler should be stopped immediately if you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using enurevo breezer . this could be a
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose of this medicine is one inhaler twice a day . you can use this in the morning and evening , and for 24 hours at 75ºc and up . you should use this this medicine every day . how to use this medicinal product comes in different pack sizes . each pack contains an inhaler and capsules ( in blisters ) that contain the medicine as inhalation powder . the capsules are provided in separate blisters . the inhaler is for
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious . tell your doctor immediately if you experience any of the following : uncommon ( may affect up to 1 in 100 people ): irregular heart beat high level of blood sugar ( hyperglycaemia ). typical symptoms are excessive thirst , hunger ( frequent urination ), rash , itching , hives , difficulty breathing or swallowing , dizziness . allergic reaction may include swelling mainly of the tongue , lips , face or throat ( angioedema ). if any of these side effects gets serious , tell your physician immediately . some other side
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyroniumbromide ( equivalent to 50 microgram of glyopyrronia ). - the delivered dose ( the delivered amount that leaves the mouthpiece of the inhaler ) is 44 microgram glycopyrsronium . - the other ingredients of the formulation powder are lactose monohydrate and magnesium stearate . what enurevan breez inhaler looks like and contents of the pack enurevo breezer 44 microlitre inhalation
riximyo contains the active substance rituximab , a type of protein called a " monoclonal antibody ". it sticks to a target in a type called a white blood cell called " b - lymphocyte ". when ritukimab sticks to the target , it stops the cell from growing and dies . how riximyo works riximusyo is used for the treatment of several different conditions . rixima is used to treat : a ) non - hodgkin ' s lymphoma this is a disease of the lymph tissue that affects the immune system . it affects a type in the
do not use riximyo if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection at the moment . if you suffer from a weak immune system . if your doctor has told you that you have severe heart failure or severe uncontrolled heart disease ( granulomatosis , polyangiitis , microscopic polyangitis or pemphigus vulgaris ). warnings and precautions talk to your doctor or pharmacist before using riximusyo . if any of
your doctor will decide how much riximyo you will receive and how often you will need this treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . if you have any side effects , your doctor may decide to change your dose . riximusyo is given as a drip ( intra - venous infusion ). medicines given before each riximeyo administration you will be given rixamyo together with other medicines ( premedication ) to reduce the risk of side effects . your doctor will also tell you how long you should continue your treatment . for non
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate and will generally disappear after a few days of treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy or runny nose , vomiting , flushing or palpitations , heart attack , low
what riximyo contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab in 10 ml . each 50 ml vials contains 500 mg of the active ingredient in ritiximab , in 10ml solution . the other ingredients are sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide and hydrochloric acid ( see section 2 " rixamyo contains sodium "). what rixima looks like and contents of the pack riximusyo is a clear to slightly yellowish solution for infusion . it is supplied
topotecan actavis contains the active substance topotecin . topotecaan activ is used to treat small cell lung cancer that has come back after chemotherapy or has advanced cervical cancer that cannot be removed by surgery or radiotherapy . in this case topotican actv treatment is combined with medicines containing cisplatin .
do not use topotecan actavis - if you are allergic to topotecaan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using topotocan activ . your blood cell counts may become too low . your doctor may need to adjust your dose of topotican actis . - if your doctor has told you that you have any kidney problems . your dose should be adjusted before using this medicine . warnings and symptoms talk to a doctor or nurse before using the topotcan actv : - if severe kidney impairment
your doctor will determine the dose of topotecan actavis you will receive based on the results of blood tests carried out before treatment and on your response to treatment . adults small cell lung cancer : the usual dose is 1 . 5 mg per square metre of body surface area for the first 5 days of this treatment cycle . women with cervical cancer : a dose of 0 . 75 mg per sq metre of surface area , for the second 3 days of the treatment cycle , and will be treated at the same time each day . cervical cancer is treated with another anticancer medicines , cisplatin . cisplin is used to treat
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious sideeffects : infections very common ( may affect more than 1 in 10 people ): fever . this may be a sign of your general condition . local symptoms include sore throat , burning sensation , severe stomach pain , fever , diarrhoea and bowel inflammation ( neutropenic colitis ). topotecan actavis may reduce your ability to fight infections . lung inflammation rare ( may effect up to 1 in 1 , 000 people ): difficulty in breathing , cough and fever .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiratory date refers to the last day of that month . keep the vials in the outer carton in order to protect from light . after reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 and 2 to 8 , when stored in a refrigerator ( 2 to 9 ). the drug product solution for dilution in solutions for infusion ( nacl 0 . 9 %) has been
what topotecan actavis contains the active substance is topotan . each vial contains 1 mg or 4 mg topotecaan ( as hydrochloride ). after reconstitution , 1 ml contains 1mg topotican . the other ingredients are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide . what topoticonan actis looks like and contents of the pack topottecan actalis is a white to off - white cake with grey bromobutylic stopper and aluminium seals with plastic flip - off caps and a protective sleeve
the active substance of rivastigmine hexal is rivustigmine . rivestigmine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivostigmine works by blocking the enzymes that break down acetylCHoline : acetylchlorolinescerase and butyrylcholinestersterase .
do not take rivastigmine hexal - if you are allergic to rivasta ( the active substance in rivostigminehexal ) or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a previous skin reaction known as allergic contact dermatitis . warnings and precautions talk to your doctor or pharmacist before taking rivstigmine Hexal . if any of these apply to you , tell your doctor before taking the medicine . warnings , precautions and precautions tell your physician before taking : - if any patient of childbearing age has irregular or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . depending on how you respond to treatment , the highest dose may be 6 . 0 mg twice a day . your doctor may also increase your dose depending on your weight . your dose will depend on your response to this medicine . if you take more rivasta hexal than you should if you have taken more rvastigmin hexal in more than
like all medicines , this medicine can cause side effects , although not everybody gets them . you may get side effects more often when you start your medicine or when your dose is increased . the side effects that have been reported are : very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common ( might affect up to 1 in every 10 people ): anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite nightmares uncommon ( may affects up to1
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . the expirability refers to the last day of that month . do store below 30 . do this in the original package in order to protect from moisture .
what rivastigmine hexal contains 64 the active substance is rivasterigmine hydrogen tartrate . the other ingredients are : hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ), shellac . each rivasta hexal 1 . 5 mg capsule contains 1 . 25 mg of rivostigmine . each vial of each rivanastigme hexal 3 mg capsule releases 3 mg of the active ingredient in each riva . eachriv
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat kidney cancer ( renal cell carcinoma ) or liver cancer in patients who have previously received a specific anticancer medicine containing sorafenib . how cabometyx works cabometx blocks the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels . by blocking the action , these proteins can cause high amounts in cancer cells . cabomety is used in adults .
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabometx : - if your doctor has told you that you have high blood pressure - if the doctor has recently told you you have an aneurysm ( enlargement or weakening of a blood vessel wall ) or a tear in a blood valve wall - if this has happened to you - if diarrhoea has been reported - if any of these apply to you ( or you are not sure ),
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take this tablet at the same time each day . your doctor may increase your dose depending on how you respond to your treatment . this will help reduce the risk of serious side effects . your treatment with cabometyx will usually last for 60 days . you will usually start taking cabometometyx at least 2 hours before your next meal . you may take cabometx for 1 hour before your first meal . swallow the tablet whole with some water . do
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx and other medicines : tell your doctor straight away if your side effects get serious or if you notice any of the following serious side effects you may need urgent medical treatment : symptoms include pain in the abdomen ( nausea ), vomiting , constipation , fever . these may be signs of a gastrointestinal perforation ( a hole that develops in the stomach or intestine ). severe or uncontrollable bleeding . symptoms include vomiting blood , black stolls , bloody urine , headache , coughing up blood , swelling , pain in your
what cabometyx contains the active substances are cabozantinib and malate . cabometx 20 mg tablets : each tablet contains cabozatinib ( s ) and malates . each tablet of 20 mg contains caboxantinab . cabobometyx 40 mg tablets: each tablet contain cabozutinib_( s ) or malate and each tablet releases 40 mg cabozANTinib . cabibometyx 60 mg tablets contain caboxatinab ( s ), and malacy . each tablets releases 60 mg caboxistinib in each tablet . the other ingredients are : tablet
pemetrexed hospira is a medicine used in the treatment of cancer . pemetrexED hospira will be given to you in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . pemrexedospira will also be given in combination to cisplin for the initial treatment of patients with advanced stage of lung cancer . when pemetxed hospiera is given to treat lung cancer , your disease will be treated at once with treatment
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreed or any of the other ingredients of this medicine ( listed in section 6 ). - if breast - feeding is not recommended during treatment with pemetemetrexED hospira . - if your child has recently received or is about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using pemetxed hospir : - if there are any concerns about your kidneys . before you receive pemetrixed hospire , your doctor will have given you an infusion of some of your
the dose of pemetrexed hospira is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your entire body . your doctor will work out this body surface area using a number of different methods of treatment , depending on your blood cell counts and on your general condition . when mixed with the pemetreed hospir powder 9 mg / ml ( 0 . 9 %) solution for injection will be mixed with sodium chloride solution before it is given to you . pemetresed hospire will be given to your doctor by infusion into one of
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever or infection ( common ): if you have a temperature of 38ºc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you get chest pain ( common ) or a fast heart rate ( common ). if you are having pain , redness , swelling or sores in your mouth ( very common ) allergic reaction : if you develop skin rash ( common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . chemical and physical in - use stability of reconstituuted and infused solutions of pemetrexed were demonstrated for 24 hours at refrigerated temperature . the reconstuted solution should be administered immediately after preparation . parenteral medicines : if there is disc
what pemetrexed hospira contains the active substance is pemetreed . pemetrixed hospiras 100 mg : each vial contains 100 mg of pemetereed ( as pemetretrexed disodium hemipentahydrate ). pemetoxed hospiry 500 mg : one vial of 500 mg of dispemetrexED ( as dispemetreted dis sodium hemiptahydrates ). pemrexedospira 1 , 000 mg : the active ingredient is petrexed . after reconstitution , the solution contains 25 mg / ml of pemphrex
what ganfort is ganint contains two active substances called bimatoprost and timolol . both help to reduce pressure in the eye . bimAToprost belongs to a group of medicines called prostamides , which work together by blocking a prostaglandin analogue in the body . timolole belongs to medicines called beta - blockers . what ganf looks like and contents of the pack ganart is a clear , watery liquid that is injected into the eye by your eye . ganit is used in the treatment of glaucoma in adults . gavanfort eye drops
do not use ganfort eye drops if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ) if you have respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( signs include wheeziness and difficulty in breathing , especially if you suffer from long - standing cough ). if you know that you have heart problems ( signs may include low heart rate , heart block or heart failure warnings and precautions talk to your doctor or pharmacist before using this medicine if you : have coronary heart disease ( symptoms
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to use ganedfort your eye will be checked regularly during treatment . the bottle is for single use only . the tip should not be put into your neck . 5 . gently squeeze the bottle . 1 . wash your hands . do not touch your head . 2 . pull down your eyelid , which is a small pocket . 3 . gently press the cap back into place . do this once a day . do it at about the same time each day . if you use more ganf than
like all medicines , ganfort can cause side effects , although not everybody gets them . the drops can cause them . side effects of ganart ( multi - dose or single - dose ) are : very common side effects ( may affect more than 1 in 10 people ) the eye redness common side effect ( may affects up to 1 in 9 people ) 100 the eye burning , itching , stinging , irritation of the conjunctiva ( the transparent layer at the back of the eye ), sensitivity to light , eye pain , sticky eyes , dry eyes , feeling of something in the eye , small breaks in the surface of the
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . ganf should be used within 4 hours after first opening . do this as your doctor or pharmacist has told you . do so and follow these measures .
what ganfort contains - the active substance is bimatoprost ( 0 . 3 mg / ml ) timolol . each bottle contains 5 mg of timolole maleate in 6 . 8 ml solution . - the other ingredients are benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid and sodium hydroxide . what ganFort looks like and contents of the pack ganf is a clear to slightly yellow , round , clear liquid . it is supplied in a plastic
gefitinib mylan contains the active substance gefitinib . this protein is produced by biotechnology in cancer cells . gefitoninib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefitoninib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking gefitalinib melan if : you have any other lung problems . some lung problems may be serious . gefinib yourlan should not be used if you have problems with your liver . gifitin ib mylan should be used in children and adolescents under 18 years of age . other medicines and gefilitinib tell your doctor if you take , have recently taken
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet once a day . you can take the tablet with or without food . you may take antacids on an empty stomach for 2 to 1 hour before or after food . take gefitinib mylan at about the same time each day . if you have trouble swallowing the tablet , you can crush it and mix it with any other liquids . the tablet can be taken with or just after food , with or immediately after a meal . the total recommended daily dose
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever . these may be signs of an inflammation of the lungs called ' interstitial lung disease '. uncommon ( may affect up to 1 in 100 people ) gefitinib may cause severe skin reactions affecting parts of the body .
what gefitinib mylan contains - the active substance is gefITinib . each film - coated tablet contains 250 mg of gefinib - the other ingredients are lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidon ( k30 ), sodium laurilsulfate , magnesium stearate . - the tablet coating contains polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide red ( e 172 ). what gefitoninib melan looks like
reblozyl contains the active substance luspatercept which is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms can be a low red blood cell count ( anaemia ) which can be caused by lack of red blood infusion . reblozey is used : to treat anaemia in adults with mds who cannot be treated with red bloodcell transfusions , in combination with erythropoietin therapies ( i . e . beta - thalassaemia
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant ( it is also better to avoid rebluzyl in early pregnancy see pregnancy section ). warnings and precautions talk to your doctor or pharmacist before taking this medicine if you have thalassaemia ( a condition where your spleen removed ) or have had a blood clot . if you need hormone replacement therapy following a previous blood clot , your doctor may recommend preventive measures ( including medicines used to prevent a blood clot ). if any of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests to make sure that you are fully protected . how much reblozyl is given the recommended dose of rebl ozyl is one injection under the skin . the injections should be given every three weeks . the recommended starting dose is 1 . 0 mg for every kg of body weight . your dose may be increased or decreased depending on your blood pressure . how often reblzyl is used in patients with myelodysplastic syndromes the maximum single dose
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or in parts of the body , blurred vision , which may be symptoms of a stroke . blood clots swelling in the area around the eyes , face , lips , mouth or tongue throat allergic reactions , rashes 36 reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . very common side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expirability date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for up to 25 hours when stored at 2 8 . do away with any unused medicinal product or waste material . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what reblozyl contains the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg of luspaterscept . after reconstitution , each mlof solution contains 50 mg of the active ingredient luspetercept . the other ingredients are excipients , citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ), sodium hydroxide ( for pct and ph adjustment ). what rebl ozyl looks like and contents of the pack rebloxyl is a white to off - white powder . rebloyyl 25 mg
fotivda contains the active substance tivozanib , which is a protein kinase inhibitor . tiv ozanib works by stopping the growth of the cancer by stopping cancer cells from growing and forming new blood vessels . fotivd is used in adults with advanced kidney cancer when other treatments ( alpha or interleukin - 2 ) have not helped to stop your disease or have not worked .
do not take fotivda if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have been told that you have a problem with your heart . if you take st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking fotiveda if any of these apply to you . high blood pressure do not take more fotifda than your doctor has recommended . your doctor will check your blood pressure regularly . fotiva is
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fotivda is 1340 mg once a day for 21 days ( 7 capsules per day ). this means that you will take 1 capsule in the morning and 1 capsule once in the evening . this means you will usually take 4 capsules in the mornings and 4 capsules once in a day . if you take more fotvda than you should if you have taken too many capsules , you may experience unacceptable side effects . severe side effects may occur during fotvelda therapy . the
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure ( this side effect can occur in more than 1 in 10 people ) tell your doctor immediately if you experience any of the following : - high bloodpressure with symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor may want to monitor your blood pressure more closely while you are taking fotivda . high blood hypertension may be treated with a medicine to treat your high blood blood pressure . if you take more fot
what fotivda contains the active substance of fotive is tivozanib . each tablet contains 890 mg of tivuzanib ( as tiv ozanib hydrochloride monohydrate ). the other ingredients are : tablet core : 890mg tivzanib , mannitol ( e421 ), magnesium stearate . capsule shell : gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ), propylene glycol ( e1520 ) and strong ammonia solution ( e524 ). printing ink : titanium dioxide , tartrazine
stribild contains the active substances elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of elvitesgravira emtricitabine , an antiviral medicine called a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir disoproxil , an antitroviral medication called a nucleotide reverse transcriptases inhibitor ( rtrti ). stribild is a single tablet regimen for the treatment of human immunodeficiency virus ( hiv ) infection .
do not take stribild - if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). during treatment , you should not take any medicine containing tenofovegravira disoprofloproxel . your doctor will check your kidney function and may change your dose of these medicines . - if your doctor has told you that you have alfuzosin ( used to treat an enlarged prostate gland ), amiodar
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents 12 to less than 18 years of age : take the tablet 35 once daily by mouth . swallow the tablet whole with a glass of water . you can take your tablet with or without food . your doctor may change the dose of your medicine or interrupt the treatment if you take medicines that contain certain substances ( such as oral supplements , antacids , laxatives containing minerals , magnesium , aluminium , calcium , iron , zinc ) or other substances that may increase the risk of side effects . take the
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether unwanted effects are caused by stribild or by the hiva disease itself . serious side effects are rare . tell your doctor immediately if you experience any of the following : lactic acidosis (
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each stribil film - coated tablet contains 150 mg elvitesgravira , 150 mg cobicista , 200 mg emtracitabines , 245 mg tenofovegravirus disoproxil , 300 mg ten ofovir desoproxel fumarate , 136 mg tenorovir . the other ingredients are : tablet core : croscarmellose sodium , hydroxypropyl cellulose
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement or euphoria . zzyprex has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olan zapine treatment
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swollen face , swollen lips or shortness of breath . - if your doctor has told you that you have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before taking zypxa . zypitxa should not be given to anyone with dementia because it may cause serious side effects .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of zyprexa tablets is one tablet a day . your doctor may increase your dose to 5 mg or 20 mg depending on your symptoms . how to take zydosexa take your zypxa tablets at the same time each day . swallow the tablet whole with a glass of water . you can take your tablets with or without food . zypexa coated tablets are for oral use . swallow your tablet whole . do not chew or crush them . the
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( a side effect which may affect more than 1 in 100 people ) especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you notice any of these symptoms seek medical advice immediately ; a combination of fever , faster breathing , sweating ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . zyprexa does not require any special storage conditions . do this after the first opening of the blister . do away with the blister if you notice it is damaged or there are particles in it . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zyprexa contains - the active substance is olanzapine . each zypxa tablet contains 2 . 5 mg , 5 mg or 7 . 5mg , 10 mg , 15 mg or 20 mg of olanza . - the other ingredients are lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate , hypromellose , titanium dioxide ( e171 ), carnauba wax . the different zypyxa tablet strengths are : - zypi 2 . 0 mg , 2 . 4 mg , 7 . 0
what prolia is prolia contains denosumab , a protein ( monoclonal antibody ) that is similar to another protein that is produced naturally in the body . it is used to prevent bone loss in adult patients with osteoporosis when treatment with prolia has failed . prolia makes bone stronger , and keeps it at a low level . it helps to keep bone healthy . it reduces the amount of oestrogen that is made in the bones after the menopause . as oestrogens level drops , bones become thin and fragile . what osteopORosis is osteoporeosis is caused by low
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ). if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using prolia . if you think any of these apply to you , tell your doctor before using it . if any of them apply to your , tell the doctor before starting prolia : if you develop a skin infection with symptoms such as a swollen , red area of skin , usually in the leg , that feels hot , tender , or if you suffer from
what prolia is prolia contains one pre - filled syringe of 60 ml . it is given to you in a hospital or clinic , and it is usually given every 6 weeks . it can be given as a single injection under the skin ( subcutaneous ) in the thighs , abdomen or upper arm . if you are given more prolia than you should if you have been given too much prolia , you may receive injections at a lower dose . you should also read the package leaflets for calcium and vitamin d supplements to be taken with prolia . how prolia works prolia comes as a powder and is given as an
like all medicines , this medicine can cause side effects , although not everybody gets them . prolia can cause skin infections ( cellulitis ). if you get any of these symptoms while taking prolia : swollen , red area of skin , usually in the leg , which feels hot and tender . if you have symptoms of fever while taking this medicine , stop taking prolous and seek medical advice immediately . pain in the mouth and / or jaw , swelling or non - healing of sores in themouth or jaw ( discharge , numbness , feeling of heaviness or loosening of a tooth ), which may be signs of bone damage in the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . before you inject prolia , your pre - filled syringe may be stored at room temperature ( up to 25 ) for a single period of maximum 30 days . do this at the end of this period or when the injection is given at room temperatures ( up or
what prolia contains - the active substance is denosumab . each ml of solution contains 1 mg or 60 mg of denosumaab in 60 ml . - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear to slightly yellow solution for injection in a pre - filled syringe with a needle guard .
what ambirix is ambirrix is a vaccine used to protect adults from 1 to 15 years of age against two diseases : hepatitis a and hepatitis b . infection with the hepatitis a virus causes the liver to become swollen and inflamed . the virus can also cause faeces , serum or saliva . symptoms usually occur 3 to 6 weeks after infection . if you feel sick , have a fever , aches , pains , or feel very tired , dark urine , pale faececes or yellowish skin or eyes ( jaundice ). the severity and type of symptoms can vary from person to person . all symptoms can be
you must not be given ambirix if you are allergic to ambirux or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if you have an allergic response to any vaccine . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or nurse before you are given ambira if you : have ever had hepatitis a or hepatitis b diseases if you suffer from a severe infection with a high temperature . the vaccine may be given to you if you still
your doctor or nurse will give you ambirix as an injection into a muscle ( usually in the upper arm ). ambirux will be given into a vein . the injection will be injected into the thigh muscle . you will receive a total of two injections . the injections will be administered within 12 months . the first injection will usually be given at least 6 months after the second injection . if you are between 6 and 12 months of age , your doctor may decide to give you the first injections at least 12 months after your last injection . the second injections will usually come between 6 to 12 months at least . if the first dose is
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects reported in clinical trials with ambirix were : common ( may affect up to 1 in 10 people ): headache loss of appetite feeling tired or irritable pain and redness where
what ambirix contains 26 the active substances are hepatitis a virus ( 1 , 720 micrograms / ml ) and elisa units ( 4 , 8 , 10 , 20 microgram ) of hepatitis b surface antigen ( 4 ), human diploid ( mrc ), cells and aluminium hydroxide ( hydrated 0 . 05 %) in the form of saccharomyces cerevisiae . the other ingredients are aluminium phosphate in 0 . 4 % and sodium chloride and water for injections . what ambirax looks like and contents of the pack suspension for injection in a pre - filled syringe . ambirood is a
what bexsero is bexcero is a meningococcal group b vaccine . what bexero is used for bex serumo is given to adults , adolescents and children from 2 years of age with disease caused by the neisseria meningitidis group b bacteria . these bacteria are responsible for causing infections such as meningitis ( inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping your immune system ( the body ' s natural defences ) to fight the disease .
do not use bexsero if you are allergic to any of the ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using bexero if : you have a severe infection with a high temperature . vaccination may be delayed if you have such a minor infection as a cold . your doctor may decide to delay vaccination if you suffer from haemophilia or any other problem that may prevent your blood from clotting properly . you are using blood thinners ( anticoagulants ) as part of treatment for the immune system ( eculizumab ). if you
your doctor or nurse will give you bexsero at a dose of 5 micrograms injected into a muscle ( usually in the thigh or upper arm ). injections will be given at least 2 weeks apart . if you are given more bex serumo than you should if you have been given more than 5 doses , you will receive three injections . the vaccine may be given as an additional injection ( booster ). the first injection will be administered at least 1 month apart . the interval between injections will not be longer than 2 months . if your doctor determines that the intervalbetween injections is too long , you may receive a booster . children
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and tell your doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site , swelling of theskin at the injected site , hardness of the area under the skin around the injection area . other side effects may occur with this vaccine . common ( might affect up to 1 in every 10 people ) fever , loss of appetite , tenderness around thejection site , severe injection site
what bexsero contains the active substances are recombinant neisseria meningitidis group b nhba fusion protein 1 , 2 , 3 and 50 micrograms recombinant nisseria maningitidi group b noada protein 1 and 2 , 2 and 3 50 microgene recombinant neoisseria meeningitidis ( group b fhbp fusion protein ) 1 and 3 , 50 micros recombinated neissia meningitsidis group a fhba infusion protein 1 or 2 , and 3 microgne spheres containing 50 microsaccharides ( e . coli cells ) recombinant
nitisinone mdk contains the active substance nitisinon . this medicine is used to treat a rare disease called hereditary tyrosinemia ( hty ) in adults , adolescents and children from 1 year of age . in this disease your body does not make enough of the amino acid tyrosine ( amino acids are substances that are naturally present in the body ). nitisinnone helps to reduce the amount of tyrosinine and the harmful substances that can be present in your body . this means that tyrosaline is eliminated by the body in the form of low tyrosines and phenylalanine (
do not take nitisinone if you are allergic to nitisinfone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . pregnancy and breast - feeding nitis inone mdk is not recommended for use in children . your doctor will check your eyes regularly during nitisginone treatment . if you develop red eyes or if your eyes get darker , tell your doctor immediately . your physician may recommend an eye examination . if possible , you should inform your doctor . you may be at increased risk of eye problems due to inadequate dietary
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor who is experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 capsule for every kg of body weight taken orally once a day . the dose may be increased to 20 capsules once a daily . in this patient population , the dose is based on body weight . swallow the capsules whole with a small amount of water or formula diet . if you take more nitisinone mdk than you should if you accidentally
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 2 8 . do away with the blister if you notice it is not completely empty . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nitisinone mdk contains the active substance is nitisinoone . nitisinnone mdks 2 mg : each capsule contains 2 mg nitisine . nitesinonemdk 5 mg : one capsule contains 5 mg nitesine . each capsule of nitishinone mdky 10 mg : two capsules contain 10 mg nisinone . the other ingredients are gelatin , titanium dioxide ( e171 ), black iron oxide ( e172 ), shellac glaze . what nitisinsone mdka looks like and contents of the pack nitisinfone mdyk capsules are 15 . 7 mm long
docetaxel accord contains the active substance docetaxal . docetxel belongs to the group of anti - cancer medicines called taxoids . docnetaxel accord is used to treat breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer , gastric cancer and head and neck cancer : - for advanced breast cancer : docetixel could be administered either alone or in combination with doxorubicin , or trastuzumab , or capecitabine . - for early breast cancer with or without lymph node involvement , docetAXel could also
do not use docetaxel accord - if you are allergic ( hypersensitive ) to docetxel or any of the other ingredients of docetixel accord ( listed in section 6 ) - if your number of white blood cells is too low - if this applies to you - if a severe liver disease has been reported . warnings and precautions before you are given docetAXel accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetacord . white blood cell disturbances may occur . if you experience fever or infections , tell your doctor immediately . abdominal pain ,
docetaxel accord will be given to you by a healthcare professional . the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m² ) and will determine your dose . method and route of administration docetaxell accord will usually be given by infusion into one of your veins . the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . your blood tests will be taken regularly to check your generalcondition . docetAXel accord may be given in the presence of diarr
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord are reduction in the number of red blood cells and white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the severity of adverse events of docelaxel alone may be higher when docetxel is given in combination with other chemotherapeutic agents . during the infusion , allergic reactions may occur ( may affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store below 25 . store in the original package in order to protect from light . the vial should be used immediately after dilution . the medicine should be transferred from the infusion bag to the infusion vial within 6 hours of dilution ( see section 25 ). for infusion , the infusion solution should be stored in non - pvc bags for 48 hours at 2 to 8 . do away with the
what docetaxel accord contains - the active substance is docetxel . each ml of concentrate for solution for infusion contains 20 mg docetixel . 1 ml of the concentrate contains 20mg docetoxel . 4 ml of a concentrate contains 80 mg docelaxel . 8 ml of an 8 ml vial contains 160 mg docnetaxel - the other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 " docetacord contains ethanol "), citric acid anhydrated ( see also section 2 ) what docetAXel accord looks like and contents of the
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . this medicinal product acts on the brain to make it more aware of things that are not there ( called ' impulsive ') and to make them less hyperactive . this medication is used to treat ' attention deficit hyperactivity disorder ' ( adhd ) in adults who are not adequately responsive to current stimulant medication or whose current medication is not controlling adhd symptoms . the medicine is used in combination with a treatment programme consisting of psychological therapy , educational therapy and social therapy . intuniv is used 38 in
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine if you have low or high blood pressure . heart problems tell your doctor if you suffer from heart problems . you have ever fainted or have recently had thoughts or feelings of suicide . tell your physician if you know or have any other psychiatric conditions or withdrawal symptoms . increased heart rate and high bloodpressure tell your healthcare professional if you take this medicine or any other medicine that may increase the risk of these problems . children
your treatment will be started by a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will start your treatment with 1 tablet once daily . your dose will be gradually increased depending on your response to treatment . the starting dose is 0 . 05 mg / kg of bodyweight once daily for the first 7 days . your treatment will then be gradually reduced to 1 tablet twice daily . the maximum recommended dose for adults is 0. 05 mg per kg of weight
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , talk to your doctor or pharmacist straight away . your doctor may need to adjust your dose of your medicine . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : feeling drowsy ( feeling dizzy ) hypotension ( slow heart beat ( bradycardia ), feeling faint , loss of concentration ( syncope ), a serious withdrawal side effect from high blood pressure . symptoms may include headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephal
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister pack after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . the tablets should be used within one month after first opening of blister pack . do this to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what intuniv contains the active substance is guanfacine hydrochloride . each prolonged - release tablet contains 1 mg of guanFacine . each 2 mg prolonged -release tablet contains guanfuine hydroxychloride , corresponding to 2 mg of the active substances . each 3 mg prolonged prolonged - released tablet contains 3 mg of Guanfacice hydrochlorine , correspondingto 4 mg of of the activated substances . the 4 mg prolonged release tablet also contains guinfacine . the other ingredients are hypromellose 2208 , methacrylic acid - ethyl acrylate copolymer , lact
ecalta contains the active substance anidulafungin and is used to treat adults and children from 1 to 18 years old with a type of fungal infection that affects the blood or other internal organs called invasive candidiasis . the infection is caused by fungal cells called candida . ecalta belongs to a group of medicines called echinocandins . these medicines prevent serious fungal infections caused by the lack of fungillus ' s fungal cell walls . ecalda is used when fungalcells have incomplete or defective cell walls , which may make them fragile and unable to grow .
do not use ecalta if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using ecaltra if you have liver function problems . your doctor may decide to reduce the dose you receive , or stop your treatment , or give you anaesthetics . your treatment with ecaltfa may need to be delayed or stopped . if you experience an allergic reaction , such as itching , wheezing or blotchy skin , you should
the treatment will be given to you by a doctor or nurse . the recommended dose is 200 mg / 100 mg given once a week . the dose is 1 dose in the morning and 1 dose per day in the evening . adults ( 18 years of age and older ) the recommended starting dose is 3 . 0 mg / 200 mg given twice a week , followed by 1 . 5 mg /100 mg given two times a week depending on the patient ' s weight . ecalta is given as a slow infusion ( a drip into a vein ) over a period of 1 . 4 to 3 hours . the loading dose will be calculated by
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ecalta : potentially life - threatening allergic reactions , including difficulty breathing or wheezing , or an existing rash . ecaltra can cause serious side effects such as convulsion ( seizure ), flushing , rash , pruritis , itching , hot flush , hives , sudden contraction of the muscles , wheezed , coughing or difficulty of breathing other side effects very common side effects ( may affect more than 1 in 10 people ): low blood potassium ( hypokalaemia ), diarrhoea , nausea
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . the reconstituted solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 . if the infusion solution is not used within 24 hours , in use immediately , the infusion solutions may
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of anidulinafungan . - the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid 30 . what ecaltfa looks like and contents of the pack ecaltva is supplied as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder is white to off - white .
adenovi contains the active substance rurioctocog alfa pegol , which is a copy of pegylated human coagulation factor viii ( hcviii ). the human coaggulation factor iii is produced naturally in the body . factor v iii is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , factor v viii is not produced naturally . adynovi is used for the treatment and prevention of bleeding in adults and adolescents 12 years of age and older with haemaophilia b , an inherited bleeding disorder caused by lack of factor v
do not use adynovi - if you are allergic to rurioctocog alfa pegol , octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is allergic to adynov . warnings and precautions talk to your doctor or pharmacist before using adynocog if your newborn has had an anaphylactic reaction ( a severe , sudden allergic reaction to adnovi ). allergic reactions may include rash 95 , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . your doctor will decide how much adynovovi you need and for how long . treatment of bleeding will be initiated by your doctor . your dose of adynoc will depend on your condition and the replacement therapy you are receiving . adynova is a life - long treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . prevention of bleeding the recommended dose of adsynovi is 40 mg once a day or 50 mg once daily for
like all medicines , this medicine can cause side effects , although not everybody gets them . sudden allergic reactions ( anaphylactic ) may occur within minutes of the injection . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if severe symptoms of difficulty in breath , wheeezing or tightness around the chest ( a feeling ofbeing unwell ), dizziness or loss of awareness , severe symptoms may include difficulty in swallowing
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the powder vial may be stored at room temperature ( up to 30 ) for a maximum of 3 days . do this medicine if it has been stored at a room temperature not above 30 for a total of 3 weeks . once the vials have been removed from
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 or 2000 iu ruricoctocag alfa pepegol . the solvent vial provides 5 ml of sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrates , tris ( hydroxymethyl ) aminomethane , poly
rekovelle contains follitropin delta , a follicle stimulating hormone that belongs to a group of hormones called gonadotropins . gonadotropicins are involved in female fertility and are present in assisted reproduction programs , in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection . they work by helping the ovaries produce many egg sacs .
do not use this medicine if any of the following apply to you . if you are not sure , talk to your doctor or pharmacist before using rekovelle . warnings and precautions talk to the doctor or nurse before using this medicine : if you have a problem with your fertility problems . if your doctor thinks you may be allergic to follicle stimulating hormone or any of those other ingredients of this medicine ( listed in section 6 ). if you develop a tumour in the uterus , ovaries , breasts , pituitary gland or hypothalamus . if any or all of the above apply to your ( or you are unsure ), talk
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given as your first treatment cycle . your doctor will prescribe a type of anti - müllerian hormone to stimulate your ovaries to produce more stimulation with gonadotropins . the dose will depend on your blood weight . your dose will also be calculated using a blood sample taken every 12 months . the duration of treatment depends on your body weight . treatment will be started as a single injection . your physician will calculate the rekoevelledose based on the
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones that are used to treat infertility have been reported . this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms include pain , discomfort and swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you notice any of these symptoms , seek medical advice straight away . a side effect that may affect up to 1 in 10 people is headache . nausea ( ovarianhyperstimulation sensation ) pelvic pain and discomfort ( ovarian origin tiredness ( fatigue
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store at room temperature ( below 25 ). after reconstitution , the product may be stored at room temperatures up to a maximum of 25 for a single period of 3 days , but not beyond 3 days . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 mg of follitroin delta in 0 . 36 millilitre of solution . after dilution , each ml of solution contains 33 . 3 mg of the active ingredient follitrotin deltain each millilitere of solution ( corresponding to 0 . 35 mg / ml ). the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrates , concentrated phosphoric acid , sodium hydroxide and water
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each inhalation of revindy elliptone contains either flutic asone fibre 92 mg or vilancerol 22 mg . each inhale of fluticasa furoe 184 mg or Vilanterols 22 mg is equivalent to 92 / 22 mg of the active substances . chronic obstructive pulmonary disease ( copd ) in adults and adolescents ( 12 years of age and older ) weighing 184 kg or more . the 92 / 21 mg and 184 / 22mg formulations are used to treat chronic obstruct
do not take revinty ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking revintchy ellipta . if you have liver disease , tell your doctor straight away if you notice any of these side effects . if your doctor determines that you have moderate or severe liver disease then the lower strength of revintty ellipta 92 / 22 mg should be used instead of the usual dose . if any of your medical conditions apply to you , tell the
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use asthma the recommended dose for asthma is one inhalation twice a day ( one inhalant each day ). this is one dose in the morning and one inhaler in the evening . the dose for severe asthma is two inhalations twice a morning ( one tablet each day ) and one tablet in the afternoon ( one in the mornings and one inthe evening ). the higher strength inhaler for asthma needs to be used twice a daily ( one and a half inhalations each
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while taking ellipta stop taking this medicine and tell your doctor immediately : skin rash , hives , redness swelling , especially of the face or mouth ( angioedema ), feeling very wheezy or coughing , difficulty in breathing , feeling weak or light headed ( which may lead to collapse or loss of consciousness ) immediate breathing difficulties immediate breathing problems stop taking revinty ellipta and tell a
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . each 92 micrograms inhalation provides 92 microlitres of flutic asone firoate and 22 microlitre of vilancerol and trifenatate . each 184 microgramS inhalation delivers 184 microliters of flilitasonefuroate , 22 micrometre of the active substance is vilansterol and the other ingredients are trifnatate , lactose monohydrate ( see section 2 " revintchy ellipta is for inhalation use "
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine , a nucleosides reverse transcriptases inhibitor ( tnrtis ), tenofovir , aucleotide reverse transcript enzyme inhibitor ( snrti ). these active substances are all taken together with antiretroviral medicines . they work by interfering with an enzyme ( reverse transcriptasing ) that is essential for the virus to multiply . atripla is a
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after food . some side effects may be more common ( dizziness and drowsiness ). if you take more atripola than you should if you accidentally take too many atripa tablets , contact your doctor immediately . if you forget to take atripela if you miss a dose , take it as soon as you remember .
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) is rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following serious side effect , stop taking atripla and seek medical help immediately :
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atripera film - coated tablet contains 600 mg efavairenz and 200 mg emtracitabin , corresponding to 245 mg tenofoviir disopicroxil ( as fumarate ). the other ingredients are croscarmellose sodium , hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate ( see section 2 " atriplea contains sodium "). the tablet
orgalutran contains ganirelix which belongs to a group of medicines called anti - gonadotrophin . it is a synthetic version of the natural gonadodotrophins releasing hormone ( gnrh ). release of gonadotroprophins is a naturally occurring hormone in the body . follicles are small round sacs that contain the egg cells . gonadotsrophins play an important role in the growth and development of follicles in the ovaries . follicle sacs are small rough sacs which contain the eggs . they release the immature egg cells in the sacs and follicles from the
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - if hypersensitive to gonadotrophin releasing hormone ( gnrh ). - you have a gnrh analogue . - if your doctor has told you that you have or have had a moderate or severe kidney or liver disease . - you are pregnant . warnings and precautions talk to your doctor or pharmacist before using orgaluchran allergic reactions . if you develop an active allergic condition , your doctor may recommend additional monitoring and treatment . allergic reactions : allergic reactions are
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran is only given to you by a doctor who is experienced in the treatment of assisted reproduction techniques ( i . e . in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( fsh ), and corifollitropin . you must follow the instructions given to your doctor . on day 2 or 3 of each cycle , you will receive orgaluitran under the skin ( subcutaneously ) for 5 to 6 days . you will be given orgaluch
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect that may affect more than 1 in 10 people is local skin reactions ( redness and swelling ). the local reaction usually disappears after a few days . see section 4 for more information . uncommon ( may affect up to 1 in 100 people ) is headache , nausea , malaise . rare ( may affects up to1 in 10 , 000 people ) allergic reactions are rash facial swelling , difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat , which may cause difficulty in breathing or swallowing (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and syringes after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). syringeds should be clear , solvent - free solutions . do away with any unused syringe after the first use . do this if you notice any particles in the solution . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . - the other ingredients are mannitol and water for injections ( for the ph ) and sodium hydroxide ( for acetic acids ). what orgaluitran looks like and contents of the pack orgalUTran is a clear , colourless aqueous solution for subcutaneous administration . the needle is inserted into a dry natural rubber / latex . orgalustran is available in packs containing 1 or 5 vials . not all pack sizes may be marketed .
what blitzima is blitzima contains the active substance rituximab , a " monoclonal antibody ". it sticks to a target in a type of white blood cell called b - lymphocyte . when ritukimab sticks to this target , it stops the cell from growing and dividing . what blitzima used for blitzima has been prescribed for the treatment of two different conditions : a ) non - hodgkin ' s lymphoma this is a disease of the lymph tissue . the immune system attacks a type ( a type ) of whiteblood cell called " b - locytes ". blitzima can be
do not use blitzima - if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ) - if your child has a severe active infection - if he / she has a weak immune system - if the child has severe heart failure or severe uncontrolled heart disease - if any of these apply to your child ( see section " warnings and precautions ") warnings and risks talk to your doctor or pharmacist before using blitzima if your baby has granulomatosis , polyangiitis , microscopic polyangitis
how blitzima is given the doctor will decide how much blitzima you will receive and for how long . this treatment will be given to you by a doctor or nurse who is experienced in the use of this medicine . they will watch you closely while you are being given this medicine and will check you for any side effects . how blitzima will be administered blitzima must be given as a drip ( intravenous infusion ). medicines given before each blitzima administration you will be treated with blitzima together with other medicines ( pre - medication ) to reduce the risk of side effects during your treatment . for non - hodgkin ' s
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate and will generally go away after a few days of treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy or runny nose , vomiting , flushing or palpitations , heart attack , low
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what blitzima contains - the active substance is rituximab . one ml of solution contains 10 mg or 100 mg of ritukimab ( 10 mg / ml ). one ml contains 50 mg or 500 mg of the active ingredient ( 10mg / ml ) of rituuximib ( 10 μg / ml). - the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for infusion . it is available in 2 ml glass vials containing
roactemra contains the active substance toilizumab , a type of monoclonal antibody ( a type in the body that recognises and attaches to a specific target in the immune system ). it attaches to an antigen called interleukin - 6 ( interlek - 6 ) and blocks its action , causing the inflammation in your body to decrease . roactemrea can cause symptoms such as pain and swelling in your joints . roactorra reduces the damage to the cartilage and bone in your bones caused by the disease . roACTemra is used to treat moderate to severe active rheumat
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . warnings and precautions talk to your doctor or nurse before the infusion with roactemnra if any of these apply to you . allergic reactions may include chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips and skin rash . your doctor may decide to delay or stop the infusion . infection if you get any signs of infections , tell your doctor immediately . if you feel unwell while
the doctor or nurse will give you roactemra by infusion into a vein ( intravenous infusion ). your doctor or a nurse will decide on the dose you need . the intravenous infusion will be given over a period of one hour . the treatment will be started by a doctor or other health care professional . the recommended dose of roactemera is 8 mg / kg body weight once a week for 4 weeks . the usual dose of 8 mg is 8mg / kg ( given as 4 separate injections given as a drip in the vein ( intravenous infusion ) once a day . the maximum recommended dose is 2 mg
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in the post marketing setting in adults and children 3 years of age and older : roactemnra can be very serious and can cause serious side effects ( may affect more than 1 in 10 people ). allergic reactions such as difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections such as fever and chills , especially in the mouth and skin blisters and stomach ache signs and symptoms of liver toxicity
keep this medicine out of the sight and reach of children . do not use after the expiry date which is stated on the outer carton and the vial label after exp . the expiratory date refers to the last day of that month . this medicine does not require any special storage conditions . do this if you notice any change in the appearance of the solution . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg of tociluzumab in 20 mg . each 10 ml vials contains 200 mg of of tocizumumab ( 20 mg ). each 20 ml vray contains 400 mg of the active substances in tocilixumab , 20 mg is reconstituted in water for injections . the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for water for injection . what roactemet
what onbrez breezhaler is onbrezer contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . it relaxes the muscles in the walls of the small air passages in the lungs . what onbreez breez inhaler is used for onbreza breezcheler is prescribed to help breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine relaxes these muscles in your lungs , making it easier for air to get in and out
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma is not controlled with onbreez breez inhaler . - if any of these apply to you , tell your doctor before using onbrezer . warnings and precautions talk to your doctor or pharmacist before using this medicine : - if there are any signs of heart problems such as epilepsy , thyroid gland problems ( thyrotoxicosis ), or diabetes . treatment with on brez breezerhaler should be stopped immediately if you get tight
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 150 microgram capsule twice a day ( one 150 and one 300 microgram ). your doctor will tell you how long you should continue the treatment with your inhaler . the recommended dose is 24 micrograms twice a night . onbrez breezhaler is supplied as an inhaler and capsules ( in blisters ) containing the medicine ( inhalation powder ). the onbreez breez inhaler is for inhalation use only . the medicine is for oral use only ;
what onbrez breezhaler contains - each onbrex breez inhaler 150 micrograms inhaler contains 150 microlitres of indacaterol ( as indacathol maleate ). - the other ingredients are lactose and the capsule is made of gelatin . - eachonbrez bronzhalER 300 microgramS inhaler 300 microlitre inhaler includes 300 micrometres of of indiacaterol as indiacatholmaleate . - the ingredients are gelatin . what onbreez breezeler looks like and contents of the pack onbrezy breezer 150
clopidogrel hcs contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrel clcs is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherostrombotic events (
do not take clopidogrel hcs - if you are allergic to clopiprel or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - if the patient has severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrel clcs . warnings and precautions if any situation you are at risk of bleeding suchas : - if any member of your family has a medicalcondition that puts you at risk
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl hcs ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel hcs contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are ( see section 2 ' clopide hcs contain hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenatedcastor oil . tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc
febcroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called " cephalosporins ". antibiotics are used to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that are resistant to other antibiotics .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using fetcroj if you have ever had a severe allergic reaction to certain antibiotics ( such as penicillins or carbapenems ). if this happens , tell your doctor straight away . if you experience severe skin peeling or swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing , tell the
this medicine is given to you by a doctor or nurse as an infusion ( a drip ) into a vein . it usually takes about 3 to 2 weeks . your doctor will decide how long fetcroja treatment will last . your dose will be decided by your doctor . your infection will be treated as soon as possible . you should not feel any pain during the fetcroja infusion . it is recommended that you continue to receive fetcrora for as long as your doctor prescribes it for you . if you have kidney problems tell your doctor if you suffer from kidney problems . your recommended dose of fetcroJA is one tablet once
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : severe allergic reaction : sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions , difficulty swallowing or breathing . this reaction may lead to diarrhoea , stools , blood or mucus . treatment may be stopped or medicines may slow bowel movement . other side effects if you get any of these side effects : tell your healthcare professional straight away . the following side effects may happen
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg cefithocol . - the other ingredients are sucrose , sodium chloride and sodium hydroxide . what fetcroJA looks like and contents of the pack fetcrojia is a white to off - white powder for concentrate for solution for infusion . it is supplied in packs containing 10 vials .
depocyte is used to treat adults with lymphomatous meningitis . lymphomatinous meneningitis is a condition in which tumour cells accumulate in the membranes of the brain and spinal cord . depocyte is prepared from lymphoma tumour cell material .
do not use depocyte - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using depocyte . - if your child has a meningeal infection . - severe neurological side effects have been reported with depocyte , including symptoms related to the nervous system ( convulsions , pain , numbness , tingling , blindness , visual disturbances ). if your doctor suspects that your child may have these symptoms , stop taking depocyte and contact a doctor immediately . - taking any dexamethasone
treatment of cancer in the lumber sac will be supervised by a doctor who is experienced in the use of depocyte . depocyte will be given to you by a qualified healthcare professional . the recommended dose is one vial of 1 mg or 5 mg of dexamethasone 5 mg / ml . each depocyte dose will be monitored by a healthcare professional to detect any side effects . the dose of depocytes depends on the temperature 22 to 30 . before withdrawing depocyte from the vial , you should take proper precautions to avoid exposure to a cytotoxic drug . proper handling technique is used to ensure that the medicinal product is
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often during your treatment . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) very common (> affects 1 user per 10 ) not known ( frequency cannot be estimated from the available data ) very rare ( affects less than 1 users in 10 , 000 ): very rare (> affects lessthan 1 user / 10 ,000 ) not available (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . the expiratory date refers to the last day of that month . depocyte should be stored in a refrigerator ( 2 - 8 ). do not freeze . store in the original package in order to protect from light . after preparation , depocyte must be used within 4 hours . do this if depocyte is not used within this time period . do discard this medicine if you notice severe discolouration , a changed appearance or a defective container .
what depocyte contains - the active substance is cytarabine . one ml of suspension contains 10 mg cytarabiline . each 5 ml vial contains 50 mg cytabine ( as cholesterol , triolein ), dioleoylphosphatidylcholine , dipalmitoylophosphatylglycerol , sodium chloride and water for injections . what depocyte looks like and contents of the pack depocyte is a clear , colourless solution for injection . it is supplied in packs containing 5 ml or 10 ml vials . depocyte may be available as a single injection or as
what bemrist breezhaler is bemist breez inhaler contains two active substances called indacaterol and mometasone furoate . indacatorol belongs to a group of medicines called bronchodilators . it relaxes the muscles of the small airways in the lungs , making it easier for air to get in and out of the lungs . mometsone fruate belongs to an important group of medicine called corticosteroids ( steroids ). corticoplastics reduce the swelling and irritation ( inflammation ) in the small lungs , which can lead to breathing problems .
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). - if any of these apply to you , tell your doctor before using bemist breez inhaler . - if your doctor thinks you may be allergic . - tell your physician if you have heart problems , such as an irregular or fast heartbeat . - you have thyroid gland problems . - have diabetes , high blood sugar , seizures or low level of potassium in your blood . - suffer from severe liver problems . tell
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should be used every day . you should use the medicine every day , at the same time of the day . this will help you to remember to use it . it will also help you remember to breathe and to do so when you are using it . do not change the dose unless your doctor tells you to . it is important that you use the complete dose of the medicine prescribed for you by your doctor , pharmacist or nurse . it may help you get the best
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious . tell your doctor immediately if you experience any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives . allergic reaction uncommon ( may affects up to 1 in 100 people ): swelling of either the tongue or lips , face or throat ( angioedema ). other side effects other sideeffects include the following side effects : very commonly ( may effect more than1 in 10 users ): sore
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original blister in order to protect from light . do this after the first opening of the bottle . do away with the cap and the capsules if you notice that the cap is damaged or shows signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ) and mometasone furoate . bemist breez inhaler 125 micrograms / 62 . 5 microgram inhaled contains 173 microgram indacate . each capsule contains 150 microgram of indacatesol and 80 microgram mometsone furuate . the dose that leaves the mouthpiece of the inhaler is 125 microg / 62 , 5 microliters of indiacaterol and 160 microgrammometason furoates . each dose that leave the mouth
zyllt contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). zyllt is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis . atherostrombotic events can occur ( such as stroke , heart attack , or death ). zll
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking zylltt . warnings and precautions talk to your doctor or pharmacist before taking any of zyllT : if you think you may be at an increased risk of bleeding if you : have a risk of internal bleeding ( such as - a stomach obcer
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of zllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended daily
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). the other ingredients are lactose ( see section 2 under ' zyllT contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the film - coating and hypromellose ( e464 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in thefilm - coating . what zylltel looks like and
lamivudine teva contains the active substance lamivudrine . lamivuxine tevas is used to treat long term ( chronic ) hepatitis b infection in adults . lamibudineteva is an antiviral medicine that works by stopping the hepatitis b virus from multiplying . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver . long term (" chronic " infection can lead to liver damage . lamlivudine precludes this effect and makes sure that your liver is working properly . patients with compensated liver disease will
do not take lamivudine teva - if you are allergic to lamivu or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 lamividine tevas may be taken with other similar medicines . serious side effects if you have liver disease , such as hepatitis c . if you become overweight , your doctor may need to change your dose . you will have blood tests periodically during your treatment ( see section 4 " warnings and symptoms "). if you take more lamivuxine tev than you should if you think you may have taken more lamidudine than you were
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage your doctor lamivudine teva is used to treat your hepatitis b infection . it is important that you continue to take it until your infection is gone . your doctor will regularly monitor your illness to check that it is getting better . if you take more lamivuxine tevas than you should lamividine tella should be taken with caution . if lamivuine is not being used in your kidneys , your doctor may prescribe lamivudaine ( another medicine containing lamivub
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva in patients with other conditions linked to hepatitis b . the most serious side effects reported during therapy with lamvudine are : - tiredness - respiratory tract infections - throat discomfort - headache - stomach discomfort - pain - nausea - vomiting - diarrhoea - increases in liver enzymes - the level of enzymes in the muscles is increased . allergic reaction ( rare , may affect up to 1 in 1 , 000 people ) - swelling of eyelids , face or lips , difficulty swallowing or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . lamivudine teva should not be used if the package is damaged or shows signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamivuda . each film - coated tablet contains 100 mg of lamivUDine . - the other ingredients are microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ), iron oxide red ( e 172 ). what lamivodine teeva looks like and contents of the pack orange , biconvex film - - coated tablets , debossed with " l
nebespo is an anti - anaemic ( means that your anaemia is not caused by any other medicine ). anaemia occurs when your blood does not contain enough red blood cells . the symptoms include fatigue , weakness and shortness of breath . nespo works by inhibiting the natural hormone erythropoietin . erythrothropoioietin works by blocking the growth of your kidneys and so prevents your bone marrow from producing enough redblood cells . it is used in addition to darbepoetin alfa to treat chronic renal failure . symptomatic anaemia can occur when chronic renal fail is
do not use nespo if you have high blood pressure or are taking other medicines . if you are allergic to nesco ( darbepoetin alfa ) or r - huepo . warnings and precautions talk to your doctor or pharmacist before using nespos if you suffer from high bloodpressure or are using medicines to treat sickle cell anaemia . epileptic fits ( seizures ), convulsions or fits have been reported in patients with liver disease . drugs to treat anaemia may cause an allergy to latex . the needle that connects the pre - filled syringe with the pre filled sye is
your doctor will carry out blood tests before you are given nespo to check your haemoglobin level . the usual starting dose is 10 mg . your doctor will then increase your dose to a haemogl level of 10 mg every 12 hours . the pre - filled syringe is for injection into a vein . patients with chronic renal failure the usual dose is a single injection under the skin into a veins ( intravenous ). your anaemia will be treated with nespos . the dose will be calculated by your doctor based on your body weight . the recommended dose is 0 . 75 mg / kg or 0 . 45 mg /
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported with nespos : 471 common ( may affect up to 10 in 100 people ): high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon ( may effect up to 1 in 100 , 000 people ): blood clots ( thrombosis ) pain in the area injected rash , redness and swelling of the skin rare ( may affects up to1 in 10 , 000 , 000 patients ): serious allergic reactions sudden life - threatening allergic reactions ( anaphylaxis ) swelling of any face
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep your syringe in the outer carton in order to protect from light . after first opening , you may store nespos at room temperature ( up to 30 ) for a maximum of 7 days . do this every time you use nnespo . medicines should not be disposed of via wastewater or household waste . ask your
what nespo contains the active substance is darbepoetin alfa . each ml of solution for injection contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu of the active substances darbasin alffa . the other ingredients of nespos are sodium phosphate monobasic , sodium phosphate dibasic ( e470b ), sodium chloride , polysorbate 80 and water for injections . what nespol looks like and contents of the pack nespi is a clear , colourless to slightly
macugen is a solution for the eye called pegaptanib . this medicine works by stopping abnormal formation of new blood vessels in the eye . macugen is used for the treatment of macular degeneration in adults . in this disease , vision loss is caused by damage to a part of the retina called the macula . the macular is the thin layer at the back of the eye ( the maculose ) that lines the front part of your eye . the eye is made up of two layers : the macule and the eye - the macla is the layer at which the eye makes its blood . in amd ,
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in your eye . warnings and precautions talk to your doctor or pharmacist before using macugen . if you think you have or have had an infection or bleeding in the eye , stop using macug injection and contact your doctor immediately . if any of these occur , tell your doctor straight away . if the following symptoms occur , contact your eye doctor immediately : eye pain or increased discomfort worsening eye redness blurred or decreased vision increased sensitivity to light small particles
mugen will be given to you by a doctor or nurse . injections of macugen will usually be given by a single injection into your eye . the recommended dose is 6 to 9 ml . the injection will be injected into the vitreous part of the eye ( the front part of your eye ). your doctor will decide how much macugen you need . antibiotic eye drops will be applied to your eye and your doctor may clean your eyes with some local anaesthetic (umbing medicine ) to prevent any pain you may have after the injection . if you are allergic to antibiotic eyedrops , your doctor might clean your eye before antibiotic treatment to
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) angioedema of which symptoms may include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known . an infection in the internal portion of the eye has been reported following macugen treatment . the symptoms are described in section 2 . if you experience any of these symptoms , contact your doctor immediately . other side effects very
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaptenib in 90 ml of solution . - the other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ), water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection in a single dose pack is supplied as a pouch . each pack contains a pre -filled syringe of 0
kpivance contains the active substance palifermin , which is produced by biotechnology in the plant called escherichia coli . palifermine works by stopping the growth of epithelial cells in the mouth and digestive tract and in the tissues of the skin . paliflate is used to treat oral mucositis , which causes soreness , dryness and inflammation of the mouth . this side effect is usually treated with treatments to treat your blood cancer . if your bloodcancer is not treated with chemotherapy , radiotherapy or autologous hemopoietic stem cell transplantation ( which reduces the number of blood cells
do not use kepivance if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). children and adolescents do not give this medicine to children and teenagers under 18 years of age . other medicines and kepipivance tell your doctor or pharmacist if you have recently taken any other medicines . this is because kepivalance may interact with heparin . if you recently taken heparan , tell your physician . pregnancy and breast - feeding kepvelance is not recommended if you plan to become pregnant . if pregnant
before starting cancer treatment , your doctor will decide how much kepivance you should receive . the usual dose of kepvance is 60 mg . your doctor may decide to increase your dose of the medicine to a maximum of one kilogram . your dose will be given as an intravenous injection into a vein . how kepvelance is given kepllance will be administered to you three days before chemotherapy ( chemotherapy and radiotherapy ) in three different clinical trials : chemotherapy and radiationotherapy at least 24 to 48 hours after the chemotherapy . radiotherapy at the start of the chemotherapy and at the end of radiotherapy if
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ): side effects include skin rash , itching , redness ( pruritus and erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , raised levels of lipase and amylase levels in the blood , and increased levels of digestive enzymes in the bloodstream . the frequency of
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kepvelance looks like and contents of the pack kepiverance is a white powder supplied in a vial . each carton contains 6 vials .
cinacalcet accordpharma contains the active ingredient cinacalcitepine which reduces the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck , which are connected to the thyroid gland . cinocalcate accordphine is used in adults with secondary hyperparathyroidism ( secondary ) to treat serious kidney disease in patients who are not on dialysis or who are unable to eliminate waste products that increase the level of calcium in the bloodstream ( hypercalcaemia ). par
do not take cinacalcet accordpharma - if you are allergic to cinacealcate or any of the other ingredients of this medicine ( listed in section 6 ). - if there are low levels of calcium in your blood . your doctor will check your blood calcium levels regularly before and during treatment with cinocalcut accordpha . warnings and precautions talk to your doctor or pharmacist before taking cinicalcot accordphara : - if any of these apply to you , tell your doctor before taking this medicine . - if : you have ever had seizures ( fits or conv
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cinacalcet accordpharma must be taken orally with or without food . cinnacalcitpharma should be taken with or shortly after meals . the tablets should be swallowed whole with water . your doctor will take regular blood samples during treatment to monitor the progress of secondary hyperparathyroidism . the usual starting dose of cinocalcite accordphara is 30 mg once a day ( morning dose ). cinaconal
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : numbness or tingling around the mouth , muscle aches or cramps , seizures ( these may be signs that your calcium levels are too low ). hypocalcaemia ( swelling of the face , lips , mouth , tongue or throat , which may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . if you notice any of these side effects seek medical advice immediately . common ( might affect up to 1 in every
what cinacalcet accordpharma contains - the active substance is cinacealc . each film - coated tablet contains 30 mg , 60 mg or 90 mg cinaconalcate ( as hydrochloride ). - the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ), iron oxide yellow ( e172 ). what cinacyalcel accordpharmaceutical looks like and contents of the pack ciniacal
jentadueto contains two active substances called linagliptin and metformin . linaglptin belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) metformins belongs to the class of substances called biguanides . they work together to lower blood sugar levels in adult patients with a type of diabetes called ' type 2 diabetes mellitus '. this medicine works by reducing the amount of insulin produced by the body . this medicine can be used alone or with certain other medicines used to treat diabetes ( such as sulphonylureas or emp
do not take jentadueto - if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has severely reduced kidney function . - if he / she has uncontrolled diabetes with severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss . - lactic acidosis ( see section " risk of lacticacidosis "). what is ketoacidosis ? keto acidosis is a condition in which substances called ' ketone bodies ' accumulate in the blood and which can lead
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto should be taken with or without food . if you currently take metformin as individual tablets , or with linagliptin as metformined , do not take this more than once a day . take this this medicine with food . it is best to take this tablet at the same time each day . if an upset stomach occurs , take it at the usual time . the recommended dose is one 5 mg linaglptin tablet once a morning . if your daily dose is 2
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms may be serious and require immediate medical attention . stop taking jentadueto and contact a doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ): trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . hypoglycemia is very rare ( may affect up to 1 in 10 , 000 people ). the most serious side effect reported with jentADueto plus sulphonylurea is when the combination jentadoueto
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store the blister in the original package in order to protect from light . do this medicine if you notice any visible signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . each jentadinueto 2 . 5 mg / 850 mg film - coated tablet contains 2 . 25 mg linaglioptin and 850 mg metformine hydrochlorides . - the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hypromellose , titanium dioxide ( e171 ), talc , propylene glycol . what jentADueto looks like and contents of the pack jentado
edurant contains the active substance rilpivirine . edurant is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children aged 12 years and older who are infected with hiv . edhurant belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). edurants works by reducing the amount of hla - b * 5701 in the body . it is used in combination with hik medicines in adults and adolescents aged 12 and older infected with either hiv or hiv - b - 57
do not take edurant : if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking edurent if you : are taking any of any of these : - the following medicines : carbamazepine , oxcarbazepine ( e . g . phenobarbital ), phenytoin ( medicines used to treat epilepsy and prevent seizures ) - rifampicin , rifapentine ( medicines to treat some bacterial infections such as tuberculosis ) - omeprazole
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults and adolescents ( aged 18 years and over ) the recommended dose of edurant is 1 tablet once a day . do not take more than one tablet once daily . rifabutin is a medicine used to treat some bacterial infections . if you take more edurent than you should if you accidentally take more rifabiutin than you have been told to , contact your doctor . if possible , contact a doctor or the nearest hospital immediately . edurants can
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : headache , nausea , difficulty falling asleep , insomnia , dizziness , or changes in your routine liver tests ( transaminase ), increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your bloodstream ( triglycerides , lipase , bilirub
what edurant contains the active substance is rilpivirine . each tablet contains rilpitivirrine hydrochloride . each film - coated tablet contains 300 mg of ril piviride . the other ingredients are : tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . the film - coating : lactate monohydrate and hypromellose 2910 ( e464 ). tablet coating : 6 mm ( diameter ), titanium dioxide ( e171
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes . people with type 2abetes either don ' t make enough insulin to control their blood sugar levels or don 'T respond normally to insulin their body makes . rosigllitazONE and met formin work together by helping the insulin they make work better . this helps your body make better use of its blood sugar . avandamvet is also used as a sulphonylurea ( a type of diabetes ) in adults .
follow all your doctor ' s instructions carefully . check with your doctor or pharmacist if you are not sure . your doctor will prescribe the right dose for you . your diabetes will be checked regularly by your doctor . do not take avandamet if any of the following apply to you . if you think you may be in danger , talk to your doctor before taking avandamanet : if you have had a heart attack or severe angina if you suffer from heart failure if you had heart failure in the past if you develop severe breathing difficulties if you drink alcohol if you smoke if you know that you have liver disease if you
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is 2 mg rosiglitazone ( equivalent to 1000 mg metformin ). this dose is taken once a day , at least 1 hour apart . if you take more rosigllitazones than you should if you accidentally take too many tablets , contact your doctor . if possible , take your tablets with a glass of water . you can take this dose with or without food . if necessary , you can start taking 1 tablet once a morning
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions to avandamanet may include raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), with difficulty in breathing collapse . if you get any of these symptoms , stop taking avandandamnet and seek medical advice straight away . lactic acidosis ( build up of lacticacid in the blood ( lactic acidsosis is a common side effect in patients taking metformin , especially if they have severe kidney disease ). symptoms of lact acidosis include rapid breathing
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicinal product does not require any special storage conditions . do this if you notice any change in the appearance of the tablets . do you notice that the tablets are coloured or have particles in them ? do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what avandamet contains the active substances are rosiglitazone and metformin . avandamset tablets come in different strengths : 1 mg rosIGlitazon 500 mg metforman ( tablet ) 2 mg roSiglitizone 500 mg ( tablet) metformgin ( tablet ). each 2 mg tablet contains rosigllitazome 1000 mg met formin ( tablet ), and each 4 mg tablet contain rosigslitazione 1000 mg ( tablets ) metformformin ( tablets ). the other ingredients are sodium starch glycollate , hypromellose , microcry
clopidogrel mylan contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrel has been prescribed to you by your doctor because you have a risk of bloodclots ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to athero
do not take clopidogrel mylan 31 if you are allergic to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelmylan . warnings and precautions talk to your doctor or pharmacist before taking any of your medicines : if you think any of this applies to you : if any part of the package is affected , tell
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl mylan ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel mylan contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 " clopideogrel Mylan contains hydrogenatedcastor oil "), polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc , macrogl 3000
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease with low platelet count ( thromboocytopenia ). it is used in a medical procedure to reduce the risk of bleeding . it works by reducing the number of platelets in the blood . platelets are blood cells that help the blood to clot and reduce the chances of bleeding in adults .
do not use doptelet if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using doptelelet if : you have ever had blood clots in the veins or arteries ( which are important for blood cl clots to form ) you have a history of blood clotting ( including cancer ) you are taking the contraceptive birth control pill or hormone replacement therapy you have recently had surgery or are seriously injured 23 you are overweight or have advanced chronic liver disease you are not sure if any of these
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose for your procedure is one 5 mg tablet once a day . your doctor may increase your dose to one 8 mg tablet twice a day depending on your response to doptelet . your dose of doptelets may be increased by 20 mg , 40 mg , 60 mg or 5 mg depending on the severity of your platelet counts . swallow the tablet whole with a glass of water . do not chew or crush the tablet . you should take this tablet at least 10 to 13 hours before your planned
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( may effect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain , swelling bone pain muscle aches and fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaf
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avatormboprag maleate equivalent to 20 mg avatrambopg . - the other ingredients are lactose monohydrate ( see section 2 under ' doptelets contains lactose '), microcrystalline cellulose , crospovidone type b [ e ], silica , colloidal anhydrous , magnesium stearate . - film - coating : vinyl alcohol , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( e172 ).
rapiscan belongs to a group of medicines called ' coronary vasodilators '. it works by blocking the flow of blood through the heart arteries , thus increasing heart rate and helping to relax the muscles of the heart . rapiscan is used for a type of heart scan called ' myocardial perfusion imaging '. the scan contains a radioactive substance called a ' radiopharmaceutical '. these images are taken onto the muscles in the heart using a readmill to measure blood flow . a scan contains only a small amount of radiopharma and is carried out by a healthcare professional . it is injected into the body through a vein
do not take rapiscan if you have slow heart rate , high degree heart block , sinus node disease ( when a pacemaker is not working well ), chest pain ( unstable angina ) or treatment for low blood pressure ( hypotension ) or heart failure if you are allergic to regadenoson or any of the other ingredients of rapiscin ( listed in section 6 ). warnings and precautions talk to your doctor before taking rapiscen if any of these apply to you : if you think you may be at risk of developing a recent serious heart problem , such as a heart attack , or if you develop abnormal heart rhythms
rapiscan will be given to you by a doctor or nurse who is experienced in the treatment of your heart and blood pressure . it will be injected into a vein ( intravenously ) over a period of approximately 400 minutes . a 5 ml solution the injection will be administered over a minimum of 5 minutes . the dose may be adjusted to 10 minutes depending on your weight . your doctor will also give you an injection of sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection ( intravenous ) over the same period of time . the 5 ml vial contains a radioactive substance ( radiopharmaceutical ). the dose
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects usually occur within a few days of the rapiscin injection and usually disappear within 30 days without any treatment . tell your doctor immediately if you notice any of the following side effects : sudden stopping of the heart , which may be due to damage to the heart ( heart block ), a disorder of theheart ' s electrical signal , rapid heart beat low blood pressure , fainting , mini strokes , weakness of the face and inability to speak . rapiscans may cause a stroke or cerebrovascular accident . an allergic reaction
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . viampine is a treatment for adult men with erectile dysfunction or impotence . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking medicines called nitrates , which could lead to a dangerous fall in your blood pressure . if you have recently taken any of these medicines ( for example , angina pectoris or " chest pain "). if you think any of this applies to you , tell your doctor . - if the medicines you are using are nitric oxide donors such as amyl nitrite , which may lead to an increased risk of a dangerous
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 50 mg . viagra film - coated tablets are for oral use . viaga orodispersible tablets are also for oral administration . swallow the tablets whole with a glass of water . viagagra can be taken with or without food . viampicin is for oral treatment . swallow your tablets whole . do not chew or crush them . taking viagra with food viagra will help you to get an erection . if you feel sexually stimulated , you should continue taking viamp
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with viagra are usually mild to moderate . if you experience any of the following side effects while taking viagra : an allergic reaction ( may affect up to 1 in 100 people ): symptoms include sudden wheeziness , difficulty in breathing , dizziness , swelling of the eyelids , face , lips or throat , chest pains and may be life - threatening . if this happens , you may be in a semi - sitting position and you may need to take nitrates to control your chest pain . prolonged and sometimes painful erections (
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildenedafil ( as the citrate salt ). - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and are engraved with the
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamine receptors in the brain . stimulation of the dopamine receptors triggers nerve impulses in thebrain that help to control body movements . sifrol is used to : - treat the symptoms of primary parkinson ' s disease in adults . - in combination with levodopa ( another medicine for parkinson '. sifroll is used : - to treat the symptom of moderate to severe primary restless legs syndrome in adults , adolescents and children over one month of age .
do not take sifrol if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking sifol if you have any medical conditions or symptoms , including kidney disease . hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are visual . dyskinesia ( abnormal , uncontrolled movements of the limbs ). if you suffer from advanced parkinson ' s disease , you may be given levodopa to reduce dyskineia . if you think any of these apply to you , tell
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 tablets taken once a day . during the first week , 1 tablet of sufrol 0 . 088 mg / 0 . 264 mg tablets should be taken once daily . after 1 week , 2 tablets of sofrol 0. 088mg / 0. 264 mg should be used once daily until your symptoms improve . the usual starting dose is two tablets of 1 tablet each day . the starting dose of one tablet of either s
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common : may affect more than 1 in 10 people common : might affect up to 1 in 100 people uncommon : may affects up to1 in 1 , 000 people rare : may effect up to one in 10 , 000 patients with parkinson ' s disease the following side effects have been reported : - dyskinesia ( abnormal , uncontrolled movements of the limbs ), dizziness , nausea ( sickness ), urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg , or 0 . 35 mg , corresponding to 0 . 7 mg pramipxole ( as 0 . 125 mg , 1 mg , 2 mg , 3 mg , 4 mg , 5 mg , 6 mg , 8 mg , 10 mg , 15 mg , 20 mg , 30 mg , 50 mg , 60 mg , 100 mg , and 200 mg pramsipexol ( as 1 mg dihydrochloride monohydrate ). the other ingredients are mannitol , maize starch ,
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . allergic conditions occur when the body produces substances that can affect the eye , such as pollen , milk , or milk . the allergic reaction to allergic conjutivitis may be severe and may be life - threatening . some materials ( allergens ) can cause allergic reactions , such itching , redness or swelling on the surface of your eye . if you notice any of these , tell your doctor immediately . if any of the effects of emadine get worse , tell the doctor or nurse immediately .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is more than 3 years old . warnings and precautions talk to your doctor or pharmacist before using emadin : - if the child is less than 3 months old . benzalkonium chloride is present in emadino in the urine . see section 6 . in clinical trials with emadmine , kidney or liver problems were reported . children and adolescents do not give this medicine to children and young children under the age of 3 years . other medicines and
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use adults use in adults use 3 drops in each eye once a day . always use this tip exactly as described in this leaflet or as your eyes have been instructed . check the box at the end of this leafle to make sure that the dose is right for you . children and adolescents use in children and teenagers use in adolescents and adolescents aged 1 year and above use in infants aged 2 years and above . children aged 1 month and above do not use the emadine bottle if you
like all medicines , this medicine can cause side effects , although not everybody gets them . the effects are usually mild to moderate and will generally disappear after a few weeks . the drops should be used every day . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye and eye redness . uncommon side effects : ( may effect up to1 in 100 people )effects in the back of the eye ( corneal disorder ): abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , corneel staining and dry eye . general side effects
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . the expirment date refers to the last day of that month . do store below 25 . do this to protect from infections . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what emadine contains the active substance is emadastine 0 . 5 mg / ml . the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid , sodium hydroxide to maintain acidity levels and ph levels . what emadrine looks like and contents of the pack emadINE is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop - bottle ) bottle with a screw cap . not all pack sizes may be marketed .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetiratam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy , to treat a certain form of epilepsy . epilepsy is a condition where the patients have repeated fits ( seizures ). levantiracetaman is used for the epilepsy form in which the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the body ( partial onset seizure with or without secondary generalisation ). levevetiracam has
do not take levetiracetam actavis - if you are allergic to levetiraacetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking levetvetir acetam activ - if your child has kidney problems - if there is any slow down in the growth or unexpected puberty development of your child . anti - epileptics should not be used in children and adolescents . levetiralacetamactavis has been associated with thoughts of harming or killing themselves . tell your doctor if your baby
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . levetiracetam actavis is taken twice a day , once in the morning and once inthe evening . monotherapy dose in adults and adolescents from 16 years of age and older : one tablet of 1 , 000 mg to 3 , 000mg once a day . your doctor will tell you the dose of levetiraacetam actingavis to take . the recommended starting dose is 2 tablets once a morning , once a evening , once every two weeks . your dose may be increased to 1 , 500
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor or the nearest emergency department immediately if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms and a rash on the face followed by an extended rash with a high temperature . increased levels of liver enzymes seen in blood tests ( increase in a type of white blood cell ) 56 in patients with eos
what levetiracetam actavis contains the active substance is levetiraacetam . levetaracetamactavis 250 mg : each tablet contains 250 mg of levetoracetam as levetviracetam. leveturacetam actingavis 500 mg : one tablet contains 500 mg of the active ingredient levetmiracetam ( as levantiracetamine actavis ). each 750 mg tablet contains 750 mg of a tablet of leveriracetamate as levevetir acetam . what levetvetiratam actis looks like and contents of the pack 1 , 000 mg film
incruse ellipta contains the active substance umeclidinium bromide which belongs to a group of medicines called bronchodilators . incruse ellipta is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways in the lungs become blocked . this makes breathing difficulties difficult . difficulties in breathing can also result in tightening of the muscles around the airway . this medicine blocks the tightening of these muscles in the air passages , making it easier for air to get in and out of the lungs . this helps to control your
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine : - if your asthma is getting worse . incruruse ellipta should not be used in patients with asthma . - if the patient has heart problems . - tell your doctor if you have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ). - if any of these apply to you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . do not use more than your doctor tells you to use . if you use more incruse ellipta than you should if you have used more incrupse elliptic than you have been told to use , contact your doctor immediately . symptoms of using too much of this medicine may be a sudden attack of breathlessness or wheezing . if this attack occurs , you
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta , stop taking this medicine and seek medical help immediately : itching skin rash , hives and redness 29 common side effects ( may effect up to1 in 10 people ): faster heart beat painful and frequent urination . these may be signs of a urinary tract infection . common cold infection of nose , throat cough , feeling of pressure and pain in the cheeks and forehead . these could be signs for
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the inhalcer in the sealed tray in order to protect from light . after removing the inhaluer from the sealed tray , use within 6 months of removing the lid from the inhalere . do this once a day . after using the inhalER , use the inhal inhaler within 30 . do away with
what incruse ellipta contains - the active substance is umeclidinium bromide . each delivered dose contains 55 micrograms umecylidinia . each dose delivers 65 microgramms umecridinIUM bromides . - the other ingredients are lactose monohydrate ( see section 2 under ' incrusemipta contains lactose '), magnesium stearate . what incrusey ellipta looks like and contents of the pack incrusea ellipta is an inhalation powder . the ellipta inhaler consists of a grey plastic body , a light green mouthpiece cover
what nucala is nucal contains the active substance mepolizumab , which is a monoclonal antibody . this type of protein is designed to recognise and bind to specific proteins in the body . what nucalo is used for nucalya is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils ( a type of white blood cell that helps the lungs breathe ) in patients with eosinaophilic asthma . how nucalan works in asthma nucale is used in adults to prevent asthma attacks and to reduce
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have worsening asthma 58 patients have experienced asthma - related side effects during treatment with nucal . if your asthma does not improve after starting nucalo , your doctor may decide to reduce the dose or stop nucla treatment . allergic and injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions to other parts of your body ( see section 4 possible side
nucala is given under the skin ( subcutaneous injection ). adults and adolescents 12 years of age and older : the recommended dose is 100 mg once a day . use in children and adolescents 1 year of age or older : your doctor will decide the dose that is right for you . the pre - filled pen is for single use only . do not use nucala if you are not sure . duration of treatment with nucal your doctor may decide to continue the treatment with a lower dose . your doctor should decide if nucalo is right to you if your asthma symptoms are worsening or if attacks occur . if your
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur very commonly ( may affect more than 1 in 10 people ) after the injection . sometimes symptoms can be severe . symptoms include chest tightness , cough , difficulty breathing fainting dizziness feeling lightheaded ( this may be a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you have a reaction similar reaction to nucal . other side effects very common side effects
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the carton and on the pre - filled pen after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the nucalo pre -filled pen in the outer carton in order to protect from light . after first opening , use within 7 days . do away with the pre pre - fill pen once you have established the correct storage time . do throw away any medicines via wastewater or household waste . ask your pharmacist how
what nucala contains - the active substance is mepolizumab . each 1 ml vial contains 100 mg of mepolixumab ( as mesilate ). - the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate , water for injections . what nucal looks like and contents of the pack nucalo is supplied as a pack containing 1 vial in a multipack . each pack contains 3 vials of 1 ml .
what ninlaro is ninlar is a cancer medicine that contains the active substance ixazomib , a ' proteasome inhibitor '. what it is used for ninlara is used to treat a cancer of the bone marrow called multiple myeloma . ixezomib works by stopping cell survival and slowing down the number of myelomas cells . it also works by blocking the action of a lot of proteins called proteasomes . what ninlalo is used in adults and children with multiple myelooma , ninlAR is used alone or in combination with lenalidomide or dexameth
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ninlar if any of these apply to you . if you have any of those conditions , please tell your doctor . warnings and symptoms talk to the doctor or nurse before taking this medicine . stop taking ninlanaro and see your doctor immediately if you : - have bleeding , persistent nausea , vomiting , diarrhoea , nerve problems , tingling , numbness , swelling or a persistent rash - have liver or
instructions for use and handling of multiple myeloma are given at the end of this leaflet . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of ninlaro is lenalidomide ( a medicine that contains dexamethasone ). this is an anti - inflammatory medicine . how to take ninlar take lenalidomeide once a day on the same day of the week . for the first 3 weeks , take lenidomide 25 mg once a morning on the first day of each
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ) nose bleeds that are easily bruising nausea , vomiting , diarrhoea numbness or tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet (> peripheral oedema ) skin rash ( itchy , common side effects may affect up to 1 in 1 , 000 people ): severe skin rashes , red to purple bumps ( sweet ' s syndrome ) rash ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and carton after exp . the exp date refers to the last day of that month . do store below 30 . store in the original package in order to protect from moisture . once the capsule has been opened , use this medicinal product immediately . do this medicine only if you notice any damage or signs of tampering to medicine packaging . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ninlaro contains the active substance of ninlar 2 . 3 mg is ixazomib . each capsule contains 2 .3 mg ixizomib and 3 . 3mg ixzomib citrate . the other ingredients are microcrystalline cellulose , magnesium stearate , talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ), shellac , propylene glycol , potassium hydroxide , black iron oxide [ e172 ]. the capsule content contains gelatin, titanium dioxide , blackiron oxide [ i172 ], shellac . the
do not use palforzia if you are allergic to peanuts or arachis hypogaea . warnings and precautions talk to your doctor or pharmacist before using palfORzia . children and adolescents from 4 to 17 years of age should not receive treatment for peanut allergy because the medicine contains traces of peanut ( desensitisation ). palfiorzia is not intended to cause allergic reactions . palfofzia should not be used in children and young people with food allergies . if you have any further questions on the use of palfourzia , ask your doctor , pharmacist or nurse .
do not take palforzia if you are allergic to peanut or soya or any of the other ingredients of palforsia ( listed in section 6 ). if your asthma is getting worse or if you have a problem swallowing . if you suffer from long term problems with your digestive system . if your doctor has told you that you have or have ever had a severe mast cell disorder . if any of these apply to you ( or you are not sure ), talk to your doctor . warnings and precautions talk to you doctor or pharmacist before taking palfORzia . the symptoms of peanut allergy may occur with palf
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and frequency of administration if you have been treated for allergy , allergic reactions ( anaphylaxis ) have been reported in patients receiving palforzia . the recommended dose is 3 mg / kg body weight twice daily . treatment with palfORzia will be started with initial doseescalation . your doctor will gradually increase the dose of these treatment steps . the initial dose escalation and up - dosing steps should be repeated every 3 weeks . your physician will prescribe the right dose for you .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : severe allergic reactions : if you have any of the following symptoms after taking palfORzia , stop taking the medicine and seek medical help immediately : - trouble breathing - throat tightness - feeling offulness - trouble swallowing or speaking - changes in voice - dizziness or fainting - severe stomach cramps , pain , vomiting , diarrhoea , severe flushing or itching of the skin palforsia may cause problems with the stomach and digestive system ( eosin
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any hard lumps of powder or if the solution is discoloured . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what palforzia contains the active substance is palfoforz . each 0 . 5 mg capsule contains 1 , 10 or 20 mg of the active substances . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palfiorzia 100 mg oral powder in capsules with opening microcrycrystallrine cellulose ( e460 ), colloidalanhydroussilica and and magnesium unstearatepalforza 300 mg oralpowder in sachet microcry crystalline celluloses ( e464 ), colloid anhydrated silica , and magnesium
zerne belongs to a group of substances called benzodiazepine - related medicinal products . it is used to induce sleep and to prevent sleeping problems during treatment . it should only be used when you are having treatment for problems sleeping .
do not take zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zerenea sleep apnoea syndrome ( which may occur for short periods ) if you suffer from severe kidney or liver problems if you are suffering from myasthenia gravis ( which causes very weak and tired muscles , severe breathing and chest problems ) if any of these apply to you , tell your doctor . children and adolescents do not give this medicine to children and teenagers under 18 years of age because zeren has not been studied in this age group . the undesirable effects are
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg capsule per day to be taken orally with or without food . if you have difficulty falling asleep , you should take the capsule at least one hour before or one hour after food . use in elderly people ( over 65 years of age ) if you suffer from mild to moderate liver problems , the recommended starting dose is two 5 mg capsules per day . if your doctor determines that you suffer with mild tomoderate liver problems and you take the 5 mg capsule at the same time each
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to 5 users in 1 , 000 ) very rare ( affects less than 1 users in 10 , 000 ). very rare : very rare , affects lessthan 1 user per 10 ,000 . not known ( frequency cannot be estimated from the available data ). very common : may affect
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( i171 ). - the ingredients are gelatin , titanium dioxide , red iron oxide ( e172 ), yellow iron oxide , black iron oxide (< e172 ) and sodium laurel sulphATE ( e133 ), silicon dioxide . ( e433 ). printing ink : shellac , lecith
